var title_f42_13_43216="Moisture chambers PI";
var content_f42_13_43216=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F82900&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F82900&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Moisture chambers",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 304px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Moisture chambers like these attach to a pair of&nbsp;eyeglasses. They help trap moisture and can help&nbsp;relieve the symptoms of dry eye.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_13_43216=[""].join("\n");
var outline_f42_13_43216=null;
var title_f42_13_43217="Large basal cell carcinoma on nose";
var content_f42_13_43217=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F68274&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F68274&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Destructive basal cell carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Large basal cell carcinoma causing destruction of the nose.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_13_43217=[""].join("\n");
var outline_f42_13_43217=null;
var title_f42_13_43218="Sucrose: Pediatric drug information";
var content_f42_13_43218=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Sucrose: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?30/41/31378?source=see_link\">",
"    see \"Sucrose: Drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F13265422\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Sweet-Ease&reg; [OTC];",
"     </li>",
"     <li>",
"      TootSweet&trade; [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F10916300\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Analgesic, Nonopioid",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F12675775\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: 0.1-0.2 mL of 24% solution placed on the tongue or buccal surface 2 minutes prior to procedure; various regimens reported, effective range: 0.05-0.5 mL (maximum dose: 2 mL). For doses &gt;0.1 mL, some studies have administered in aliquots with first dose 2 minutes prior to procedure and remainder of dose given intermittently (typically 3 times) during or after procedure (Johnston, 1999; Stevens, 2010).",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F10916492\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?30/41/31378?source=see_link\">",
"      see \"Sucrose: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: Infants prior to immunization: 2 mL of 24% solution administered 1-2 minutes prior to vaccine administration has been used; others have shown 10 mL of 25% effective in infants receiving their 2-month vaccinations (Reis, 2003). For older infants, higher concentration of solution for analgesic effect: 2 mL of 50% or 75% solution has been shown effective (Harrison, 2010; Shah, 2009)",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F13265444\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Solution, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Sweet-Ease&reg; Preserved: 24% (15 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     TootSweet&trade;: 24% (0.5 mL, 1 mL, 2 mL, 12 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Solution, oral [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Sweet-Ease Natural&reg;: 24% (15 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F13265423\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F10916493\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     For single oral use only. May be administered directly into baby&rsquo;s mouth or via a pacifier dipped into solution. Do not reuse or sterilize; dispose product after use.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F10916464\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at 4&deg;C to 32&deg;C (40&deg;F to 90&deg;F); for some products, concentration may increase (up to 40%) when stored over a 6-month period. Unused portion should be discarded.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F10916302\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Provide short-term analgesia in neonates during minor procedures (eg, heel stick, eye exam for retinopathy of prematurity, circumcision, immunization, venipuncture, ET intubation and suctioning, NG tube insertion, I.M. or subcutaneous injection); provide short-term analgesia in infants during immunization administration",
"    </p>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F13265432\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiovascular: Bradycardia (self-limiting)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Respiratory: Oxygen desaturation or brief apnea in premature neonates (spontaneous resolution)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F10916303\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to sucrose, corn, corn products, or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F10916462\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Efficacy in unstable or extremely low birthweight, premature neonates has not been established.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F10916444\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Patients should have a functioning gastrointestinal tract; avoid use in patients with gastrointestinal tract abnormalities (eg, esophageal atresia or tracheal esophageal fistula); while necrotizing enterocolitis (NEC) has not been reported with sucrose administration, risk:benefit assessment should be considered in patients at high risk for NEC.  Avoid use in patients at risk for aspiration; sucrose should not be used for patients requiring ongoing analgesia. Oxygen desaturation or brief apnea in premature neonates (spontaneous resolution)  has been reported. Concentration of some products has been shown to increase (up to 40%) when stored over a 6-month period.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F10916494\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Heart rate, respiratory rate, pain relief",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F10916465\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Exact mechanism is not known; it has been proposed that sucrose induces endogenous opioid release.",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F10916466\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Maximum effect: 2 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Duration: 3-5 minutes",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Blass EM and Hoffmeyer LB, \"Sucrose as an Analgesic for Newborn Infants,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1991, 87(2):215-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/13/43218/abstract-text/1987534/pubmed\" id=\"1987534\" target=\"_blank\">",
"        1987534",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Harrison D, Stevens B, Bueno M, et al, \"Efficacy of Sweet Solutions for Analgesia in Infants Between 1 and 12 Months of Age: A Systematic Review,\"",
"      <i>",
"       Arch Dis Child",
"      </i>",
"      , 2010, 95(6):406-13.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/13/43218/abstract-text/20463370/pubmed\" id=\"20463370\" target=\"_blank\">",
"        20463370",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Johnston CC, Stremler R, Horton L, et al, \"Effect of Repeated Doses of Sucrose During Heel Stick Procedure in Preterm Neonates,\"",
"      <i>",
"       Biol Neonate",
"      </i>",
"      , 1999, 75(3):160-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/13/43218/abstract-text/9925903/pubmed\" id=\"9925903\" target=\"_blank\">",
"        9925903",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Reis EC, Roth EK, Syphan JL, et al, \"Effective Pain Reduction for Multiple Immunization Injections in Young Infants,\"",
"      <i>",
"       Arch Pediatr Adolesc Med",
"      </i>",
"      , 2003, 157(11):1115-20.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/13/43218/abstract-text/14609903/pubmed\" id=\"14609903\" target=\"_blank\">",
"        14609903",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Shah V, Taddio A, Rieder MJ, et al, \"Effectiveness and Tolerability of Pharmacologic and Combined Interventions for Reducing Injection Pain During Routine Childhood Immunizations: Systematic Review and Meta-Analyses,\"",
"      <i>",
"       Clin Ther",
"      </i>",
"      , 2009, 31(Suppl 2):S104-51.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/13/43218/abstract-text/19781433/pubmed\" id=\"19781433\" target=\"_blank\">",
"        19781433",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Stevens B, Yamada J, and Ohlsson A, \"Sucrose for Analgesia in Newborn Infants Undergoing Painful Procedures,\"",
"      <i>",
"       Cochrane Database Syst Rev",
"      </i>",
"      , 2010, (1):CD001069.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/13/43218/abstract-text/20091512/pubmed\" id=\"20091512\" target=\"_blank\">",
"        20091512",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16103 Version 16.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-201.211.0.116-790B5E06CF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_13_43218=[""].join("\n");
var outline_f42_13_43218=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13265422\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10916300\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12675775\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10916492\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13265444\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13265423\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10916493\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10916464\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10916302\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13265432\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10916303\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10916462\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10916444\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10916494\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10916465\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10916466\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/16103\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/16103|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?30/41/31378?source=related_link\">",
"      Sucrose: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_13_43219="Metyrapone: Pediatric drug information";
var content_f42_13_43219=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Metyrapone: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?15/12/15556?source=see_link\">",
"    see \"Metyrapone: Drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F12806507\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Metopirone&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1060385\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Diagnostic Agent, Hypothalamic-Pituitary ACTH Function",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1060379\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?15/12/15556?source=see_link\">",
"      see \"Metyrapone: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      ACTH function, diagnostic test:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Single-dose/overnight test: Children and Adults: 30 mg/kg as a single dose (maximum dose: 3000 mg) given at midnight the night before the test",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Multiple-dose test:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children: 15 mg/kg/dose every 4 hours for 6 doses; minimum dose: 250 mg; maximum dose: 750 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: 750 mg every 4 hours for 6 doses",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F195988\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Metopirone&reg;: 250 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F195977\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block accres drugH1Div\" id=\"F11345045\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Prescribing and Access Restrictions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Metopirone&reg; is available from Novartis Pharmaceuticals via special allocation only. Contact the manufacturer for additional information at 888-669-6682.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1060389\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: May administer with food or milk to reduce GI irritation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Single-dose/overnight test: Administer dose at midnight with yogurt or milk.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multiple-dose test: Administer with milk or snack 2 days following ACTH test.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1060382\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at &le;30&deg;C (86&deg;F); protect from heat and moisture.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1060388\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Diagnostic agent for testing hypothalamic-pituitary ACTH function [FDA approved in pediatric patients (age not specified) and adults]",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F196020\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Metyrapone may be confused with metyrosine",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F196019\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Hypotension",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Dizziness, headache, sedation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Allergic rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal discomfort or pain, nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Bone marrow suppression (rare), white blood cell count decreased (rare)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1060393\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to metyrapone or any component; adrenal cortical insufficiency",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1060378\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Response to test may be subnormal in patients with hypo- or hyperthyroidism. Prior to use of metapyrone, the ability of the patient&rsquo;s adrenal glands to respond to exogenous ACTH should be demonstrated. Metyrapone may cause dizziness and sedation which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1060377\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     All corticosteroid therapy should be discontinued prior to and during the metyrapone test; administration of metyrapone may induce acute adrenal insufficiency in patients with reduced adrenal secretory capacity; patients with suspected adrenocortical insufficiency should be observed closely over 24 hours",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F196012\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP2A6 (weak);",
"     <b>",
"      Induces",
"     </b>",
"     CYP3A4 (weak/moderate)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F195983\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetaminophen: Metyrapone may increase the serum concentration of Acetaminophen. More importantly, by inhibiting the conjugative metabolism of acetaminophen, metyrapone may shift the metabolism towards the oxidative route that produces a hepatotoxic metabolite.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inducers may decrease the serum concentration of ARIPiprazole.  Management: Double the oral aripiprazole dose and closely monitor clinical response.  Reduce the oral aripiprazole dose to 10-15 mg/day if the inducer is discontinued. Avoid use of CYP3A4 inducers for more than 14 days with extended-release injectable aripiprazole.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Axitinib: CYP3A4 Inducers (Weakly to Moderately Effective) may decrease the serum concentration of Axitinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: May decrease the serum concentration of Metyrapone. The oral metyrapone test would thus be unreliable unless the metapyrone dosage was substantially increased (e.g., 750 mg every 2 hours).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: May decrease the serum concentration of Metyrapone. The oral metyrapone test would thus be unreliable unless the metapyrone dosage was substantially increased (e.g., 750 mg every 2 hours).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Saxagliptin: CYP3A4 Inducers may decrease the serum concentration of Saxagliptin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F195985\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F195992\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted. Subnormal response may occur in pregnant women and the fetal pituitary may be affected.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F14787784\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Urinary 17-OHCS; urinary 17-KGS; plasma 11-deoxycortisol",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Single-dose/overnight test: Blood samples are taken the following morning (7:30-8:00 am).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multiple-dose test: Urine is collected for 24 hours following the last day of administration.",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F1060387\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Normal 24-hour urinary excretion of 17-OHCS: 3-12 mg (increases following ACTH infusion)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Normal response to metyrapone:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Plasma ACTH: 44 pmol/L (200 ng/L)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Plasma 11-desoxycortisol: 0.2 micromoles/L (70 mcg/L)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     24 hour urinary excretion of 17-OHCS: 2-4 time increase",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     24 hour urinary excretion of 17-KGS: 2 time increase",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     A subnormal response may be indicative of panhypopituitarism or partial hypopituitarism. An excessive response is suggestive of Cushing's syndrome associated with adrenal hyperplasia.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1060376\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reduces cortisol and corticosterone production by inhibition of 11-beta-hydroxylation of precursors in the adrenal cortex. Continued inhibition stimulates increased ACTH production by the pituitary; increased precursor levels have a weak suppressive activity on ACTH release. Elevated levels of precursor metabolites [17-hydroxycorticosteroids (17-OHCS) or 17-ketogenic steroids (17-KGS)] appear in the urine which can easily serve as an index of pituitary ACTH responsiveness. Production of aldosterone may also be suppressed by metyrapone. The adrenal cortex must have the ability to respond to ACTH before metyrapone is employed to test the capacity of the pituitary to respond to a decreased concentration of plasma cortisol.",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1060391\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Maximum effect: Peak excretion of steroid during the first 24 hours after administration",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1060392\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Well absorbed; rapid",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Reduced to metyrapol (active metabolite); parent drug and metabolite also undergo glucuronide conjugation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life, elimination:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Metyrapone: 1.9 &plusmn; 0.7 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Metyrapol (active metabolite): Takes twice as long as metyrapone to be eliminated",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: 1 hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Urine; ~5% as metyrapone (primarily as glucuronide conjugate) and ~38% as metyrapol (primarily as glucuronide conjugate)",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1060384\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Arise slowly from prolonged sitting or lying position; may cause drowsiness and impair ability to perform activities requiring mental alertness or physical coordination",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12607 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-110.137.129.113-2110654F66-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_13_43219=[""].join("\n");
var outline_f42_13_43219=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12806507\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060385\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060379\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F195988\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F195977\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11345045\">",
"      Prescribing and Access Restrictions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060389\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060382\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060388\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196020\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196019\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060393\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060378\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060377\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196012\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F195983\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F195985\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F195992\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14787784\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060387\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060376\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060391\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060392\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060384\">",
"      Patient Information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12607\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12607|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?15/12/15556?source=related_link\">",
"      Metyrapone: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_13_43220="Prednisolone (ophthalmic): Patient drug information";
var content_f42_13_43220=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Prednisolone (ophthalmic): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?30/0/30723?source=see_link\">",
"     see \"Prednisolone (ophthalmic): Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?36/49/37650?source=see_link\">",
"     see \"Prednisolone (ophthalmic): Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F9505541\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Omnipred&trade;;",
"     </li>",
"     <li>",
"      Pred Forte&reg;;",
"     </li>",
"     <li>",
"      Pred Mild&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F9505548\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Diopred&reg;;",
"     </li>",
"     <li>",
"      Ophtho-Tate&reg;;",
"     </li>",
"     <li>",
"      Pred Forte&reg;;",
"     </li>",
"     <li>",
"      Pred Mild&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10024520\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691836",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat eye swelling.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10024519\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to prednisolone or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705252",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a very bad eye infection.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10024524\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10024525\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698333",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Short-term pain after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697932",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cataracts or glaucoma with long-term use.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10024527\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10024522\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694913",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For the eye only.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695632",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shake suspension well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695783",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take out contact lenses before using this drug. Lenses may be put back in 15 minutes after this drug is given. Do not put contacts back in if your eyes are irritated or infected.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not touch the container tip to the eye, lid, or other skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696124",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tilt your head back and drop drug into the eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694401",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       After use, keep your eyes closed. Put pressure on the inside corner of the eye. Do this for 1 to 2 minutes. This keeps the drug in your eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Space each eye drug by 5 minutes.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10024523\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696583",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10024528\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699383",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store eye solution and suspension at room temperature. Do not freeze.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10024529\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12297 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.55.141.10-3C5F28D7A6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_13_43220=[""].join("\n");
var outline_f42_13_43220=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9505541\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9505548\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024520\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024519\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024524\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024525\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024527\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024522\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024523\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024528\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024529\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?30/0/30723?source=related_link\">",
"      Prednisolone (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?36/49/37650?source=related_link\">",
"      Prednisolone (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?39/27/40376?source=related_link\">",
"      Prednisolone (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?29/12/29894?source=related_link\">",
"      Prednisolone (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?1/54/1896?source=related_link\">",
"      Prednisolone (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_13_43221="Sweet syndrome vesicles";
var content_f42_13_43221=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F50526&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F50526&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Sweet syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF6AfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDyVSdvDn/GiKIStiWmZ+X1x6VNEpk2CNTuJ7dayi7bnoPVA1snnfIcL3zQ6xpIWI6DArYj0zCbm3Fj2qeDSVklVZQB3xUTkug0jnN8pCqkRI6cd6e1rNgFoiMciu4XSYEG4FRio5Uhj5faR2FYc77FpI4d7eXBYoR61EFEZJZc89xXWz3NioIZkrFu7vTvMwgOT/dHFVzMDEuD8u5Ay4P8NT2zsY/mOdoyQaLiSIqRCGJb1FJCIChV1dXIxwetWldaj5rFoMrIMnaP504GPODzg9hVAxmUjlgF6jNW47wqgQRIHzwR6VHLFbsXMTSFWX5WBPtRkgJsA+hPNVikjSNI+Tjt049aTy8hcZ6cnOaOVdRuTHXM4VcY+ZvTpSi4VoxGNyOB0ToaEh3HBKrjuxpnlbCeBgelUmlsJ3loyNZnRjsB+hNMSV5hIvlFpDwNtWVhU4I3E9asQF7fJj+T1x1pKY7MzzbzJt3xsi+op+24APz5APTvV/Dk7n+YHoWORTGUht24Hsabmg5Sh9n3uu+ULnqSM4pUtwAMckD0rUgt1dgy4YY+61Plt4zGUCCPH8RzSu2gsZbdAoOc00wHPzBiK041WHMarvY8cd/pRsli5MZAPQMeanW1yrFNLaMDLI+RwOOKcluAx+UDI5zVhYzK25m8oewyc1N5Me75ycjuB/Ok9NR2M8wKZASTg9BU1vbK0hEny+zCrvliJgUwc9P/ANVOkXzBuLZwDz0pXQ7FVYFT5UbaB1+brSCEZHQjHyjFWo4Akf8ArFPGaY0UhKknpyMUr3GkVRGd4OAWHTJp6xOZMnAX0PSrLRLuGVPPvSBlWQ4+YdMGlogtcpPBu+cQuyjI3AcZpsduA5Iyi46E96vlzux8yhuw4FNEe4k9RjuelDaBIz34lyq5J/GopobstlYJMf3lHH41pmLAYKv6UMkigDzXCkc46VpBx6ial0M91mjcKeT1I9KkVSHIyOe1TtGq4Acsc5AI5NP3xsSGCjHr2pS8hpEQjY8fcJ9qfsOVDk57n1qWMA7+SR1wOBT1VAuZFJPselZX1KK7jByAWJ7LSIHGVY/KPuirK/6tVUjgnB601oNxG0nOetAELI2A+5Qc4xjkUBQ4wX/dnkj1qxJbloyVY5B7moUiw4XILHtjpTsA0usbYDDr3FJl+rEgDtirHk75Tu+XHNSgICWyTgcH1pq3UZR8gOoJ3AH86k8pdu7oOmM1Mhxu3DJ7d8VMyI7KDwP93ioYFPygNwck+mBSIhHIiAToM960GjjUHIA9T6U0xvLwoCgHIz3pDKyxFzkKScHqeKVYD5eCdhHBIPT61YMDE/OxUDkDPelMKKu5QxJ+9k9apK2giso8tAPl3dN3rUM8BPzy5YDgL2JqRg00m2IouDwaAJYJyrne36U+VpXFoxGtXMYUBV47DGKbBp8AAZiXI67upPrV+Mu4wBj1yKaPnh3ALtyQAT1pqox8pn+SgkxtXGeKteQrEbSAc9B6Vb3ZhAHlgHkVFKRJxGMAgdKlu4wW2XaNuMj1PH50yWFlwHUFiMcClMJlwqsykcntzU6IFQef8zg8HdSEUbaCNQxkLBs9cZwKbeWsQYGNmKdm6ZrTeP5do3fN1AqMpHsx1AycGr59Atrczwm3hl3Drz3oq9JAGjIUAL2XNFTZPUZl28ZlO9yEU961ra5s9Njwq+dMw471llGCrnkNzj6UkcY4aMFWP6Cu7Q4bXLR1W6huA4ZirDOxx0on1m5aUyQlY2x2FVFD71O4nqM9eKlig3Z2g5Hapb1HawSajeSnLXBORzjiqkrSzN9+RsdTmrDq5LZRQy8fQVcgtYgu+S4YA/wgYNEYt6DbsY3ljpk5PXNR7diDd0Hf0rcuoPKXZEsbo/G5uTVJLQKu/rg7SuOD70OOu4JlRI3fBSMuR2AxUqaddsqybNgPIJOOlabSnGwAIo9Byaa8krER7x7c8Ch8q3BJsyREy4Eg+bqTUyg4XA53ZBx1q+IFbDSZDEYOPSmIoUuGHyDgHNZu3Q0SK5RgQzkso9ODT0i3rwOD6jpU6RCRgCSvv7UvkIs+wOSnXg0raXHYihtxubLIB704QOxUPjax4PrVmOFWbLBirdMDtVmW2Ec8ZBw2M47Ck27Atyi9pggRgDPc80sqZiA25XoSO5q6eWG4Y3enemoAWZGGB6EcfhWbLRVjC5UhcIOgxwafsLuykDPoBU/llydzFFXjGOtPMESsFikkDdDkUAVo4lBOcjI4waGSTzOHZwR36VYMCtIxc42+gwCasQthcbmwfvYXj2ovYLFHaeoCjOOVHQVJsVSu3LEjgHmpHJG5vMOR6DAoySVHU49cYprsBX8slmAAD56H1phtpyQSmccHAq8uFP8AE2fUd6cGbZzmPPBHrSGUniIK7sAt/dpfIQHCk+pHc+1WyrEkgg7ePl6GlcAqGG1GIxzyTQOxVMfzch+emT0p32aaRcxtk9AKsRxux27AQBnNPuIyiApkZ6letK7QWKjxMqYlRQO+c5qPZGoxjODyR6VNJejcfOySMdulSqglY+UQdwzu9aNdwsU3iRiuBlgc88YFSPAGI2uxYDBwKsPGBIobO7HJI4qUZOMMdvoBgUgKMsDQrhhx781CYN6E5xu6DFaTZzksQM8HFQygkljkqe6r0oQWM9bZo1II+cjg1VNqm0s+SzdOOK1RsJ2oCdv61YeOKRQdgU4+7ngVoqmlieVXM+O1CINr7l71PGkbLtYbQeGpwVUbI7dABxQ74wWChh3Ws99iyN7eNH/dHAXr707ylzgBgBzkU0NGmc+ZuYcMe9WEBZ+BwQORnik7gVw0SBskg9gwpibWclQuemamkRA5WQllP60z7OqEFVCfjVWEOlzsDYBwMD1qKRY+Mvgnt6VYRVdslwhHHHSnrHEFf5S+c4NLrqMofZFLKRjHrmrEcfVATx2zT9ihQSuAD9amSSGNvljDHPOaqzAEhQqyFsevenxfIIyPmPfPY0R4YkL8uT3PGadCWYkbhge1R1AYUkPzFQNvYmo5oT8uAAO/tU0hAdVK/L7HrTJC7sNgwg4NFrgVpURCCikg9SRjNASRrjJVAmM4yf1q8sR43ttYfwmpovMCgNtK9u1NyvuFiiqNGokwNp4OB0oVI9wSPDY/vcYq7hWiJdFJJzjNIqo6q3IPQAipGVVtdi/NtxnqOlSPGhUELwBz60+RV2szkYUZHHH5UgIba27JAx60X1CxS8s5OA249u1POdyCVRg9iKvI6MD/AAt2xUflEz5eLgjGM809gIYl+c+X933HWhUZP4GU/pUxjMXG4/j2pS6vgEgvjp2qdhldcDI+8T1zRVlY1dimUD9QAeKKBWMJlVcL5o6nFO2oQCmRnqT/ACqdYtrBSuQTxg80uw+ZlVwMDv0rtuzktYqFGWIqM56CrFuGiX5RhjxmnKoRcEsxzg4HUUrMoUFQAMHOfT0pKWo7FfarSMWYbh3p4ASTcQWOMZNS9SWZcL2PeiBGk+U8LnHJ61LbKSGCIbRknJ7nvUm0BGzIuBxjpmpWgx3Hy8E5702dCuAQGAHBBqbjsQNGSwOQCeMntTkjWMjDEntgVIiDCrwSxzjqeKRYg8hEjFFHbrzTuMi2tIDj5yOAaesPzBZD8uOVx1qzyjZUAr0AH86mhRSWMQxng5PIpJhZlOSIKvyElfftmgQso5A3YwO1X4ozsYlML69TUcylhujbdxgZ9am47FeIuQqg4PUkDtT02F90rFh29/WrIg8uFSwLFuuOmaYLd4jtwp8zrlc04+YWGsq5D/LjtjrimPhiwVO3TNTlW2qoIweyipDAwRgijLLxnqMVL3KSsUo48H95EC2Mjk8VOqrtDKfmHAC9/c09bdlCs7Zycbs5/CnoDHGI26H+6Af1pMCuAGk2/Lxzz1PvTkUB8gjGMDBqz5JLK2zkDoP60ND8u0LkZ6gYz+NAylMpfG8nAHQcmqqHdOEgwCTnLngfiavEoilSVK/3SMYoaIXFm0JSMKQcjFa04Ju7IlJroVIGSSYxxXCyXJ+bA71ajWZpz5u0kHuen4Vl2+nLasChdinI+XkH03da2rYPN93aMDhsda0koImLl1G425UZ69zgZpkUaFgVBIB6nvUjwqrDzZATjnApv2uJUAjQN256k+1YNX2Nbjyv73OWKDqo5xUksMky/KVVccjuKhiuCW2FNhI5zxzV2FgSfl+ZeCSetJpoDOFtamJztdWBwB1z9TU9pbiHLFgueq+lWpLdMZw7g9VHenbdvyKrIDzkc/nTlLmCxRnZo2ZR8+eQcUiuYxlivPByf5VdcMW/d7jj9afNbiWMF9isp+uKjRjM0XAJAYFgDnNPKoY8qSVPbPH5VrxxqwSIrkYPyqBnFQuiI5Vd6gngHkkU9OgFBIYiEAVAemGOSaDHBEMeYck42+laKQoQOjHpnuKbIq5CuqOvoeoNDlcDOkibdhgQMZyBkU1kBK42+xq9MvzhgNq44/wNMZEwMr9cDkUkwKM9pvXluB6ChbdgWBdsADheatFJfMBJGzHQcEUojkIJU7VPbPSiTuBREQ6sGKjrjjBpXUMoIG70IFXEDn7uNv55pjRBQAGYhsll6YPtUgVUCt8oyGI4wKfAA43HPBwafGrLEQ0gXHPTNKxjCkplTnlzxmrSVgESKM7t5Ix074oSJDMxYFeOGx1pUuI1YlGXf05707c4XLOGLHI75pMB21EBCNznrilcb2VkHQYOO/uaiWQJkMV+tPwWO8sOTgj1pO+4DliSQ71O7HQnp+VEiBXjC4YE5OTxUd062/3jtZewPAqmt1uJxEZAORxyaEmxmi+NpdgDz3GafEozlFyDzj0qpDcrMo/dgN3x/T0p6hhGfMO5G49D+dHKBI6qGCurKD/F2P1pSsaKu1Bx0OeaikuFiRo3JKdQCc1QN+T8vy/KcZPU+1CjzbCvY0WkBOeF9qmk8tpQ+1UyACkY4PHWsiCYyN5hCyIDgc4OfpWmnEeDxnuR0oacStBDGHZljj2LnjNMeAAmQodwOA2c5qdXMigBjt/2eKk8vdINwG0DqecVN7AV8B+C5B9BSBecElSDnO3tU/JY7Q21RyOKViRkDB77SOgoAijIClNgXHO4Dk0VKX81doXLDqCMYooAyFEjDjHy8ZPSkZHZlBfB46VKAFBQHluQDT3RGQFWO7ue1dTOZEPlgFgWwx+YMTjFNYosZygZj0OKdwz45wD2FSOBjn+HkD2prQLEXkRFQxZyD2AFMVVVMg4X37GpWSPbuIAzzyOaVzH5SA5UD1HJpO17FAqKzbjj86Cp3fIpwB3pFilGWSBjCvVqstCrRF1BJHHzdqnltuUVgqxBSxG8nmpXUE8k7Scg9h9ame1RlDb8OBnAPFNj8sgMVJB754qNQGYzgYIwep/pTkAkO0llABYcdPrU5CxkMULE9GxzTtjFCXKljwcUDGR5RQMtvOOAO1OyqKxwAf8AdqTy8SquQO+S3NDLJtfgEk8E8mgCvJuTpnBx9anKNG24ncDwqkc1LFkSNvPTuO1DlBMu5CNuOc9TQIqx+UrBmX5jxuxyKVpsgOOgOFNWJWDMw2dPmG0daYpaGLLADPTHOacVfcpCwuJE2CLcDyc9BTHVh8uwYHHHrU8BXJDbwPr1oZhkYwPxzUtWERRscBZAww3UHrTGkYfPtL8nGegq8yomwkEE9yaRWBiAwCc5wTz+QpjMxbSR5EdmbfjuOKtiIR9JipPovUfWpZI5mOVIUHgHHNTQw4AL7iB3K0cz3AgSHykZh8ue5HWlZEhTGxAD3U5OT7VNKQjfMdyf3QOTSpHMzY8rnqCQKd29QsYrRxyyHzFdYw3Qnk+1TJpsHlSXMoSPJwiiTkVburXLGTgtnIHWmSQ71KMxQHsema2jNIiUWyiuI3B3DHclulW47mJ4gM5PTA6N70kdunmgS8oOD9KtXcFswRrW2EKDsWyxpS1VykrEBEm0AKDk8D2pTE2AuVxnG33q5bKwX5i3PQY7fWiSaNGZmIQkfTFYooQxqkSCN244IY9D7U1GUIw3DKnnjNPhSNyzqVcrzjOan8gMN5cbjxjHB+tS99AKwy5Up8jHpgdakiDqp8zZ83tzUm1kdMYwOSQOBUU88iMyohyRyVHSlqAsqLvUDucnA7UMqoW+UccgkUsDPsUkfX1NPcorl3XCdRk9aQytJIuWyuMdMj9abMRuZkYhemdv3qsTyPPt2BQD0wKR0MhAfcu3uBQKxV27snCMpwARUckrAhViGAc7s4FWhF5cmNwbHPTBFStCCgGQTnPIqklcZnRASLgkFs9P/r1KV+dl3MhHc9KWeEMmVOHB9aki39fvAjB9M0MRA28MCqqwxjC81RvEc5cgr6CtI7YnJj6njaDnBpTbq4+8d3U7gKE7O47FC20iK5tZZRPb7oxkq74LfQd6z1tXMmyJGZiOOfu/lWytuChZhkk+lR2xlsrhJosGQHjB4Arbni3qZ8rWxly6fNb7Hk3JvHykjg+31qa1BbiRSGHQtWvcy3VxD5LrmMPuGexqqlq24lv50qnK9IlQT+0UbqFpnO3ce249K0pYtPhsojA0n2xMFmwcOfQemKlFs25cZ46ZqZ1YJ5bOnPOQM/hShUsrBKN2ZkIaS4eWROv8Qp0gOCwOewB/pVsRN5e7Iz6+tCIMh8Ej+IYzUPV3ZSKktuWtV/0cLhs9cEmsu8tPOEaklQnO1R8v/wCuuikjDuSquAefmpJI8OCyGMds96FV5dhOKe5nW1rJ9lEZiUqBhcjBFWYkIRRlNw45FT+SZWIYNnrkdqeYR2wxXqTUzqORSikZ8qXPmmJApC4JzwBVpCWG5iAw4znqamKA7i0eR3201Yx/dII9ulJtWAhcKJAVIHuc4/CnlHdxtZdpNOmXcW34wvT5cVQmu8YCJ8g+UketJJgWjbEgOjjzBwcnr7UVElymCSF5xtAFFMCjIwkba3yL69aeUUJhCSvrRISRwMjOeOlIZcjOGUdQCMV1HOLI+xCIxuz1OOlRYXZvZgG9jximXEpAZY15IGP/AK9LA9sgWS8LOAM7Qcce5q1Tb2JcrbkbXaAnHPapBdI+BhNoHAYUyO5TULt0tYoosHGzByv1J7Ulxa+W4AG78ep+lP2dhKoi5DKzqAv3QO/TNWHlVWCKCd3pWfaoojJLEMpxtPp61pLEAq7F3DqWrKS7mqdxojcS5fLJ1IHYUnknzT5ZwCMkY4NWvmJY7eQAORgYqvNIqKY0XLE87ei+3vWYxXhbcASQFH3c8fWpImPyrGmUzznoabAVIX52GBgmpUyG98fQZpBqAYGXouAOSB+lNhHLCNgSx7ntUpDbiFwc8nio5blAxTcqqMfMBjJ9Kq3YdyXswdeDwSP50jY2klwvOCMVUmuFkwwxtBxgDlquwln8v7pcnP09KVrAQOA4LHgBeetTRQqlupDFjjn2ouSBv35bb94Z/rVd70jiEk54BPb6Va8guT8Kkm5lZyOBjpSxKdpO0bmA59KoxToJGCtuLcH5uf8A61S2twC+ANqE4x97BpODFzFpYnfBQhQQTzyTSRxsuYwGBHO9uo+lRyTgOdg2le4q3aOzkiV2JPqP6UmmkUh8JRSAzZK9N3UmppE85k3sqY5PPGaeArhNgAAPLMMZp80fmABUYsD2HWouMgmTeFKsm339qUqzFTuGT05xUgRwztNI2F5AxjFRB9zkgtnrjGTRfSwDhEyqUj5frkGo2gLhS7BiccZ4B96eIZQd0TbP7wIpzR7XG4yBWzjnAJ9aGwGpbpvb92Mk53Z6VHLEdoHzMxPQcn86sxyKy9HY8jBHX8adCzvFlN8RPBA7immMqMQrRhgw78Lg1VltRNcdQR/Fk4J/wrVcFSEjc7T82AP600rkhQsfPXJxmmpJaiKAihhvSLe2aNMdS2atBWSdTGBg+varErqu0ZUHoMCh1yoLYK9ip61MnfUBsscrgbE3lckjGBUcZ/dlCgTJxwtP8xWJRGZSPvc5yKXcYWIkwqAcKB+uakaFaNdh2BuOd2KryAtIo25bH8WMVbBWSPCnAPvTZFOSQVbaMbgKVxlKD5nO3+E9AvWnqMSZHY8girCMHHA5zjpUWVjuAqxk8ZyaLAPZQWO3A7EnuKjVVZivmENn65p84yw5LHOdo7UwYjwSm057CgCrd7UyPLGe5APFEcJC7kBbI9aulpNxjjIBPt1qE9DtAGOBkc5piK0gAYKoJUAZOP8AOakC4YZzjp0p6nczF88fgDUhUkh0GCeCSeKQysQCpAVQDk+1NVI3jIcMWHGCM4qcoHVgTjceoGKRIUjIO7OOueM0XtsJCIFxgbTjpjjNK+3ncFwP7vOKRpVkcYYhM9T0BoRQ7MF+ZvY0NtDE2oCAAePfk1Gx4+VSFB4wOtTAbQF24x6jmmyKGIUAgEd+PxoTAiSYbWyFLtwCe1Sryh24AYfwD+dQRIchj8zY5x3q4EwQUUhyMkUXAgPCYVskDgc8fjT/ACpAA5wzEc5oQIFwAwOepFO2qz5GVIHIOc0gImG0KX3Fj6tims7gcMyjuCODUko2fLljnq3Uj8aRQNhLbWPcn+KgCMygSAkj0DDjNLgmIOGIVjxjnH1pxRJh8pTIPfAA/CkCGRQJWYgcDBAxTsrAytOA0e1AXbp6c1HHFbG08p7ZvPP/AC1DZOfp0FXogisdqkkHAz6U442noHHTjIxThNx2BpGXbWyiQmUuePungUU+5mZMDY2SehNFP3nrYZGykqQXPPYDGKoTyAkjv+laRkJ4X7mcZx+dVJ4t8pKLkLxgn+ddEd9TmZWjyoZy+T6HpWdP8yIJFIeXO1R1IHfJrUSI5y2SOcHsfpUcdhHPMjsyrgYYNk4FdMGtmYyTEttPtrdIla8i81huCp87DPZsdKtXkBLiNCxCABmY+taMk8alUtLe3ATgYUKD7n3rORfMmfb+8cnJG7H0pzcdkEIvdk0mitb2qTCeGQOMlUblR7iprbayhWyMAHgU2KBw7+eATjgLzj2qeC3V0TClBjBYHOa5qjXQ3gmlqPmYkNtOAeckdqhswWBDlgAc7e1WWtlQgAgqeAxOMfhTmtwHRiwK4IBB5rO5ohobcOFAwM9OaX5sjZgL3J7+1K7soOF3ZxuIIGBSCR3JwrE9MqeMVNtQGSRlQZMnpnBIqlFaxXMoSeR0CruYIM59BV6WSJGw+Wx6+tNUIcHLn0ABwfxrSL5SWrjY7VFmk8jzNuOAxH61PPKqY2gKw+8e34Urt5WGABHY9qpXeCG+UmPI3Gj42LZFG5eSSQtvwOo44NYGr3c6Ws1wp3FBlR2/Kt2/KxuhUEIP7vbPTNZzwK05TBJI6YyT7AV0xgkjFy1MfRL6S9yDE6uqgmRDnce/0roYL90k8ic7o1wF3cZP1q/o/hu5jnFzBZeZbwHdOWB8pc/3iO9VZ0S+vGj8pI5UyAU6Nz1onHqUpJvQvRhigCREAfNlTnP1rVs0xHiZm3EcYqkrPb/uowcnCsW9frV9FcxlcqeABg81jNaFxZaiKxqVLKARkgHmpbdvkByVQ9+9V4LZSSJl+Yj5CD0Per8kYGAd2UHVjwK5nE1K5/1hVD8uert1NPSMoRluT15/rTmUKx+Ylj/s9Kfs6bipwd2KnYBYkYIwjKsOm1cHioPKO4NIpJ9AOBVyNVCqEySwOcDA/OopldWdERRkcDJH5+tPcdrkYJTKxgtngY7fjUjIvlsHLDac8nlqjt4yAynr0zT2EkYJQghOWJOaAsMjmBUKeMDsabuXYUZSQPm5PSqd04hBZiD3IYfyqBHeQblHC96ai2IvyIjsCR8vp7VVlu4EHlx8kD1xip0wM7lAI7qf0rJuInaWU7CWOB9AacY3dmNiPf4chFBB6gdKRbuadsZI6cKCc1p6DoljdrI99dvAFbbhYizfX6VLqOmWcMiGxeQpgbvMOCTjnAFbulZXIVRN2RDa7wyhVC98sw5q22FDAqdrfxD+VVYY0ilBRSrfX9KvwOob5Qx7c8gVzTVmaWIVQBchWUA5AJOSKWbl1UBlOehPWp5XVUA3KDnn2pm8NGflDkflUgM+UZC/eHX0+lRyEbPmZgpzwBSs4VmUccckHpTk3YORnb0bFAFaHdNbhVAIJxxw2Ki8soNoLIqcnkk5qzFNiQjemenHGKlMiYVgQwPcdKfNYCgWOBv3E9TgdakimJGSMA8YzjirO4gEjPfPNRy7HTcDwO2OtDsBCzMvRVAPfOcU/YjxrgbgeSOvNNzmLMeM/wC3yKdGj4UBtgIyccCjcBsrKUVTkDjjA4p4Rs/f+XqR0zQpVJWxkFP7y9aWSVJZBsAU5ycUnoCGuRtwqgjIB3f40jBA6gnCkZ+9wKdcrvJaMMEJyMnPFQ5cqGEe7HTPSgB+REuFztzjg5zUBmAfI5Oe570qxhmAZC0g7Z6VO0SqRuBB647fnQAib8ANxk5+U81I5Zh8x+XPY4quJFUEbstnPBIxTWlTfly209AATj60WAWd13HbnI9W4FRSASqSTHtB6ZJJ/wAKZKyndgSGNvTvT7ciKIiSIsWHG5cZqrW1AdFbkMxQKigZ9cGpEy2OVcnqaERGUg/IvUDFOZ3QdOMeo/lUPUb1GmIkkk7m9Oo/Okfg4Knpk/4UqmWRf4gFNIcu5DgkDkc9aEIzLoqrjePn745oqyiMk+NuQ3Xd1BorZWtqF2VI0QMVjLAkc47VItqpDhSrY96eATsCqqnBDYOT9aUlY0G6RWyQNo6/iasxsQNbLLKhkVgADwD/ACpfsAwgVXGTwAev1q0P3RBjUDsMHOPpUpjfZuaQDA428mnz2Fa5U+zJkj7pPDbfahI1TDx4xuJwFOfzp6yBJMZZiTk5Hf39qfaglnVy5Y/QflS5rjURyBlyGU5fsOMURy4QAgZB4A6j61K6FZAw3blB7dfrUatGinP3ickbelS2VYlMkZdgwY8Z55GKZA6uoA35HHAxj3qFiXjZWdix+6PrVswPFEmGBJGMDoP8aQDJAsce3JYAZwOcmqFzchYx5ivH3GfSrk7fKVEgOOijGfpVRYRJOFkRppJf+Wa84PYVrCNyZMq21ytyp3GRQDkDFaltI85RFCtj5VGNo/GoLTTLm0kM07ReUwO2IsAfyFLAN07CMBVBzyea1lGyJTuyVklaJkcdGPy5wKq3BkKKFUnPp/8AXrajiwNzhS7jOOv51DewM0IXgIDxzwDWKkkW1cxVHnpOjgAEYHfB9c1RFlqEcaSxCNmBOGDfMB61tNZvGrjG04AIHerj2c8NojO8bKRkBeSPqK3jU7GLgUpta1+50GHRJpmhtFkMhB4D59cdfxqNLOK3iLqfMZh94/0rRsZRb3HmvGJJBgqD0Bqq372RwwCEsenOKqU+YmNOw2NTIyFlwD6jNXYUbaUVQA3qajtsh2EjCRl5I6VfhHyhuASwAVe1YTkbRiXII2UByFYBcHcaZJJsBwhYtx04BqYIV5kJznhc5/GqzAM53nCKOB61zdTRDliyw3ttbOQopzD5x5iLt+6MHrVUyPGzCPBK+v8ASiPzpXUxQszqCcHp+dPlb2GXV2KGQAJID2HApoUjDFzIAMdPeq8FyWJzxnoOvNTRjDp5hALdB3NTZoZPlVUEKATzzzxTJHJjKqCvBqWAK2VRcHuoPT3qtcRO1xhTkE9TzSAqCKJ7h5JkkdVxweB/9erbSm5VDDbiAR5AZQAXHvUr20qFd7IAAOMZqTYEGGcBh2HpWvtWlZByrcqQwOjnGTn1zVW9thu8yQEMTz1xWuORgkK3XPFV5WZ48YwwPOeOKhS1uFjP2yRqEibCY5yCM06KCUPk7sYxjHAq9tXYCzfN2wc0k8hMbbnAOMcjNX7RvRha2pAY8qxZVB7Z5pQ0kW3aMZ7elJD5RQ8sXXoGH8qimSZvlhAdic4J61PxDHyHLFSxOfTFMEShVJk7880kUcpTJJGCMnOcGrogklUEOCncVL0KKTKpbLBs9io/nU0cpW38vc6kDsOtWZEKgrhduO1VXZEwFYE9MA0LUTKUsMtzKqQKM+3U0yWCe1uJIZUy46+xq5KyKCQSrnoOeD71GgYAGZ9+7kZ61rpy7E63K7ZdlRjt75PNSHaPnbJA7MKthEIHz4HRQOtZN+5aYch3zxg5x9amKuJsbNeRxy/u2VT6LzzViK7D9GJY+tV10vzo3lMwAHX1p0do1qTk7+fvLgitJ0uVXJjNSdi95ispO4/RlJNRuShPlMpHqSVFWYVTO4bXQrzknOc1DPEzMQWULnAQYAFZRSb1NLFVLhSNrBiB3Bp+/YvyudpGNzc4pt1AkU2FUZOCAR1qdQ3l7ZFCgjOCKpwSBEM90I496hR74yTWbc6hcXACoSh/hA4yKu36EriNQxbABxjBqCy0me8bMJXzVP3c85qqcL7EydiqrXEZ2yKdzD+I1p27NsPyNtA5G7iqJim37X37hwuDjH41Y2TQxMsiAH+8xGRRJWYJkpuIo4yFB3eg5z7VCb8EkFCF6c5/yKozRzzlUtpIo5CMsxb5QB70tzpRsVUm6Wdyu47cgj2zVOm2tBcyTsa0Fz5oULkk8Yx0/GpAjsrMyYJ6AHvWbZRhpM4YrjgA85rVO9QC0gbn7o9a55KzsaCOhVB83Oc5x0pnyI+AzM57ZqR2O3G1/m7+lMEP8WSvOMngmkhMjl4zJ8zE8EN1NFL5QbcmcAmiqSAh+U4Zzwe4GN1IY0nCYQgAnOBxVmXY0YAUhuoweAfTio4kkRRvXnrgd60uQTR2+F2H5MDgZyPrUbwpHHsJ+YgnHT9al80SrJuUh88AHAFQzoxMZkHHXrUiI0j2EiBWcEfM+M06U7QHZcEYwB6+9TFT5YMQI7HDdRUQthNOpmZkh25yOv4VcVcB4BZiVVsEZGTkU24jZkLhgQcZJ6Z9qW3AXDIHKZwB1IFTs/mkK0ZkVeAoOKT0GVYoHa3DAluc528Z9KlSJxvIYlupxwoqxIyKAoJTaORntWYL1EmYZ4OcEjPNG7FqWzGkowFIOMLgDrUS2zIhZG2sR1xz7gZpbect5e0hhk4+bvWohMpUg5YAAAnhfehNxGUlgZE/elSd54x0BH61LbxRxygJGijpkDrUswxGe5zyxPSlUOMmPBU9wf5USqNiUUOwh+ZtjMDgqD0+tTTW4eAHKHb/AAjqTUcEfmtuK9c4I6ClBKTEcnjG4jmo2KsQeWpmyYyu0D7vQn0p10ylgAVI4JAHT8KkAaNFWUqz55IOce1MYK0gJjBPOBj/ADxVqVhNXIBbjbIeiehPJrPud4jHlxbcPgvjArcRC8IkAG5lwMD+VUxDKBICm8scEHt6VcZaicTD2TROwJYoffg1v2Bby1wAI/Vl4q4bnGniyCQtblQoDLkgg5+ueagEaR25UOCD1UDjFFRRtoEW3uJcXARsx5CqMMfX6VnzXioxLsQ7DGFHT0FSXEE95cNBbMIoVGTIxwAuP51i28TXFyUX5iW2jn7xpRp6XBy6F+K8AcvuBOM5INXra4jnTaQFBGSMnmq0mlXMVzHaTYhueTiX5QBjNTWKruBMZJHBIOKtx5QjJSLkcUYcYhWMYznq341pRuI2LALjbt4HJpltEpbKjHGee5+tSJIpkzIBjGORWE5cxa0HsFKFowM98dBUKho3UyBAD90gfzqVZR0XmPPcVGXLuHKOADxxxWRViaSUpG23cxbA3DqfpWeYZkkQkEhyeGPQVobsAqCFwM4znNG6UYHyBT0AHX600+4FWIsBlj8vfpx9KcUhkRc5RQeMmnXCgyHbLnH8OMCmMxEWELO3fijqMbLIEfYpO08nAGKr/aQJNg69sDJ/GkyN2SwwCcgY/nVKa7jErYPzDjHJI/GrUbk8yRqFWwWBwD1CnNGUZdynBx39PSsiO+jVMjIzycHPNNS6mlkAhieVgM429AKpU2LmRqdJNuF5PI7CpkYHcV2qo9qy0uZrkhIY9sjHncKgluJkn8kzRSbTyUbIHtmhwfUaetjYkO9fnOP9npSLbxtIpkXAA5AX8qzBLKGVpUGB0bmrf2xBlWdn9SBS5WmJu5OLWMAq8jbQOduOT261TkhSEglgA3TnLUscx2nDfIc9QMmkuJoY0ChCnfPUt7n/AAqktLMdiMebOVht4pJJGJAK8U2DzrO4kSaNfMxgrIM/jVu0uYA+8gT7ezEjj3xRKxk+eJgEPXj36DvWkbJENO5VeISEiMKj56ZP8qmjhWNMs+w56bc1PDGxy2ASfTim+Q4bsQepI3Vm25FKNhp8pXG1VZj94E1Lsw2QoPpt7H3qRYSVz5mAOMbefwFJMGI2KMAdcKQD9az6jM+TJDZAAY4U9SPepEjJGGcsvXjOafNbOq5kCkg8LmiCPEZO/a2clRziqmBBduIowuxVyMA9zWat5JAAYSV78Dn3rQvowSGA25znOSadbNYhWR7cvlQqnkbff3rSmtNyZFS2KNLuy+44wSeBVu4TDb2VenXHFJFDGQwQeWM5A2nNJJIFZtyMenyr3rOV76FJIo/ZQ7eZGCrHnIHU0NCZJArtkA4KjoKvxSq0ZX5lU/Nt9TUrMiyJiMLgYz6Ue0aCyIIbWNPvMV9CT29akWNA23b8nrnirCEbiw5HODUZAfI+7x2PFZt31AJUEiFdvA5OD2qJcHAD8Dv6VI4KBcjgdlP60yR0bKqRvHOBU2uA1ZowxEatuHXFFQyzspIZkDY7CiqHYE2qdqDnqQBinxDMp3AkgZIB5AqaMKSQ7AHO7Hr7k0jyBY1IRDk8k1ZmIY/LCgABW+8e9NEeZA4ycDAJ5FV3lYlh845+U7M5/wDrVNaksgDMycndxwfpT21Cw642gjK4G3JxUUeOsjBQenvU84EPl8DGASCOn1rOvbl3wlqDvx1HX8KuKbYFxX2bjGCsgX7oJ6d6Yt2YgCN3zcAbgAfr6VWudPurK0jmvA8YmyQCwycdcisw3UkhKrhUAxgDqKtwtuSnfY1Z5Xu1MedgBwQuDmp7ezs44UMojmmfjCMcJ/8AXFZFrKAfKA5J6+laFs8YkC4Ckdz3px90N9C+NHtYrJJReL5xbBiAzn0qSI4kKkZYYOOpU0xjv+YxsRwOvT6Cn2cCujDa0RGTlRncc9OaiT5ykmlqWHy3BZsEjIx1PrTkg2Bi/wAm3+HdmmvG3lsY22EHvwTS7iiYkw79z2/GsnoMlhjUuVBkC4JDHjmo5G3RsehHVj6f0pZ5MsxVcDjABx/Os/7QizMJH4OQVHNCTYy3EArqu12ZudpOae33HLDAyR0xSWUkUg3hSQPfJNXTIxh2hV3KOOM4psBtspKKc/MO/TA9qmXywy9WOCSWx+tVA7JkAnAAwOpNU70uxZFwoxyQc0RVxMsNLE8gGAMHHB5FJCmXfamw43Bj0BqlEgWWMAP1xkkc+9abZlnUE44wSeeKclyiILi1X5mBDohPDHGSazfsaxTKy/JMDnenA/Ct+aKNjmLBkxy3UfgKhjZfmdlKKOM4yWP1qo1LA4jL66u9RZ5byR5pn2jzZW5XFRrbonlZcvnrgnp6VaiRWfAdmOPlzUn2cpuJTL9AO4onVcgjFIj/AHaqpD5CngBulL+6JBj6gZIZuPypwi2vuCkn2FOjtyUVsDrksx5HsKxNEKYwwzu+Un06VKNyMVEg245706AbVZXOV7EgDFRtIiIBEqkk4Oe9IB8ca5/eYZ1/2sgU4qCUyQB6n09RVeIvK4YIEViflB7+tTysZHbnBAwSBkUNAQSW8fmboiSO47VDcbUjIcnHPAqW635BQnb9OlUpLYyTczyOSOeOR9KuKuxGZfzCOMLEGJHJXHOayrpWlgX94zXDNjYi5wvvWxfQFJDuLAZwNzdf/r1JZ6LDKzzXBCRqu1XJOd3tXZSSe5hUvbQq2+mBITPbTho0wHGeQfSrVpezWkW6JlDEEEkYOD+tPO90hR0H7seXuXCkgdCcVILFnX92Se/Xn86U5JPQIxbWpjXqSkpmQ/MevTOe1W77QbjTUtHuVCrcLvRQeXXpn86sm2ZZczYeNeikbh/n3pwkZ8JFGZDGcKT/AAihWsOz6FZPlt1R2LAZGxhnbVjTprOF5jcwtLkYXttPqKdJG7Q5SA7QcNKD61ZtEsHt5ElgldiMIYj0Pqc9aSY2rlC2iWR8h2wD/c+9T1tla9jeVZDArfN2yO/NTRwGCLOwEjux/pVaa9Hm7XVEAGcD1rJNt3RoJeWsUt5stYnSItx83b39aff2BsLhY45lkKn+Hoc+ntQkqSgnYS/rk1fEKs6NLlhjGSSKbqRS95C5XdWY+3QtDmQYbGAAMmp2RF4+ZifUcUkUTE7VyRnnBxgfWkYJIQGDexBrmbLGnexAEYRQOq85phJkUgLgAHG4HrT2GCNrDAGOBzUQcbmUknAwF5pIBhjZHG9VJxkupqF5AAA5bnPJ71BqbzIoES4z2AquIb622SzZVXHylgMMK1UW9RF9gqov3ioHPb8qqNEjDCZz1z3qxGpeENIeTggF6Jo2DYQKE6bscmlG6GVJCiNx5jkD+KqM1w0SMC4UDndnBHtVm8QIVPmEjpjGAKrzWUeoK6Ss25l2xqDtAJ/iY+g9O9bwipGcpcpn2+oh2G0h3XqSf5CtSzvFyAwI9SeTVSPw/aaVEVW6lllcBlYDgnuMVJHazJcDzUxg9CORTnSsTCfMbC5YKQu1QeST2p0kQCBkUnuTUccbDaMcfXGKfdsVXCNvIHA6DNcrRqRSFmT7nB9KhcjyztRRk8EnpT7aO4uJo7cBTNKyqADwCTgVcm06zg8QHT5dRb7Oh2PdxxZ2yD0HdQ3enFCbOcu/MMsiSq8bKcMrAgg/Q80Vq69p94mtXUV+7TXaviSYnO89mz7jFFX7o1sEYO+PjIyePQVYZCVBO0BvlUEdKpxzSEsYsBBgZ96ulZJWCjcWIzgH86GjMUsUMkY64wWBpufJBU5+7nFA+Tcq5Vudx9AO1VZ5NyIIgRkEl368UJN6ASTkSRFCuQOdueD6Vn72gnZ41Ks2AGHTjrT4UuCwkZdqHozfLn3HrSXKFpAHztBJPoDW8VyuwPUra1eSSyq80pcHKs3vW34W0rQpS7eIdVNskahxFFEZGl9gegrHntxOx89VMKjcdw6+lWbWRBEPLjiBXn5h09q1TV7sxcXayJtVsbH7e0+nLcR2APyeeRuI9eKiG6SMCJm+U4BYDn/Cr0EvnlvNPys+98LgDj0qdY1mOQiqoI5UHJFROSLgmtyGFDsbdlT3bGav25KlfLJCgZIcdfw7Ux4wDlWwvvzUSiWJiYGDKMAsep9q5r3NSaSUqd4w6kZ4zgUyUutsW3EsBkgngmrDKQgYhd0gwvHQU3EYLIXGDwBjgVAIzR9qlVJJImjhY4DnnJ/oKWKK3a4jeUNIoY5RB1HbNaksJVVOCEU9S3X8KjdYdjCJ8HBzg8j2z9a1UknoPcihCGV2TCE8KCOMVZ2fMcfO46Go41PyBeIwAME8k09Vj8zChz82WOelRJ3YivGZpLp2Yfuycbc4zTlCyO2Uzg8r/wDWqSQ7FPygHPO3k4qoxaKaNjISxPCjov1px8hExXY7yMzI2MBcAAVNB5jxlZGBQKCyIvX2qrDDeajPMEiVEQbmBYA49eetW7WPyoCpb5yccN0pyTSuwXYRJh5ojRXUqMDjpUisNm3DDBJO7vT5ziFsEbCc5xjJ/rVOCUljuj+QnAGf5VCV9Si9hl8x3JbHAAOCB+FLKQQHyQc4x1JqBXUSFQ20eg60+UfvnxIdoxkgZJ9sVPUCbGwbgxI7k81Ck3zrtDlRyAeMH1qVy/lgKCCRnHc+1Q3M3lruO7hcHnPNCAsRucFdpU9STyPzo8wBlTeAF+bJ6n6Vy93qjl87/lBAUZ71btL6d5FG1ZFYdMcfnV+zkO6N/wAoFhJtBOfmJPSnJiIlmfkP0qBcOQZGbIONowOanIGH+UqznPIz+FQ0+owlLSE5bIXnYM//AKqZHHiMszkY42KM89smpCpkQqrvvLcseRTrcLAxRpGY8knHT3oApTQkYLAFhjGRz/8AWpnkeZgEHA5LBcj6VfuQjrwC7HHAPJ+tRoiFZCgZeg2hj07gVcZOwrIrLCkcfzJg9tverECptBEpUDp9agluIIeSzMM4244FNS/hKEhgpJ42rzn60nzASzRF2ZY3LnHI65qmbM7goQqvUnbUwE7zxhHLuSfk3YANXI5MAI8eGPVi+cU9UrgkiKCFdrIG+QdRuwAfWmiKOGAukYCjjcBVifcpyIV6feA60QruiwrvweQATzS5mOxj6ozKqgNsXGeKZaWK3NurPKkEaffUrkyfjWpc2bsyMHJOCfX+dZ08UcaSK7KrdQD/ADropzSInFy2KjhYwFhhbBPDbuCKu2jSLsJznp0pkE6IAEcF16qo6iljMspxnYo54Uk+wx3qJq+xUV3LgSUsXV0Y9MFu1KwCyZcs2TgEcAUy3EsLlLiIqQeR0pt9ciOUKSDxzjrWDg72GOWQCY/Px1OeKQNE7Mx3E+q8j86zZb23V84BYHqBkmkOqxuCAHDDjg8CnyMReuFAzsUc4G49qq7S0gAkaQqcAA5FE4e4UMhXOfuDjNSoVjjUyBCem0c4pptKw7CPFKsOXZFUnAwcn64ogh+Q72JAP3uhJpr3aQqcKABnqQKox6h5rZDIAf7pz+tPlb2GWprZGUMOCO55H5VXMEWCZHY4HIUc5q7byecmQAxJHOKkltjIVOFQqegOc/WnGVtyWrmWdOu5LWW58lvsynbvzgZ9KktppFhA8t17ZznNaMiN5KxNKCMngNn9KijiWNQB067e9Ock9giu5E7scDDCQjOOtQsF7vh+gGM/iTVlsY4YrkH5QefxNV5dsgO1V+q9TUJICJJZIJYrhJtrRuCpU8hgeK7htOe5uRqE/hG5+2ufMYC5CRM3XJTrz1IrhbcOl/ZTW7xeYkyMfMGFGGGc+1dJqXh9m1S7vE8U2UkM8jSL5sjhlyc46dvX2reMNDGpLWyMzVJbqXWbw6gjLdmTMyA4Cn0/LFFULrbbXMsUcsdyI2wJU+ZX9xnk0VjynQti6kKIAuQF3dfXjsKdIhyWbIYrhV9qjz5Zcp8rquQzdcn+VRwmTLfOX4yxIxRra5kUZG2iSWXzNqjjHQ89KZBDcTxvKhCWoOPmPLewrYmj3pgqrDptyAMetVrSEJIvlSklM7Qein1rWMl1E/IWNGk2LOcFOADzjinSwF4xgNwcA461ajiVmClUG5fmY549/rQcSYyTtQ8c4zUud3cEQyReYCzZ3s2Gx7DtVGdyrqsf7tQDtXIO33Jq/Nk4BLK68DB6A+/eqF9EAkyJtUgjHfP496uDYNFV5NxGWbI/iFXbW8Pm+VCWKMQNrNyPx6Vc0JYLGJ2vbVJLhhujk+9sHcFe5NNigh2gx7lQ8kkd60lHS7JUtbWJWMiyM7AMABx1Ap0Uxbb8ylj2bjFKsQdZI/mRO7E9fpUa28u85cCLOAD82cetc6insaFtZWmB2ruAXC7uoqGUiIZCKdvcnt3qW1Y7AsiqvHCg4Jqd4cxMJQvz91PQelRs7DsVLdhKQYwyqTgDOSfxqa4jGws7bHLY5/iWpI0AYF9h2j5eOAD61HIhZ+fKTJ+8Qc/ShWuBWMoeQIkbGMDORxn86kWRixRF5OSQDux+VLKm+UZBbeMhdvUjpk1X1Cae3jMaHa+7JA6CrtfYTFnnSOM7mO85yOmPxqgL3eFG3zNqnhWwSfrWQ0skzNl13Dpx2rRs9LkmjLKo2gZ54rWNMlySLtjcRruD5ZscLjcB9fpWrESUSTAJK8Aqe3fFYGno3ZWxu4OMgit2KORkycbwvGX5A9MVNS+w4lW9Z3gTbu8w8Aeopos5IEV5HZWcEgBs/nWl9mLKhj+8Mbn9B6USwKvybgzEYAHb60oSSVmOzZBCrmNS2BuGM5GanjhRSSQF559aiZWgIkZsxkcE4GPpUkd1FIWaNmPH3QABms5J9CkTrGIg7h9wPAbuaqarHvhO3d1xjGPxq0kxUr5kZBJ6Z/lSOuwtl2bdyxA4HtUx0YHN3WhR3mmsHMcKEDcZPvSDsF9KfY26W4ijjwqgYyx61ueTG4DM3AORuHJ/wFRzQbFJkUmTk4/lXVKqraGSg0yzZ8RqqsDtwScY4p1zOVwY85X5m54NQRLKoCyjY6jJ8tuPx96liRmlT7rKeCx5I71zy31NlYclx9ojLvlM9ufzp1rGictubHOc/wBasgKhOckdeQOTRIy43bA6ngrg5H1qGF0QKodywJXHYd6bdbl652Z6FsD6mp1QxKfKUAE7skdPao53XYGcDpzjvQtxGGbNr65UzM0UAIG7bnj1q5d6Xp9tCJre6mJOCVZQPl9arNcLPPgFztGOM8VZeGVkS4lKsifdQjPT1rrja2qIlF9zJRbmedhaxvInUYXLY96sRmVJtsoKMhwVxyPwqxZ3Elpcvc27TQSOhQtGdoYHtinQW008qs+AeCQ2CT+NElGwotp6mrahmizsbcxwM81I8Od+CVGQGHcn1qIRCJySXdSNuzoKr3txJgRwKdxHHOAPrXNa7saplqfBU4HzY9eg965+7hkuJdgCRxlhkle1XnsryJ/3s8UqnGQrDjNTm1YRBeQck7l7fjV8vI9RpqS0MvUNMtoLrbZStLEo/wBZINpJ9qdZxSIm443jpz0FaL2I8jc+SAB83JrJmvLiJykSOxGdoXvVOXPsJK25aE8hTYWAyccnk1Tv5AjMrjcWGBjrVtFdIEmkkUOTtKBuV/Co7uKORF/eKGc4GeopJcr1FdNaGfo2gX2vvO1kIUig+aWWaQJGn1Jp1/o9zpl+0DurOqh/MhcFWB6Eetalrb/ZmMkBUMjDlQDu/OkZZ7iRXnzknI2itXKKRC5myGH90ehctyWAyafdEPAMKMeiqcmruZEkJjCjjgAcj1yaUK0sHmSK4J4OO9c7avc0Vznl0+C6ZY7qUxxMPnZRyo/HvVmbQtItkLae12XzlfNwAw+laUdujOHGCfTHAqNkEWSoLE9cdfxq1WSVrC5bu9yvFbJhSAyc5OakO8uMbgfb0qQy/usqTH/eGetRbugJDZ69az1ZQgGMFMliOwp0MWVIZ3yvUgZ/OnJ5juwQqAPU9KehKR4LMRnjsKSWgWGrbMCSx3HoAoyaimjVE2tH14wB2qVblJGKQM4bnnpVVzKJG2M/I5AFOPmFibTNZXTY2QadZT7jkNOm4qBxhamufFTNlF0PSO33oicfXmsuOJ3bMg4+n8qcLNCyZbacjcT0A966Iy6IzlTT1I9Q0+8kaW/NvDbJK29YohhV/wB0elFdLMtpY5bT766uYQQHZo9vPbGexopygmyYSlbQwY9pcgMfLXue/r9ant5NjNu2cjge1QzbhjcwzH85yRzn0FQTyyPKiKjFSNx4/XNYWuOxLdyKq7kJVVHOBkt+dVY7h5HUKrHbngDIFXooEKfvOWcFuATk/WmbGDKkQcptI+XofU59quHL1AdZ3Hn7w2QBhTnn9Ks7d+SBnsu4cYqCSNcodgt0RQAyn7x/rVgxo0EajLEH+LgD61Mkr6ANYMsZ3fdUZ3+/rVaRPMLFdyoe3ce9XF8tJEdijxyHJwc8elOaHE253KBx0ZuaSbQENvHsAk5yBkZ9e9SwICRu4ck7nLfpipyGdP3Y5wVbgABf8aEhKRhlUlRxwOAPWk5NjQ12GVXc8hI28HH4ClKj5RAgU4ILnnb7/nSwhoXOPLKdAEHzGkWNlVlKhVXkg55pXsBIFHlyDf8AvO7YGGPsafF+9TCIAjLgE9ahknyVEcLv8vRRnj+lTqFAywKhl5UfypMYirG8m0YDEAcnv9KY52bRyQT1b19alEi4eVnAYjaCRjBprRhIxJv3Pt6bef8A9VAhjbFbcXIKg7cnJPuKytSi+QJIfnIyOCfwrWjGVIyNuANoGSfU/SoL2ESJuUhsYXIHX6CrhKzuDRiaHDaRX5fUElmiRSQkQ5c9hn0zXS69fNqlvY/6BDp6WQ2NGhz5o65I6ms1bWaF9pQohA+XpgduamjgLJI0rFiXKgk5GOn411qaSMJU+Z3KU8pMiRpEyleAAvQela9rbEojhyoXl2HJ+lQWluq3EzHexGOSO4FWyksa7gV5GT3zXPVmm9DaMbBK+PlX7jEcY5+pp67mAeRWC87j6iow0pkCl+WOScdfpVwKGjG4DBJwPWsdS0Z2oRGZC0e51XGFPIAqOG0keNGkiVGUbgEAz+NaDnaThXOSODxj3zUvlKIyE2tkAbugWrUnawFZoY0g84yMHboD1P8A9aoo5bd2Y+blhjDY5P0q1cRGRz8qMij5ie4HamT7Qd+3MgGQSAABUpJq4EsezeFLElQSxJ5xVa6lCyRqEBB5yTnPHU02G5CruYnbznnmmPMBGzbUGePc01G7FcgvLowozp/q/UqBmqEGsBgSUIyeMdKZdwSTkglz7eg9QKWLTLd7YSQTOZUcB42TGFI61vGnchysaNnfg7mRnYZwcjAAqy10QpEbjLc5DDH/ANesqKRCwTyQ4GcbiQPY4q21lBHCZYpWe7P3gygJj2pOknsPmNSPBRTKJGfHXrn8BTLtvMGzbu38Yzk8dqksYv3QUsQcgfL3q3DYx25ZzsLsCRkbjj/Gue1maox7NJ7aCbyYVj34B71ctvM8kM23BHQr0NXCGVABtyB93aBjPc0yOInJIRSOT6mrlVcloK1iCe0cv5iRqXONxkHP4VIFQSqPLwR23YzT5nQxsVWQN1weM/hUFniZyXGxegO7JqdWiiV45SAoBVeucdR9aDbAYfjPIIYZx9BVqJFPKJ869SzdqgnjLSN8wUqeQeM0lKxLIFtw067ztYfNtK4/z9KsK+AwJADDJGOAKZEm3pKNxPuaeZuqlFULxkjt65pSm3uMV4vNiZcjd6A1Shi+yu22LOep74xV5WAU4288A8k1XaP/AEn5TIRt3M7fdPt9aISa1EzD1DMfmuMe23r9MmsuGSeVmDxuR1B7/hXQXtvmQlUyO5IwPoKfaxIlu6RoOnMrjlT6CuiMlLVku62MuxB88iTzDtXkEdK2Qnqrjt07VWgtWCbzDhieWbgGryhvLAjDA4yfb61hUab0LsVbhhGgaILj+LPNIm6YlpAVB689KklZYyx4GAD8q5JNNFwJucsAeeSKlD2I12q21Y8Y7k5OKpXD7mKJkY7CrFxJyxdwCe26qF1KA3zcjOQAcDPtVRVxFWefycsSMnv1xWdJrJU/u2KkdT1qee3a6LLnacHk9BVGx01rfUgrKFjTkysT82e+K64U7rUxqTs9DRt72RhtZmVm9B1rRtokaXMyPIq89cA+1SXZi4iggDL6kYNWdPhec+ayPnpgDpUzUaZcG5LUmitYciSOBY8Z4/8Ar1bFoOH2lcjqF5NWkhUsocs5PbGOaWbhd4DLjjJOf0rllO7NEinHYwy3kPmMI42kVCW7Anmuilsl09rm4i0qA3U1wLa1tpE3Aov3mAPr61lwwm7lSEg75CFG48c1r30NnbpBPuvZBbXPkPI0mWKgclR/CKqEjOa1SOa120+x6zcx2y7YFkOzp8vfAPsc0VZ163a21GaBSztGxG9umOo4oq37zujSOiRyNwEMbeWx8zICbB/OmR2cy28cssuXcnbGp5AHr/hWfa+aSyHeuAD9P8a37SL7R5aI5DE5Y9Ktrk3MUECNHECQV3cAgkkCnpGy7htbaeBuwM04RgPkNlgc5DZFP+ZssCAM+nJ461nzajIIDcN0jxtHLseF+gp8syxxtviB42gDnFPbmMSFgmGwqk9eKjj5TaCWYtljxge1O9xEKyRsihjjaOT1/Kq73JDGONScgf7RHsK0jZpIEXDKvQlh0HrVS1tZVmZ4V3KCSHY4wKqKT3GT21z5q43BSPbkVMHLSIgkyobhScmq1vbmQ/vMthshsEcVdVI0n+XIfAPyqMAewqJJX0HYtFcM7GUKPvHdxk1GMqJFQkhzjdnAOacZEOSFIAyecZzjrTIjuVWwzKpztPQe9RcB4gkSbP7wHYQzFhzikBRdzPxtwNqnqaliIwuJHOerFcAZpVwhYIwQgcuR1pvUCKVXIYKQpyMMR938aIVKRqHcYfsTySPWo2k+/Iyqyt0AOT9aSOISfdGX4AYfdA9TQMkkkCY+UZY5QjrTQu5gibwxODgcYxyaZLZykjHzRhuTjk+tLCFScEIxUKT35HpT5bILXJTFtO0Mr5wd2OMU52WSNizKuOAmOvv7VHHulDBF2opB3Z7U75juyzE9VYAc+1FmFu5KkSeSCOu4du9TSAYZSXx/ntT4sMASjncc/X6UwMwaQbc53ZwOg9KVxGfJIFmijijLybtu3GSf8BWhAZF3b1bdg444FVDComSSVfLIPOByfxqQ3S+RtZmLZxjNNpW8y9ySJdhKsjAY3M7ZIP4U6eQ7NrNhe+B/Omh2dlDMVLdSwycVCrqd+GZjgqCx5PsPSlYky73Uo4QQS7yH16Ypsd87lsK2W6AgAY+lJLZCS5VpFBVH5GcAj0z61pXLQXN1+7tlit/+eSPkL2xuPNdCpq12K+timY3kGEY+cSNqoo5PuarF59juyvcfNgyN91cdhWs1qY2VoA/yrgdsVXuojbwxw71ChSzAEHBPJqoWsRK5QO1ZhujbJ5JJxn0qWS6ZbZIi6x4P3ccn0461n3GoO0xEKgLjHPJ/A0yGSUyCVrcrj7zgf5xVLyI9S0u7apAz3LE4H0FWvMDqqlow3qvJrHuLtXuJgItzEADLEYPrUunSFFYyxSBchQ5Uj8c0NCUjcivRgxFnJHG3hQPqauw3MoRsOcAZXa2QP/r1hy5Y4jbJBIPH5GrNmskZSJMtn7zAEgVlKmmbRkbcm+aGP5mwo647/XvUduGiZ1k2mTH3QelWIiSF3MQw+U7hwPzqdbeNYtxwz5yWz0rC3QsbGzIiAxDJ5JGMAUqW0JYOHdSDyoORUVxcRwI+3kIeoPH4ZqnFqkMkmxSyv0+9xnPtU2ZRrM6jBGRx1YZyagnYOmSN2cj0x71GzeYmGfcFPJzzVG5upCRBapvkJwBt6/jSipPQC1FES25SwVeobjmnwl1Z8KCmcjI6/U1TglMw+dQzZ+ba3AI7H3q6WYADaODnPFDjZ2YiSON+XRM9SSB+tNuW5VmIBzkhTkmow6jJcNtGd3OBiq/2hGO2NgozyTU2Yxwd+X3gj89v1qMYVA6sfmzziiaES4+YbVPJ6ZP0oaJmcBJDtA471aVwHBhv+ZwMcBTyc1KJmDKC+CQcDrgU1Y4okQrGFkH3snO6pBtRS+dzMMnjken0FS1rYbZW2LJlmfLbcqvQD61XnULGsjgH+6PX8KtgJtUgHJPSsm/J8zAJLZ2gZ4FVFX0EUpbpftLBzHubPbO0VEYZJHLLlkHAY9D+Papre2VJApjMrSHbjoT+Park0Ygi/eMMqdpjAz+fpXSlZaEdbGe6s+N+5k4GFGAT6e9TJH5YdnjYseBxjFS+fFuBTzCoHVuxq7BGkxV3Vzz+fvmjmsHIitJFLcmNthTHQZ4H/wBetSwjMKgKoOOST61YighjX5QCAc4Y9qld08sjB2jk8VjUqcxaXYRZsoSxLE/d7c00uHAJXjkH2pySJJH8qkEjBwP84qs915DFdowOuKwe5SJfIlE0bWTskm4EMO5z6niuziS/aIJNo8LTl/NJ81cM/wDe25rmtOuUeWJ2XeqsCV7kZzitWW0tJr5r2PVUVGkMuWYiRe+APUVrBmVVXt/X5GZrlrexu01+j5lJYupBXPfJH8qKt3uoWbWt2A4Z7u68xYMH92o7n3NFaxS7lwvbVHDzym+kW4+5IqBMqgG4Dj8+9MT5XRGc4H3iR196TSWdCEONwPykryTV4FIy3J3FvnZx94/0p1JNuzMErDUX90DuG5iSfk7e9Nh2xpIytuAGACOpp4Dum18nkk7hjHvU8X3/AJwqlVA68VlcZVnR44YgiplzgY6tThaiPDFQZNuNxOcNTZHJZto3ksSPX/6wqSGdMqiqN4xxnOD6mmtNRiojiZNwbjhtxIA9qcsiRpsDdD8xBzgelKrLJExKcgkq/PP4VEsKoSXbP8RROhNG4D4TJInzsUjBxgDrT4ssxKRpggkDOBgepqG5vGTeRJgEYACjj1FAniWMKXZWHJjU/wA88U7MZZULtU7MIBnJ7nuaEaFUAD5bBGc/jUF5PutJCmNpGFDN0+lZdpaXMlrJOZEitwSFOcFz6L3pxpth6lvULpoiXMhYnkjPT0GarWtzNMjSHAjz90HBz9auS2XnQqdrBCA3J6+1WRZg2BgO7ahLKoAHPuauEU9weg1FR4QCGlkOOp+UD3Aq3I6+XGyjAAzhR1xRFEYtkXz7iCC2f0GKkgAjbJyH5AIXjHoKxbGRuEf5Y2IYkELnHHemmPeTlSWbgAHHH0pziQjfIQIyeeAB7e9L5QL+aZFkPCj39qAWgvlIFdihz93JOMe2KViyR5EOSBnJG0fQU2NSGJZU3KSQAc4pszMXPmSAFmB3Mc/kKa3B6jIZXlTY8RVvYkBB9KskG3jLyoTg4AbqahtlKhGyWJJ+96+tPhe5nkJlQMinr3FNxQbDY5WuIm3IVfIwHBPFMlVAUKjYuSMqvUetaIQyRklnXcpyc9fb6VA3luqjaAEX36000nYLmNJqsUbGHy2GOCxHLfh61espomYuoAz91j1NZdvYbrozTxgx5JK7sH61rW9lFE8Zjx5ZbO0NnFaOC5bivrYmS1WUhiON24EDirX2ZSM7c4bOMdPb3pGWV4WVQETGFGep9sVLFG6xqJtxYLuUDgfWsXJjIzE5iIkdULHjnBx71g3kOHk3EgM2AT+vNbUnynG0hyxy27oKz5BDLMfMcM2eF54Hv71cJO4nExfDsmm2+o+ZrEbyQxjPkxnDSHsM+lXJyZJp7lYxbvI+YYG/gUHIHvViZI7Zo8IpmGcuygD2Aqsqyi4My4c5yoPPzV0xloYShrczYbe41bVZnUrdX0xLvuwMH6f0pZoPs19HpkM4uJAN0zIxKxkdeelX49PtnnWSZ0Erbt2wnLH0z2qWOGK2j8m1RQpAIweSfr1JrXmVjPldyFU4YRBirevqO9W9LRyiBG5HO0cfjUL28klso2bQ2SM8E/iaYkjqoKBwEAA46/jXPJaG8dzpIWcR7n5Z+7DP8+lE80BJJbd0G7r+NZcN+uFWRDu5GW5qySrEmXA29AK5OVpmxk3vky3bxGfG49WHQVZmsLdSPsoHyKOSPvn6Zq/b2sMbTyGGOYyoVGf4D6j3qS3QeWAqDcWz2zXQmlENWzMdrmG2B+ZwOBtHSsz7azyMxaVCBg7Tjmt++eQIwUlgSeFO2ubu4Xub9YRmOLIB2Ln/ACaKeuwpuyLcd/IrASHA65wDz+Hep7fVSPmUSDacEt/Sl06ySJpYpElnGdqEHHNR3kCxjCwhpSw5J4HNOcNbBGV0R6jcuEJJZmODnd2qpayyCVXkUhWHHGM1p3VpIYTbzBYpFfduIyWOOAPUVtXcj6vFbi62iWIFA6oF4x0AHvQoqzuw5nfQoJKSnyBuBxzyaZczXIbMSZVRlst0FWPLaONlZWlIYcj3qK9CspUNx/Fz96sLK+pb8houH8wneihAOKT7Ydz4wSOQ2OBWc0hVQUTABwT1yfYVDLcCAlJDlsfdBzirdOIr2NRrtnQLIxBH8QGPyqF9uMbRuHoelZ0cwmbJP3SByDircbHkuCwJ6+op8lgTuT2qbAzRcNnOc88elQXH2i4miQvvYcKDV6z3F2O0hOw6HFX7dUgkeWKNWZlIOecA007bjZUGhjTXleeSG5MbYfy36EjjB79aljQiT5jvyRx796szuNi4VVKjgKOtQwrNJOQoyw5PtSnJW0BX6lmRU2KrBlHJOODiq7yRqvy4wBjk1NIhjUqwdiRnI/lUBtYlGXwWYcEnAFZKNyrDVlUceW/PAAbqa0bDykkMstvklcfPz9ayolDTuFSQIPu5wR+datmNsZl2sMDr2qrKOodNSzpECG7iBLeUX+6wxgZrqJZ2ijn2WUBaCcKYhDyUPT/9dc1aObm8hjBwJCEBPANbwe2trp9lzfmdf3ZfcBkDihSa3MqiTZmatHAl9co4j8wOSXxjLHp+QoqG6jDTMRuMTZZGY5Y+5PrRQ5XNYqyscRbIbZnbeC+Mkn37CrKuu7LLwoyvcA+mKjvh+6eSPoeBnilt0JRDM4zjjHak9dTAmIkadFkmCqg+ZR79qjKtBIZMKylsKOvWpWjjLM2AyKPvHrTJ8SMilc47Ad6kCBowT8uVZmIO08Mf8KkjgjiaQ4LAggnoCasSeUihlzlOeR1NNO5sb49zgE4HrTvZDIYUA4LMQANo6ZouMbJxFnO4EkHj8KsytIsaMqLyMA9ST3+gqoyukZMoXzHGQFJJBPb604oDn7iSaSVtqD94dvzHOf8ACrqW1zaSussSq0ZGV6n60TxJAzAurZ+bkZya0BI91C8zDDHHyqAMj/IrpSjYhtkrRxzrGuVORkttpyaeog3FywAxjPA571UkldjGNu1iOFHp61atJJBiOeGVSp4JIGaz1S0Gnc044kjQgOXUkfuyMZFMdMGUlEyB8q4zt460+OUtHvVcDuWyaaJGYssRCq+M/T1rEpDLdZEbNw4ULyrHtmo0mEtz5bBguPlqdiyu/Rl28MSBj3pHkKrE2O3AI5NFhklxCmABgBWG7b0P40GMiZTJsWPqwHQAdar7naNOu7OSWHT6VYkkIIEbbUX77sefyoQFGRVlkd1zHEM7QzZYD0AH86imleO4G/O1Rx7Z7U6a+Tzy4wSAQoPb3p5eJyzSbcBOcHJGf61aj1QEtpcCRRtAOW5LDOKuxvI4+Y7z97PAFU3uoIIxgbgFAUE4X/69FldiUjy2Qr0B7Zpy0Fa5oFirSkkq4AX5eR75pcqJDwm1VA2sSc/hSJCCshbnHAK8f5NUb2ZYRIXXY2Bhc5LfWs0rjJ1kh2kzAAPkEjHP9amEeIYyFKKDwepP0xWDDqCTTK7wjy1+RQBxuNbFnIAOrN8vIA7Vck11AmZRDsJcZLZwAc9f51KpA678AcB+v40RqcqSpDE7ueadI2HAyNzEY5/z+dRuMqTxMwWT5gQ33Qe/9acunxMssjhSzAYPTbx2xVjfuVY1U5bOccnFW7dAxxjAGPlU9OO5NEZWBrQ5+7ixOpOXYnBJG7Hpx60iwMowitgHBycHnqa1JYwZOG4ds+pPuPaoLxNkbvHwcEj2rVTJauY00X7xSqDaAQcZ4NRxll2HAUpnoMn9adbJeSgSncYQcZY5A/wpLzjAbDKTuOOlbpmclYra1qDW8KI53LGP9Xnn8TWRa3F7eTs0VoVTgEgkgCp76ya6mIZjhiHx6+grR0a0byJNtyuwsB5W3vWsYp7mUpNbE9lAXKCYDlsEKvIrWt7OMH5QzYJwc5yvv71UWPDIqghj80bE4HHXNXojsIaJGbA6qSOe9YVEkb022W1RAoXZljjr0/Kql1M8IdoHXHTCnn6U557h5gqRAQY2kk9zWZq8sFvEGgMpbPUnAJ9qyjC+5o21sNkM0jfdwyKQwx9yktmjYI7hskY6DB9fxrE+3yF2LoGY8Ekn9Kuw3UB/1u9Dj5cAYB9610WxL13NW6uIg7NCCsakbQCTj2GakjG6FjjHGBx1qpbxrNH1dwxwpC44retbLEW9E+UjBOc4FZ1JJaouKSRCPmYSltwhUdRkD2FPicSWx8s9D3Hb0qW4gUclsKMYz/QVEieVMuyQZxnaox9BmsJNvUpIlUuwUKApCgYx0FUjBAZXeRunZegFW2d4wzNks5OSvXNV7i5aOAq0ahWIJGB19zRELXMS9ZfP/dHIXkbRxXKan9oeaMWqFCCdznkE+g/wrrp5BdMwCBfmJwKc1siJDh1Vl+cOo5VvauqC11M6l+hR0rSrkqou3hV2TfiQn5Bj0/ve1X7fT445AyEupySrN938T1NAk8sAk9JN2GJJJPcnvRcX+1jGgaSQtnGOMVVRroRTi+ppWtsC+52DYHrn8KbMxgYhd33cbRzU1qkskceIiN+AM8fj9KlNpuuVaVTJGp+4D1P1rls29Te5VhnMzAgKVGD0q0kwjSQr1LZOP8a0DGvkLuWNVb5QFXGKzZ7aCJ8AZLDOemB70+VXsFyBbppFBRGY85I9Kcjl2SONGZz12jOTS24iIQBi/HzBeOPTNXIVeES7CScDaMZxmq5exTYsVvBDaArGyzrkOzvkk+noKkfCogBII4yRkdKguXEJdgS6HBZyvHvxTknBJIGCfm453LRJXaQdLmhY3Aup4o7iMY8xeEHO2ulka6Ezq1jEVBIU+USSO3Peub0qK0fFxPeGJgSqAIT/AC6VpQz2smVGsTNg5PysKDGer/4chnH+mMJIvLKf6wKNoUkcYFFFxCZp/v8AmxykkOQQXA7n0oqORs1TVjznUN+wGIo3zA8jG0VaXADDO4uADgcY9qjl2xGNXHy49MsxpQ7vsAUsr8fhR5GCLTjcU8uMKvQDd19c1EFbaCSM5IUZyeaYIlhUudxZMgKD94moZ5fLkCsAzjt159qW7AsFlcuq7sKAuScYzSsAJCCGY4Az0J44FRtOIgYcEycsduDg1lx6m010w3HAHryapQbdgNxHdYT8oREXvwapqzSRuxQq5AXOegquLvylPmqGAIIwCQxq9FJFJCc5/vHA6mr5XHQSZFLboCtwYlVUXKK7btx96lgXzyP3eGIGRjj/AOsKkRnuSvknpnO4fdHbNXofkBErABOSR396rmfLYLFcQrHKqiPJVhuIPJ9h7U8LK21HwAo4Qc8mpYwSykNt3Ek+vr+VSKm1kXaMjkjqfz7VPtNLAlYZBiKBisfAwBz3/rTJGX5NoC56j3/wqclWbgY2LgOTgD2x3qKc4wYyxOBjHGayKRWjZzH8i7YS21m6EfhTBKROiKhLFckN2X8amF0koO0EuuByeM/T1qte4ju8yMUlOAy/3R65qoq+g3oX2Yl1dSq5HXjAUetVbjmNSGB35OQv6YrEbU9jPGGJUMRlh+prQsrl5XhK7Sxbapyecjr/APXqvZtK4riQw28bnz1Jkkzxj7vpShDBbZkTAk4BPBY561dFuqsHbCbWILEk9fSmXk8SSN8wwB95uufatLpqwtmIkHnvHE4Ai7Ljg1atyvlQq0SRxx/Lx8pNUBfAqWDqVwDyeR/9elE4kDRxHdIq5DEYApO9rIXMafmIJJcEogHGKpXcQdVDkqCThSMZH1qJA4lXdcLtKlsZ6fWodVnL2rOg5YBcnk1Ci4su9x1hIkcP2VCAhkMm0EHa2PetaAhUIB52cknAJrDstPCWqSrsMzYYru5wauzF3uoYYpGVAu0rn7p+taVFJ2uTGxqQyqImCgb3Xkseh9arQ27Pc7mG5R02+lPiVoIz5jI2Rwep61NPcm3UmGNWO0fLj9T/AIVlZp2KRoW8yxIAsgEgB5UdM+ppCkSrErZyf7vrVOLaqFnAc7sMAwHPpVhZdsiqeN3OARUONtBkJjJQFGUIOWIPLelJJEryYaTKHDcnBz70TSLGyYyvUsF681Tkvf3qNHtY/d+XkmnFXAcUAiZJMLuO4gcZOe3pVW/Me5mCgO2UVV7/AP1qu4MpZpjtcnlSMbqyZrsRXUO5XwM/6sjcQeOvauiLIkk0Zckss8ywW8BaTcFAHJBz0AFXbeWe1n8i5h8qeFtwQpjPsc96t+H7ufTIrtrRWj1R5Bsm27hHGeSRnvUt4l3Ndm/vnW4upWG9mXqAOv1rZbXMGtbLYbp2WKFtu4McgDgAmrptJXmEZLLuyNqiprSF4oZIwVy/zYIHetGFURgvO487QcDNc06mp0QRQEO22kQDaeAG67T3rm9QtndnXBMh/wBWD65712kwWRnkBB2HC9h6VmXmlfaLlVR2ROD5nqfb0ohO+5T1MfTGnsrO7tX0qB5p18v7RKN3l+pUetR6Ppltcai9tdSiBthKGT7rt2Ge1bqJi0SM/M3IZhwTg5xTrewi3bnzgjcB149BW3MnuQoW2KVhaT28MeTGpLE7Bk7BWzCPljUklsc46D8KsSIi4ZGLIFyCffsKrBliHOVUrxj+KuWo77GsVoV71GfBH3iOMn9ahs4DEZHYBuR8xOfwqy0omUeW3OPm54HtUzEjCAFQefpjuayT0sPYhuY2kY792cjP07Cs6+iBDNuG7d93GeB2/wDr1oSyFScty3GT296qMGnZ2PyA9eevtVRkIx5EZykSIUVcyEnoKYd7HhyYyvzE8buentW15EZyiqScDGKjkskZQASS2QOwrdVUgMlY3aT96c9CfU+gFbOlxxWz+cTkPuDIB0yMCobfS5mlBjZeP4s8VpxWnl2qnbldwHoc+lUprcLdCNEVMpEzsgGOvWrURKqq/LgDLcdKZHCVUYbb83r0qxGjCMHcAAOFx96sJu7BEUkqmIszFVUfdwOT9a57WJGFuGhY/McMc/dFbF5CzoHbBQHBA7GkEISMFtuxgcgj09a0hC+o27GBa2k0D2bo42TgsCrZGM1vWkNw8u4n90vTjgmqsqW1o7+Sihy3VVP6+1XYb5kR7YMhYkM5HBI7VpKCtoQm2SLbtJOMlGCk/K44yPSpoIDEBJcQhd6nAU888/lRLNEWVXT70nIHU0qyBViMY34JyN2cD/Cpbsiia30+4v41Nui5T5X5AwfpUcOgaksio1qqxgH5lkXJ571PZTo0kajasjuF3Aeprdk/s9EfekrRwyeSWD5Iz3pRStqZznKLsn/X3mM7zWszRSZIjBTcvc8GiprxVg1B4o4flGVUbiQB/wDXopKdtDRaq55vFOu85GSGLMWzx7VeZvNWN5M7QQFQY6ehNYNlblrTz9skgY/e3fdq9F5ktxtb5ExkAHPX1NN0rK5l1sXbpgY9sZ+Yty2OnGMD/Gublt55dXFqhZ34A8s/yropIPstorSMCzAgluSpz6fSq8tpGGhKMGLHexHBXHbNOCS3JbM1o1iRwkzM5Q5O3v6GmrqC6ZA626q0si4Z2UH8vSr1+WkuEcr5ZZGwExjA7VzF9te4UTMyAnBwM/kK3StsZc3c0ZHklCuVIYjBBfnP0qdTgn53ygzgj7xqK3tprRJBNEshcfIjj5iP72ex9qmRFkXzHwGU8qB/UdaqUe5MZ3N6yjTyN6FgzMBhAcH1/GtGWAlG27fLyFI9D71l6Y8scu62iLhDwMYxWpvE0aIwZI1+Yg5y30rlmjdC5KTFZGYxAjgn2qR5WkdjFwpYDIOAOKrXCbmcKPlGPvcDNOdmRFTKjzOqp/D7Vny3LEitCVeVZ1bd0Ujt6inogJ+X7u4Lu/vfSpVUlkZ0IwmFOenuaJhO33EXCnap5+aiXkBD5EcUgAUsxJYDOMCsu/cGOXfjyi+XlA5J/ug1tOCrLGXwCCC6AYPqBn3rG1E7IAVXrnb83Cj19zV03qSzK09oILqRp4BcK6Hy8yYAb/aq9amO1ERQLhsj5gcn6egrM06Ka5mkRBiNVILDg+ua1tLt3mhjaWRgAGVGHqO1dG6M+poPIJ4mjLgRqBtzx9cVk3SNJEFLEhmPyL96r8cXlxO0ibcDEZxkD1+tUJZOcoG+U87e5/z2rKC7lNhNbWEFjDl5PPU/vNrkg+nHaod6o4I3IinJLkLn8O9YOsX5ispSmfNY8EngZ9qbZ6VqJt1vZQrK/Qbvu8elbWb2RGkVds6aKeN2XylJ2j5y3OavFBiMoBgjnnII9qy9MCyW4Eku5sHdGq88dOa0oAqx4DEtuG8EcD8B1pOI4yLcAClliXbGyhcBeSO+ajkkWJ0LKRhQCFOO/X8qsSXAVNy4yzYABArn7++RQVA3SSHv0Qf1NZ6vc0voakOoQRttEJUBTzkc/U1Olw0zsjAkNhsAgD8K5N5J2UbSxj96v287JapOG2Mcpwc4+gqrXDm6HXwoigecMFzkHOePWnzAMo2N5fT5sckelczZahdbxNIjiLpnPBrorcmS1WR13FumGySOp/CsJQadzS/Yw9VuJYIiIRhHAUknknPNJbabdnS4tRb5LcvsjcsBkjtWktik0009wPkVCq8jG7HFQ6cZjYWkLMJIYHZol7KW43YPetoRSV2RKT2RPBKZASA5Zlzk4CgdCTVLTraMapG9+rPB8xXA4J7A/U1sbY1jjLBnVQVwewqrHAJ/LQF41Lf6z0pJ66FNaCFYlLN8iSE8iMfKvfH/ANerkbqxC7vnIIwo4HuTVEW7MxEMjBN2W39SPWtG2g8tnjkKMxYZA+6R+FObdrkqyJnmQEIHB+XGPTnoKikvFMgRYmOOnHT3pyxARyYGGLE7zjOPb2qbd5cc4hUhAFALHGPeufkv1NSK6u9tow3bjnBOOAadbytLbfdMW4gjJ6+9MLJIwjJwxfduJzmr0IRkK5DMF5KnFNqwylJas9wdz7uflB/XNQTRmHY/LAjGelawRXOVXajHGT61G0KyMgdysaEsQRU8zFcgh3SKrMWQNgBifTtipWhDuUAyenA6DvUhIfgfLx1pyrFsCkYyd3DcVmwKcVlHArEkf74P6YqRpCSmEO9uCOufQUjuNjs+SQePQD0FOO8kEqNowNgPPrmh6oCG8I+U+WzFs8Coggby8DBxnHarAKszLgnYew6e1Edo0ksaBlUMvOD3NCQEDQqCWBAUHauOfw+tJ9maWVdkZfapLlj8q1eigCxoYt4wMtnGQR2pYIXhXeH5kJyAeua0jZDTsPRI0jZl2RkAHYo6YqIIOc8jOR+VSXDbCqlQXHVBzj2pCGDFsZU8fMOc+lSMy7+8FsAqEAEY3NT9Plmuo2YDESDqxwfwoubZb5lYoP3R5HY46itSWG2EryW8CQFkAQIxIOfrW8YprUTetkV4xui+fgBsj3HvVS6X52K7WOcKD71rNFiKUheQo47E1Qa0jjLCQl2IyG3cZojuKTKVvB5k0aPLGoWQnk5HSoFgYSvsACZyG69Dyc1ceCWKMMMNG0mQP7pORTEkcKzSJhQxG4cZ4roVjFu2oyF0USTJuWUEEEnrzyaWRkkZi03lIOM4yT360zbBH80kbOwUYHTn1NQ293EGAWVZSjHah6GjlJ59SaBnWaJbWZ5GMmF45z7e+a6WK9lj1iS1uJLUmZU8zcv7sOPUj+LNczDdTF1mhDIYpNxbGRuzkL9TWnE2nXN55ostXSV33vB5R2k57MegosiZT7mpOFj1OeSYksRl1J5znpj+VFY17eTSalLcTxNGC+0r0Iwf8KKzdFvU2jNWONieO2jTcVy7HJX+laFpEzMWtVVFYZc7ugFZVjZtOWlcAbX2xqT9761uWiFmcouPm7dAfQetKV7CGypE4TByufnLcgGmyRB7hyyLgORyOCMdasRqzhx8jKCDhupPc+lMnkQmaRI/mBICNzvyetYxlYmxgXoEbxBQ8qmMqxJ659PSsyaBnuQ/+qeLldvqOcVoazcywmFQRJ82Vzjn8KWzSfylkmUMr5AUL0GR+ddUG2ZyiLaTNZSyG/Q3KS4CyLGCOnPvxmr0NpAwla3SdI9wC+b0znt/s06NWJiEqblBOAT9z/E1bs5VtTLjoGyQScjnpVyqXVjONOzuWoYZEeba6uT3Rcf/AFxmnqQ8rBiGIwBg8ke3pikMvnI0pZnZ3+gyT39aSQhJQJFUtySGOCfy6CuSXvM6FoicIDL8g2jO4KTkEDqSe9MQvKm3aSm8545Ynt9KrteqgdH2szDbtUZ2+3pVi1dRICNolOFx6e3PepWm5Q+U+XCMmRj0YegprShyqebxyQR/QUskmHcMQYz8rEjgfSo4YY2uVaJXZguBuwAR7UluBOxVcBDvl+6FHYfSs+5s4TGTKrEDKrjjk1NL/rUMZ2/MB8owc1ajQNuSM8KRkMc9utNaO47HPWsUunyQXVvcxQlA5yy7t3bGO/pWjYIAsasm0Z3DkjIPUYq89hG0SuViZmzjcOg9PrUIYwgvD+8ljxhmGQf9mtfaaWIUQlHmQeWW4DlkX0PrWBfqwMzgqqhsZX19q3nmedUEh3MQWYDv+FZc0ajO/BXPyg/n+NVT1ZM9DkdUtJZciKJQT90t0J9T7Vv+GL2/1MyQuwntIv3TTxR+Wp9GAPr0NS3VirZV2KkgliDx06Vd8PxPa6fLaxqq2zyb3fdhgQOg9a6aasc03dGfcFpr+K2hkSMno5woJ9zV+ezlsZ3sr0NDcIRkh9yMOxB7ipr1Ld5ZJ5IAU2rtTHGPU01jHHH5YUsgUks/AAPQj0qZKxUWV7z/AI92QMrKXACjj6nNYuqQyJGkm1mCZVlVeg7fWprm+a4LCEhVHJfv9KuaXJK0DyD94/UbuQ31rP4tDV6ai6d4jiHhmfR006Ke5mfInKnzFHoKfZWW2ztw3DF28xcHPToavROoQyFEEpYMD02jPOMVbjTzZ1IClAN4G/OT0JqpK25MfISyiZNN+zGUi0aUkQkA4btz1xWjCY127F3ttA4Hy5ogtdkMfzhRkg4H3cd6j8020irGI03KMk4P48+tYTkmbxQmoyQRxOBlfnL7M+o71jafcyySoI42KHgEgZP41cuGS7LR+bGFJOT1/Km2MU8cESSyqyREny2UDrwfmHWnBXWpT0NB0M8REeVAG4gNjn/CrEFptUY3RAuuM9vxqZYpUgjghWPOSPm9OtWnWSTYsqh3Lbm3HAY/TtU3tsUVEiXnZu/eKyl24zjpUlskiuY0J2LFkljgE1OJM/MdvOVUDt9akjhSF3Vo+Yxt4bvnvUOVwsR/YT5jB3XCqAoH8RPJpmoWojiYwOd7kgnt9MVoPG8krPICseASR/L6VFK4KoiHLDLYI689fypc1ikYMNgyRoyq6uV/1hbcC2ewrTg2qswRiNvAJHfpk1d4iiQbV+fgbe2OaryrhV4OWO4+/NKUrjZINoiAB6EAY5FRzMQW2nG0Yz/hTVVo1KpgouWPc+xpssMpgLFtm7t6c1ncRn316LJcsN7McAYzz2AqG1upgV82IK5J3Ke1aF9p8e6NmB3KdxJ5HTrUUFuRj5ud3zHHrV2jy+Y+YmCqcMRn5R26VJsXezdhzweSacAu9Qw59P8APekkVmbbnAG3cT1/Cs7dwbGLtMgbZt3EngdaeSI2D9So4x7U2KVZpWUKSoYqPf2NPnR2UiPHU5zTsxCwnYu0+u4n1pglDJ5fmKoHVj0Bz0Bqtcyi0iOM+ZjJ+vYVk+czqxlb5QAMg960jB2Gjo2kj2yBMlCQAe/1qSRgFDnaWyW6dDXO28r9VO7cRyTwK1Eu2lkZCCTt9Ogp8jWormlZwxRwsrbSHwT7561K21pEZVIIwQXH3R2qvpwk8sNIFVW4J3dB2qVi4yCFyiA5PU+hpczAinYHam8bcn64NYklxCtyFbIKvnr+lal4uWkWPdlF3YOCSaqwW1vbskkgzJnEiP2PU4ranFkSdgyruWw3lu4AQHJHamS71t2jOPNEhOQeAuec0gfynkUfLAU8x88c1TYsm0SYJYMGb2Pb3rpUTnnIg1m/gjzg+XvHbqPSudutWtUPk6cjTuOD8uCx65x7VF4unYvHIikhhhdvTiqWu3MWg6NbRWdsDeS/vpLk/eXP8I9PrTtfUzvaxo6ZNePLBG73CQTTI21Rgk54IHrXoOoGxa+htYPEWowSQMFlY5cOT754Fef+DtRdlhS6nMkrqrxkKGZSpyAM+/eu0tbPzdRa8k0KdLpsuYmu1CueufL+8AeuKTjy7EOXMyfUbHyxPLHdveSxTjzvMXayNj5c+oPrRT2u47izvI7iFkklk8y5kz1b+FQO2KKEzeG2pxPlrFcu6sWhU42k9fpWnFNmJpYwqRAll4zj1xVVrYyhSQAqvuA7Y7k1YLxGKSMqYwT8xUHhfYVx6s0ZJ5xeNicL8vGQMkeppZBiJUwyhpM+Y3UgDPSo1njihDBEK45UDJY5wM0t64jdcMS2zD5GNpPXFQPyMLULRrl45M/M7fIAOD9fSr0krtYgS7vMt8RqQMAjJOfr704yEyRiVGEYydpGWNV9VvWjtmC4GDkr649a6IT6ESVxzskSB3YldudpPX2Bqo9/KdkanP8AGQOgJ6c1my3qyuWnTaqjdw2FUfSrGmPDI4AuFkExBBU5OB2x2NaKKZm3Y20unCAtuO0Z5IAJrKv72ea/8iAOZXcDKnJOfT61euopWu1Eax+WFOD0BP8AU1UNi5viY28uZXBYAY28c0pQ5diozuTRC5t7qa2u4ZFkhfYWHOw+nHetu0kQRgu4x3kxk/X61mrOdlxHJIzNIQwkI5+X1PamrOsqzSBsEIT8/f2pSgmrIpSNBxJLIQiERMdiFs4P0pzQtFdxhZWeI54XsR6/jVeHUTmJpmLFewbG3jj/APXV43KssTCM7DlgFG5ue2R1+tQ48qtYL3YvlSu6tGNqh+RwSfWi93TM4t5MQbgMHAJz7elPjmXcQ6qrMuMA56+p9adMQsyRspHygNgc4+vastVoaJ2J/ljSDDAknBOeFPt+FZkrkEwooRWJbOeW9DitC4Q/Z0EYKOjYzngjHp2rGlaRtQSMSNFEw2tKFJJHvjtTjG7HfqWhLJ5e7YSVJ5x0H+NRS267QFXM4O5mbt/hVq3h8uORxI0gH8CrjI9R6VbeMBPmjCF1AAJzj2J7mrT5XYiSuY0keQRgMpXDdse9SonlAxxklgCcryParP2cNmTjauMjqATUqxASsqlOm3J6A+p/wrVVOxm4aGPhi+efmXCD8P5VlazOyxkxk7cDOB8o7cVrtKVVmbna2xc8f/qFYOuP5iSqp+ZnCrGOmP8A9dVuiVox+j2f2xXhi5LdD3pGNxpd35JIOThgRxV3wlrKeGb7z54UkuIVOIZBxnHBP51AksuuahLf3mEQvuOOMnrx7UWXKu4rtyfY1bV4/KVyUyE+QZ/iHXn0rWSbc6zIq7ivVSMA+wrOtgWs22xKsYQK7jkjPStS2tfJiE0YLxJtHzEAsfQD+tTO7RpTLcQDgKMiIgscHOSapawglgYKNpLBQOpPFXZpkjQlMfu4yAcgc/41St9rQSB2QSqBgk4FYKBrcxbXyBDLulMV3G21No+8M810Wnw5t3kkw754UDI+tUbZGRCUREAyzE4Yj/8AWa6CzjXy8lSGkOzI6kn+KqqPTQI7tk6rtcu3Jfk8cnimMgKRAMV5PJPfuakZ9vyk4LALnoQAeetMiJYg7iTk4+lYFj9yrF5bJk7wys3GF/xpFleW7ZYwxHBc+mKLjMqMpLKwKneDwnHT3pbWTyyHaZXIB5Xgt9aTQyZ5v35RGOGYjcRwBUCSmOZRnLlSCg5zzxThva2VjGqksMAnORTpolRVlbaMoWHPNFgJ3ZJbgIBsVFBO48YJ5qtM4FuJQMop4bPOCajEiyqxbDjAVQTnNOdBIY1wOW5x0A/pR6gQQ/MC8aEjd3PT8KtSMr7tvyjgDnqe4qq4bzJtvzZkAABqYkqhZCV2pj5uefWhlIXfvMjfcR04XPaobS2dpy8m5UJ7CpSjhcRgB2ygLc+9RtL5RA3thTkjORmkkIWVPJncliwJwMnpUSyGXeGyqhRgjtRLcLId4K/dwBSPGHynrjao6f8A16YizFDsX5TycnA/z1qWTDKyKoHzYU5/E806KFBI7o25ckAE4xUE2FnA4UBsgE8fjRa7GZmsKPMEpBWMhVxnpXMXrvNKseT5ZHyjpya6jU0BMjMAwACjrg1lX2myXUaTW7KssYAyRjiuhLSwm7DY7C40/VEsrgPEZkDJuGNx7EVqw4SZTyzszAcdapRTapqE0D6qRLHZriI/xegFb1vZyKEQoMxONxPOQR1H51o0raERb6jZGYllb74UZAxxxVqK4Myuu3amBwRg+lPjtQ0hnl43MR8vpUiO/wBkiCgEo3U9a51FbmpA+Q2VZcOhTkYyaznjaeS2aQLJGxyzc4U+laUEMgh80ZfL42kcjPU5qrdIYgse1vLDEIQ33jjkn6VvT00MpopzMjrdRqzHHHzAAnHvVS8jXa0cb7d21yCcgcdM1ZmZWhDDcgChWDHhz/Ws7VkA88EMZeNqg8Y9q3uczRz3iK3lliiEC48wkoF5574FYvj0RtY6dbRQzQ+XGFYu24se9XU1e80/VE+fEjHYWJGVB9D2qT4i6U0c6XSSzS6fKo2TuCFJxyF9cetNL3W0Zt2krmHpV2iajpE8QLNZTIDjghA3T8ea9IfS4r7xVcavb6rp5tvM8zzDP84PU/L1yB/KuT8H6VbNpsV1Fbz3E5Zg3lxFgh7bseta+maFfJc+YmnSqwO8kRMBz+FD2J66G7eaj9u1K8ngAa2Mvy5OOOBu/TNFXNUtBHrk8ZygllLAKox90ce1FZs6ISskYSN5iPKvyb8KOPugUhjIaYsRnGN3UH1qZlSUR/Z4kXamNoBIHPU+9IIgEmMuQhyM9hXHaxfmQvtaNQnyxr3A6DHWiXbczSKod9pVFXPLH1zVq3aMqNo3MegbpjtmoVGwySPxu3bdg701roGzuRqMSI5OGBK5+voKoamoEQAWP5zzz835VcDLDkMDuGDuBzWeZwsbLIvmvL8pPoPrWsFqRJmNbbbcrcqqsd+1TIOM+pHpTbPQDPdLqEd1bpJGS8jdCp9AKmQoYtk5MipHyc9z/npUn2NEZvs4KT7wCo6N710pIwZbuXEcgid4WkbH1Hf8CatWySLFNuDDkZK4yp9TWTpps3sr4XdrdyXbD/RpYyAobvuB6j6VrRWci6Y3yuwMQkZ+n1PvUuTb1KSsUp7tFcgsw8zAbHfHY/WsO4v5biY+WOB8uD3xUuuFgyReXsVejBuvHSp9BubCxntbm9gFxGrjdATjcB2/GoersjR6K42K7nV0FyNqkjpwSPSuo09pzIXBEcZw4Jb7q+vFZvivWLfxNrVudM0yKyRFEapGeoz3PSr1vObeECQK4iR4irNwvPqOtOwoyvboatmsflxM46Mcc8H6D196uQwMziRMna/zBuA3sM96woNRjZ4yG/dxjbnZw5Fbtu/mIs1wx/efMgY4AOPX1rnkmjZXIbiRmtgxB81nyR2VaSS3CZkjBQlSSeuc+vtT2BiiAzuYOS24ZAGP51TEm/zY0Xc7kAhm4AqU2thosrlcuM4Crk56n0FKzLCFbILKDhB0BznmoI5Czf6wlmXlEAAXHHNVopV3yCVztLLkDrgUasZZM29FjZSCMn5Rzj3qO4lEB5ACoBIUIzg+5p17diCEhQQZOck+/estp3u5ZnhA5BBGeMAVtCPUzk7Irv8A6xdxA3HcDuyACP8A69Z1y0cmqJNAwCq3K55AH1p+p3X2bYzD53A2Z7AVn6TZRX5lkuLsW2G5Zwdpz/n9K0td2Rk3bVmxNpkF5dPPdIbyRlZpZnbaWPb6VLAULCP5baFcEblLLx7iqVyJNKm221358LD7+0qrD6Hmug0fbKsbThpEC7cKw2gY96q+oltcu2Za4lmVPmiZQThPvt2OOwq3JasI2kc7iEXy2I4Y55A+lQaQyLCzSN5e0q5VHwzL9PSlvELW0xQZHDrl8YVj2FQ9zZKxUudzyIY+is5xnqAOetZqXkbTRKpGMkyc8ewFJeo8kV1MTIYlUZZjgkk4xUGlWdlcaFdzPIftiH92ucDHemk3ohN2NnT3SOILneSxVhuxhfWtWC5lkMIjDNFgKOd3Pr9KxbERNZWzThxCDt+U43k9s1twQhIzuURtCVBIOcjPGfSs6kdC6crmpLCsxmWUtwONoyPekSM2wMUaccEO/J98UrbgmYiC5YMzDjk+9RAtcTMX3DAGVXg5Nc3KahcgtGyKAquS44PNIVSGXa6D5Bk8dTxge9Th9kEkhLsuAVbGQAOvNOaF9rM/ytJtYbm5OTxinZjuKQojVDGQD82M9TVW8y4baeiDcOu7uRVsxl7qUcArncQeRj0qgkRcOMMQxwQw+6T/APWqUgI1d5FxGv8AqhuyegzVxFCxuW+bgbtoxmq0UYjeaNJHyygFCO/b8KuSpEnlopZkYBnLdyPerdugXKckojcgHaCchRyenX2pkNx5qgIuQTxzxx6VX1OAXIO0sCWycGrljbBVSIbV25Taep9/rU6MZm6hfTtdrDAQGL4UZ4Jxyc02WWUwYfG1WxkdD7ZqS8gRn5YYVcAY6H1/Suav5XgtZWWSXCtwD71tCKtqRJmxauRcKkbhjuOV6Y963tOlj8xFAXdg9u/tXIWi6c+lQTW12X1F5MGMDOFHU102lJJHqLpJAhWRNyEg5UD0q5wFGaaN7cghdZAokGOOvOahmQsjdFkzvLY4YUtvw3mMBkkDOKikuYo7mQsFO4hFHoPWsEtS7sSK2jfcsmRlDuJPFVoLV2kkt0OY3wWyPT3rSjUTSEptGCSvp+PrUjIBKCuNqgsvqTVKTTG1cyobB/KUq42qG9+c9a3Y1yqufkO5dxA5J+lNjjYwiFNihl3BewIPNTyBePNOTvBZQM/N7UObFYa0iNbT/OEYEklvfjFZkxCJMclySuAv8PvVq+C+YxRE5UKwHOSap274gaR8lyu3C8c5/Wle41oTiXerPhUymERjx9frVC4HmosuS20EkdQafcsPMVWAikKMF3VE8y24ACiT93hVIxk+tbw11Ikhkh+fb5Koihd+T/F2+nFRXSgySR7PlQZH+0PepAkmQ0mChA3YGct70piw8txGRvyePw7+lap6mE1oeW+PLfZdqUC+XtA+Tv8AWofEHi6bWtBt7CcgraoIoQBgBfb3966nXNL+3xxxvIY8oWHy9a5P/hG5EK4QmINyzDpRzNbEWi7XOj8ENeW2kwNDePaQPvmwjYLsOOR3rq7DVb9H826vLqTPCKjfriqHhSGCPQ1nuLXzxausCITgFmyS5xz26VufZ7eaMX+mxFlSQCaEsSY19VP93PrVGbs3qV4C940RBkeRVaScnn2zmipdVRba/wBRW2XZCgEQUH+I88GigtbGDaqyxRuckYOwE9c1LOrRuVmUhUOMjoRjpVO5nliEcMSklTuGRnAP9KuyHEaGdARggjOTk1wNmxTtrMCWUTSMp2llI52+lTlVRh5uGKJt2jtU0oVWlYJIgUKcDvVe7O8uG2Fn6YGAPQ/WmtgG3ZVI2BVZJBHtAP8ADiss/JOsIkAjh/uHOCTz+vFW76VkfzY8luQSRnpxx7Vzs3yvEgdvM3ly6/xcZ5rakr7mUxu6Py5/M+WMttZsfd+b17mpo3YxuYT8jHs2N2PX1rnry9ku3AJCxAkKi8L68+tJDBMIPN2uFH8Q5Bq+d9CeXudpbQRysI1YI0inaZDgZA7GrFtciW2WFJAGwEY5wAD/AI1zujTGWOSNwSyfdY9FHeti02xww4lJV2AfABwP/rVb95XEnZ2INU037YzRleCu5ecbce9VLfw/BG8Zm8yVCgkZCd23/PpWzDcC5uJI0QFFyoJwMgd6tRW6qBLKhePG1wvTB471Ckr+8aOLM2SGGyWWO1RF8tlbJGCc+ntT7h7dw8LfKu4OWBxyeMVX1qaaAXDTSFGdVUKDy3pn04qlpOk3OpxTPBHJI0S7iUBOB6mqbu7IjRas6OzAhtTbpcLKIV5XYMAt3B6mt6LEYRDjy4yGJK5GT1xXIaPKbi1e3VQrohLtnn0FdJprNP5AklUK4Chm9vU1FT3loaRdjN1a6KopLBI/Mzt9B6n/AAqjBdTSwieS3do5GO2Q5ILfStPXbBiLoozugKBSg+8f8KqWMk9taLaNjyvM3r8vKt0OamKTNG3bQluW4G0sWKgntjHJOaNKtI5IjdyyAOztGsW/G3vz+dOjj3FrdQzHZtKqDk4P6fWpEs4YTH5UDiZpOGPcY6e9ONrilexBqBjYPNM2UDGPYHxubHUe2azr7UVtbWG0yC6IVDRgrjPqe5q1qLvPHt8sxZk4GOFIz/OuYuJ/NvSxBfDchj96rRnK5ZuMy2DvcD5l4UZ5FVrS9hiTYzJNBv3tEf4mxj+tdjrNtGNP0/8AcKjDBmUAhgCe/rxWBrPhmzvHNzbv5CB2ACL95QeuKtws7oxUk9Ga+ueKrLVNItLI6RBG1uoVJ1yHOBxk96n0K3DWGx953xl+BnB7fhVG20G2hEcUWGfALbieR/eBPQ1u6TGWi2RZKSxtnCE5A9PQ1Mr7s1hFLY0LMP8AZ5pWUHEW2Vh1diMA4PpTbqJo7XDSDzVC+YoX5sfw/hVnLSSndIhOVwuMAcenepBEJITvdDK7jBTtjsfXiudy1N7I5jVIYcTBmJUuPlfrk+n0rPj0ZDG0iFyFySIzgt+FdDeRbppMjZhgmdu7OO+ajsLfN0qBmkZyUVs4wO/0raMklqRKLF01Gg8mAtI8ZIcKR0GOn51cYviYSASOWO4AY29ME1JHZR+cJHBVQGyQ24NgYq5HC6W7hSS8xGSrfeX0/CpnURUI2DEghZSoUkKS3J+Ue1TKgXcFbc4UFSrcMOmKbcSBFbKEyH5GOeFA71PPLvmLy4VG/d5j9AO1YORohCEWKbzCSpKhRjpTYCTKodhtz/FzgD+tPjcTecItvlovH1HrT4lRFCyGMfKME5456mk2MaFPl7WAySwZm7UbdsQKoSzr2P4cUGQA7lb7pOSTnJz1p1ukv7zzEbfj9378VKYFW4hjgvWuIQ0m2TlW6HjBp0k+H2lT3Uc9aluVQxSIcvnGDnkHvxVNnbnzBkbjjsRS8hoJcLuYY2kg5btj0qJpsuXDbiWY4HJ9jWfqdwXjJB2477vXsKx11fLFYkZ1U4J6ZrRQBux00zo8XlKMMXG44zx71gzwRtNIsgYoWJBx1q6l7HLBHJDvKhiXVqZFtmmji3BQFJC4zg+n8q1irEOzKGn2MNvMXs1wZCAzAcEdxXS2aBWM7pt2JsGD6+tNjtkhMSxqMhVOe5Oe4rVsyTbZYqUyN2Rgn0pylpYSj1Ibm4JiEaDLcA56cViFtl+6SrKIvvA4zuateabbIRuI3HcO34UhsY3tfMLsRvOQPpWcGrmiZPaiOWdUt1wicliORn0q/MWRLdIyqFQRu65J6D61RsomtVhWXONu8Y5LHsDVJ75jJGzEAKwGDyV+lV8T0E2jVubnyljYE7tu1nHHFXoCzGNip3A5Ax1BHU1zcd6Z42SGRXYvkr3HNbEEwe8XBy5UZGNoIPfH0qXHqBMw3QlmU+YflCDoMVFJC2Aq7dwYNgDkDHSrRA8pQi4TcAD3Zs96ZPHHKRE8nzBmLOOO3Q1D3GjMuLaNpjuzJFGdpOOh9aFELTxFclFVlXIzk461fhiyNwI27Tgju1VWTa0YADGLOD0zxVxk1oMaVeNQcYCRg4I4Oe9YZDw5Tc2GUlhnvWs1zHcRpArsZsfP8uAB6VXnhEqFI1AdmByx6DpmrUjJxvuZc22QW4YMTGvzEnnrxx2pLa2R1ZXwYi5DN2B9MVfnhRZg0gJG1vYcdKz4mkBiyx2cyOR0rZPuZygaOlpPaxM2mwySpMQrp5e7jnr7+lMtLXU7O4EkFndo0WQpVD82TyMdxiiwvrm3nhSLLpI+x41/5aL6cdD71O1rdwSSttviHJxvLAIOxzV8xi4kOpGT7RdTXKhZJZFkeMjDE8Z47UVWluN8bnfvlKBVkZck88mioczSMdCoIvLM0nmkuiYXucAd/emSuNw3PwGG4txjIp2xVikaTAyGLAnkccGqxmVo1UtIUfjOPT2rktcsuxIXY5xg8bmPTjn8KqCeN2QyxABC2MHhgPWo45ZWmuFRHYIu5j1x2qS6kdUjDIF2Rk/KOGye9GwFeVHS2hBBZScE9CB1Oa5W/neJGZQyyksMp/CPQ11t3C7RO5YrvC7EB6rjmuc1OKKKdkUONspJxz1ropvQylqckI28yRMjchzg16/8ONFt9V8G6zNe7BFHCfJJPKuBnIH4V5DqkDQXDzqNyhyWI71o6b4ultNNmsYrgpHOMMoXkVVP3XqZzvJFjRGcaq0K4+YEAZwp+tbnlAxbiWQFmjC7cfN2FUPCKeRdC5nZcyRnaGTcfyrRjllW8AjRf3jhgXPRuuM1SdkPd6GppsCW9qsMkMivGxJkDA9x1rXuokaGZUBXc+VJOd3Hb0/+vVSGymt7rbcNEZZVMiKjEjnvnuas20xMEW8sQu5uV5yOuKynpubLVHLeI7ISTEohWRzsRW/DknpVXRNQ1nTbe7hsleETDypSMYIz/KuiurdnG4MGfd91jjt6VSgZ1+1zLH5scbqsrkADngDHc5px11JaJtCsDYSSzXZjkJTcyr8wJzjtW3bh1mtkQDCrlwp4zjpj6VXCLHqUhIAleNU+YcjnnA7HHer/AO7VpicQHfhR/dGPWlUlZWQ4rqxs7tLbzENhOG54IXsMVSRY4o5cj+JChB5HPf1zWhcYkhIRclhtLE5bcO9QTxAW8RYIMHaT3PfB96yi2maXM4T+TJvTduckNg/e56YqaMlo0Yg7chuT0+lYryPFcpuYiNZCHaPlsdCB+Fa8zQgSfZsJFlRGAOSPUj1rVx0uQ3qQX0WyzR3O/wA18k9NpzXNaxZfMwhyJYmAXj+ddJeK0k7RoXIcq2cdfU/Ws2yS51DWk063lhj8yQrvmOFx7mqi9CZLqRWsGoXEkCXNw4QERH5t59fwrcwYUMcjearMw54Kj6D1pLWPbJHvfzvLcouDjOP4q0IoVks5FRSVVnfqMn6mrcrExhcCixFfMeVPLdSzbBjHpntipbXzY1iYkKrlyPn6D09qieM/Y3JjyX2YBOcfQd81bX955YkkRFfd1HHvxWMp8yNlGxIdymaTYoGOCDyxNTWp80RIpIZeJC2FAPOMVA5CH5mDNklc+3equpagtrDMJPkfIGOu/wB6xtdllyaJp1RLhlxkABRg5FTLE6FkBSPa6hCAOtVdIvo7m6jKMNkisTuXvjv/ACrR+dLOMCIEhhgnGQep+tDvHcYpKxGPbtDAdVHPJ709wzLD/rGMXGQcZJP+FMjxcI5CBWZcnPDDB55qG4nKwK7bUVpMkg89MDFTLcEPhRQ0R2sQxYghuSB60ydHmlcjKlQCAONx9KS2M0l5GqROkbts2kDcOOTirMg2PP8AOx+QD5T27cVTjbcFuR20mfMSXarM3yKBkn1qctFJczFifLBG/jGT1wKppH+9XiVdi5AGOfX9asqN8Y25VWRiwJ549vxpPYdyQ7Wd0jwFKbzjuaVF8rzGL42gc/e571G7hIXbawQIFDg5HPfFRRMrRHeclmC7R6dagaJWjUHILE4wcjBOaq3roIo2JOSvyqe9SyuWQFEy5b5cnnIHNZmqSSOkqqFYqoK/1qox1uM5zX7lo0WH7qscAL6iq+h2Ml55kdtt87HIJ5NRanbmeJ1jP76PB5Ock9hWRZXtzaXqoivHOTjBHf611RsnqYzbtZG5byXmm3S2V1GykN/quh5963bZfJkjzJslhYEuOTzzj61z9mNQv9R+0XyyMYm25Y8lh0Fb9uCL6FTGWYkyPjkA45q9CEzTtJC7JIFLsc7uM+4yatBsBVfGV+Zsc89hVOKTyk2xlE+UqQnGfp71SF2XvAVB2khQW4H1rCUG2bJ6FjVTMssTxqMdcHpnqRV7S5FlmElxwrYG0DaoOKgQ74ZG++Ef09T1FaMMSqgKyZ2MMk88/Ss3Fx0GRX8/2ZIpAQ7LnIU9e3Fcjq1+0cSCML8+MHqc1113H+4Viq/PuCj+tcLq8DuFVPlY4I9fwrSDshM6R7NdM0jSb4TGSW8co6bhlB7e9acc2y4RM751YJtPRePWuG02ymleJ725yA+Aoz26Guq0og33mKFEZJHznvjrWjslcmN1udJDKEYxfMV55B5PtUU0zLHubhSMlc557c1FnyiSAzooz6ZzVOZlV2EuBCUGecD6VzqNzVGha3bSwOjHbtUEFfzNWW2+ercAhRgdevr71mwzZKtGdokO0YHRR7VcEqRq3UhRgD146k1Ti0Fyv5aW8gdyMgscjvSGTHLhC7jBwc45/wAKkziBEjO6Rsq2RjAIqGG2ELBo4wwEfDAE9aSZJBfxmSaQ7NxBVRtPUYqK9hBndjHmNUCBV5wT0/CtkiKHf5uGXaHXaOQe5JquYwLZZNyKSS2TngdiatMkraKsv2LUEs3WO6L4VmO07cYOG7c0WFpr0EiySzsj9MyzDaOep554qxbw2yWlzNcgzQxyDEYbaDxnJNVprWK4Rbux8xoVbLwsctGWIGfdferTMpWuxL23hutQvBAoWEuvk44BHoPYnmin6zbvp0t4sMe2ORz5e1uQoAHFFNouL0Ryio8lvNJsBVW3FgcFu549KkDAeW0abScsvy8KDVW2CzQoc+Wm4pktnB7n9K0HkU25Yn7rGMKOw9qytYzuJHK0SNICfMdRluMcmoTFvtPNyR5j7emB65pYFRZF7KiEkHn1wMUisGKPKR5QcqdpyOnSpeoDpZI9i7QyNGuMNzWbPZgxyI4zJI+/zM5zz+lX2IJmi29xIUznjqAKijPmAzOu1ME4yT17VUdAepgf2fHNK6iDILFx744/EVn2mg2nnLcxxKjEbm+bJU9uDXTSQJGyGNgQh53ZPTv9Kq2ab1aMoGIIIwMYH866IyVjKULle7jVJbdd6GTucYwDjaDWtDa29x5SSxqyj/WFTyPTmnwwRPclHKMANu6XOd3sKlslRHVmEWMlSSvUetKUlcqMSTTIRFITEZmjRmKEvkKvpVyxQNbKq4COWy3cfQUyNWhvFEEBcr8zL2Ix/OpLUL5ULkSblYkKRwDg84rKTu9TXoLNFueR9saRhdyErwWHGTWZFpUcNzB57NJnLvEvyjd2OfWr07yxwxtjJB5LEZznOKueZGWGXLnaHww6t3z6Uk7BczrmUpBHuVQxByfbPX61kQXV1qK3DwWs03lYZnRSVjX1PpW5fjzk8uNt24AgEfmKyNFE8Nu8DzstpcSktErFVYgcbsdR7VUEnqF9NDSgWaRsP8oVfMVmOM54I4rSvAt1t8oDbHnzPlPXHX3rMmkkFtAhRhuP75hjaxzwBWlMyi22IY1JfI2jORj1pSSV7AzDTTtsucsiFmdX253cdKtIhNvGdsjM+Sz8Dkegq9NJIAXdQvyhhuHeokjeO1cTREyEZBHTp39qSk9gIpox+5fG3cclQc5H9BXP3WlLNcCSMOqEuflbAFbl9KpwAGxhcDHI+pqCP53kEiop2EA7hxiqhd7jbE09Y4bZMn7mGC8bfr61qxtFEybFwNm9l7E4PP8A9asiLyWTYzhmZVBCDBGPetSORixf76snB6cdOtXJEpotNEstmhWQ793QHHQUgjAu4mXcVz0bkZq2qL5khCDcUGHPGfYVVj4cSFCxCkFcfLk9qxfRF3uAnHkANIv3sEEckf4ZrntUhlkkWYFCxcKEByBWnKGRJQ8O7aNmB/DWVAsS30sd58sRjJBHG044OKqK1K6GhpI2X8Tzw7VQHdGMjdW/G4U25EZySdu5s+WuaxtFlBWCaSMn5NoY9SB3rVkdUO6UsxMgCDOM98YqZ7ghzuJC6SOoJLFMDP41kajOzkRwkkJyHx0I7Cr18QkcjKjKY9r8HgZPQ1y+q6hLE8zbdhlPyAHgCnTiuopSsdBBeTrOGMq5ZCpdlOQx74HerFndtIwDAHMYUOOMgHk1zkNrqFvYRa0Z0ktJX8pyrAsmPVe1bB1ON5cRFXHlhfl4wOuK1cdNSIzubocNIsnL7WVAAcZPfj0pyMI1fIG0kgqeNuetUhcPEvn4/ebQxJ7VnJqLtePFvDRqRJhm61zNXdjVG0xBjVFwcHODwBjvUELEI53chcDPJzUc0pktN5LAuxbaOuMdvasm6uityqlii+ucnAHA+tLl1GjbYs8brgbhyB6niq8iNiNCFVScHjr3xToZ4xskkRULJjLdv/r1K7AAkkYUcH39aNUK5y19ZFLlzHxuO7bntWZqFq0rOI1+ZTv69DXVX9puld4wQ2zAGMcVkRo4mcyA7jg9fu1rCXRktdhtoJGdTcEtKT5jDoBgYwa2Xt/Js47kj91K3ybTj8PeqUIUFSAc5JdmH3jmm3DTpbpCJOAwZF3E7c+laqV9COW2pI13GJ4lkdlCsW5HQ+hNLOZHWNjtMrjjPAbnPFYNrqUGm6sf7VtheRcqI2Jxz3yK27XzPItzNGpCLuVRyRk8An2FUtgu72NSC4Xybl5VHmHCgdh3q9DdKQqhlxhXKkdTmqAj82HLYA8z5mA9uBipLSPmMOoEwBABPH1NYTd2aXNC4Vw8iyoAyKcY7Z6Csu7sVkIeMANCOxz9c1qSybo2Y7CzEgHOM4pcBmQCMhGAB2jk1mpWegzm4tJcx71OMfPkn3rorS0jFnHLEoIUFWdjks1RzBbgSMgCLgbwTz1plv5UDjYfMB5Zc9s8VTnd6klqZykshOeVxx3OKxryGeaJlBR+MAFvxrUkiDRK38TZGfQf41kTEoo3gsoPTqSKIbl30GNqVwbhJJ9ykKFIUABlHatF9ahupVWFV8sgFgeORWclrJNAQoxGxwGzjn/61T6fYog3YAAXJYDv/nvVzkC0NcsXY4AJK7s5604PcBHUYSNAEXHH1pscJkEC5CNJknP8Y/p9KITuEayEgliTkVnqJk0bAiN2IKSp5e4fw+31qG4VbhgqMUiUAN6fhUStlQCegymB36Zq15bhXbG0rtUkkYB/x71STJuR28xggvVYReU/BSQZDjoOPUetXdFW3tbkXjPhFjMfXJkPYY9M1Bp1ik8cc0yZIbywrg7VJySzeuKsT3McytxbSGF8hY12OFB++CO464rSN7akSad0ZGvXMs4uEkASfPRemSec+gAoqvqUTwS3MYbzFik2lm/jJOc570VWpSaRzdvKv2dHkZssV6LwDnnj1ovrtpJkj4HPzMD2PHbvS2wBt4AQMecv9aiCgPa4AGVP/oVZPUyLTM6TERqFZQVOFzkYp8WTbRMwQbHYY+o61XuWbde8nuOv0p9r/wAe0X1FLuhvYiuWkFmkihQF+Tcf4RnNPti8Vorq7BJCMjsADwarap/qMdix/lWlafNpL7ucQcZppC6DZZBcT4RRG8kYUgD07k1nXG1HjBb5jlmOcYHSp3J8+I5OfLb+VMm5t5s/88jTW9gMxNUMc4QuN2S2cdMitiyiMs6RgSJE6Eo7sOccGsDRlV/EFkrqGXA4IyK2rhj/AGg4ycLJgDPQe1bR1REnqa1ozhyMHCZQgZI471FJcrFbK+8hlxnPfnAqO1J8g8n74qrfc21zntsrJLU0GjUjJNIsTbdxOC3JJq3BcrPcgsd2flzvADYrj9QJEXBI6Vq6GMrZZ9RTUU9AbOrlkR7otGpkVeDx7dP/AK9Z6PFBNG7jEeAQV6g554qaPiS4xxx/Ws7VuL+1A6BqjZlR1NdJF+yPnIi3b8NyG5/SneYrrBtRCyEtGBwQMVPF9x1/hBPH/AqjvflLkcHe449MUNK4XInuPMMiZA2kYJJJ+lFx+7EoO/bwCQRwCKz9M5nuM/8APQUSE7brnsf50og2RXAdvMG4JvwMZzgZrEv7stMBDgn7uF/z1q7McST4/vLWXgHVCMcZH863itCJOxt2NpKIxcPg/IGUBwPl5zn0Oa0LeQIgV+diZURkt+Jx/KsC+dl8ZzIrEIwwVB4I9MV0w+SSAJ8oMRyBxnmtbKxzqTuWEuCZZNuVjRccdSW6GrsO9pNk0hRQcdcHp1NZF2MTNjj5I61LL/j8X3jOffiuWW51xJpEAguPLC/MQpYjJzkc1liyje5/f+SVAzuI5JrXwBZvgAfP2+tZep8ahbY9KlllqCCMjbErMozyB0WnX1urSFIyCFG9W54JHSnAlYI9pIyvOPpVW6ZiJgWONo71LGF22bUL8ylGAHHB75NczewyzIYhjexJZiO2eldbLwYccZAz+VYoAbUJAQCPObg/StKTvuRLY5u3gujiCeYCFXDBATgg966HT44d7AABSGIKqSSPQ0wKBcWmAPuf+zVo6WAA+OPnP9a0eiJRow/vY4i5zvAyuPQcZrHudO3yC4jVvmzuz0xWpb/6mD6U6+JEc2Dj/wDXXMzRMSDDKgbIcITkdx0qlJakvE8ifKBnJ5OfenWJJnAP9z+tX5P9fOO248fhRbqO9iIR4+WVP4sAEdO9SCYyBniXgEAjtxVp+VGefnH8qpvw82OPkahiJZeCr4ADErjPIFVLmLy952qzMCB3/OpICSseTnk/ypJOYZSeTk8/jTDqZ9xlPMERy5AXPbFTNJDPAscjbZUKnK9WGOarHmyuyeoK8/hV/TQDZxEjJ3dT9KuDGzmryz3TMdgQEH5TyRzmtDTzLvRpHLurfKvYDHWtGABo7jcAf3jdaggACTEAA7hT5iWXN7xLgAMQwYj3PPNaAd3mOwbTgtj1Pp9Kpzj5wOxB4/AVoxf6zHYRce1Ta7C+hXCu6xnzDg88DIX1qXzkSQ+dIFxjqevtTof+PFf94fyrPvQDO3A++KlIottIi2pVV+Z3IO7sM8Um0OyFeHKDcPU571HEMxvn/nsKfLxcTEdd39KGriH21yklxIoyWClhz3qmYo3YZ5LjawB6H2rGu2ZbxdrEZTsa17IkoSeuDz+FaJWSaK2HJ52+NWl/coSdv+e9S20oh3MvzFQCOc4HvUXWK3/3TUkgx9ox/wA8ql6k3JxKBFCqAls/M5ONoNJcXMStI0Lh1VRjAO7OcVXn4Qgeo/lUF2AthIygBsDkdaI6sC7NeK7u0X3gqrkDgc/0pJJrlboRxybkMgYDbkZHeqlmeJP+un9Ku2//AB6QnvsatbEyNS01NYIlt7q5CR+fvMoGVL+jex6UkjQpEHlitraORW81o5fMZlz0UDpn3rOlALFSBtETHHbO2qDEgR44yAD+VWkZuPUs3l8peaSQK7ljIY8Yx6c9uMUVmarxI47F+aKZR//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Vesicles and&nbsp;inflammatory papules and plaques are present&nbsp;in this patient with Sweet syndrome.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from:",
"     <a href=\"file://www.visualdx.com\" target=\"_blank\">",
"      www.visualdx.com",
"     </a>",
"     . Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_13_43221=[""].join("\n");
var outline_f42_13_43221=null;
var title_f42_13_43222="Axitinib: Drug information";
var content_f42_13_43222=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Axitinib: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?18/61/19414?source=see_link\">",
"    see \"Axitinib: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F13811819\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Inlyta&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F15125561\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Inlyta&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F13745298\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antineoplastic Agent, Tyrosine Kinase Inhibitor;",
"     </li>",
"     <li>",
"      Vascular Endothelial Growth Factor (VEGF) Inhibitor",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F13786577\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Renal cell cancer, advanced:",
"     </b>",
"     Oral: Initial: 5 mg twice daily (approximately every 12 hours)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <i>",
"      Dose increases:",
"     </i>",
"     If dose is tolerated (no adverse events above grade 2, blood pressure is normal and no antihypertensive use) for at least 2 consecutive weeks, may increase the dose to 7 mg twice daily, and then further increase (using the same tolerance criteria) to 10 mg twice daily.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <i>",
"      Dose decreases:",
"     </i>",
"     For adverse events, reduce dose from 5 mg twice daily to 3 mg twice daily; further reduce to 2 mg twice daily if adverse events persist.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <i>",
"      Dosage adjustment for strong CYP3A4 inhibitors:",
"     </i>",
"     Avoid concomitant administration with strong CYP3A4 inhibitors (eg, clarithromycin, itraconazole, ketoconazole, nefazodone, protease inhibitors, telithromycin, voriconazole, grapefruit juice); if concomitant administration with a strong CYP3A4 inhibitor cannot be avoided, ~50% dosage reduction is recommended; adjust dose based on individual tolerance and safety. When the strong CYP3A4 inhibitor is discontinued, resume previous axitinib dose after 3-5 half-lives of the inhibitor have passed.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F13786578\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing. No adjustment necessary.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F13786575\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     Mild-to-severe renal impairment (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     15 to &lt;89 mL/minute): No initial dosage adjustment necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     End-stage renal disease: (ESRD) No dosage adjustment provided in the manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F13786574\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     Mild impairment (Child-Pugh class A): No starting dosage adjustment necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     Moderate impairment (Child-Pugh class B): Reduce starting dose by ~50%; increase or decrease based on individual tolerance.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     Severe impairment (Child-Pugh class C): No dosage adjustment provided in the manufacturer&rsquo;s labeling (has not been studied).",
"    </p>",
"   </div>",
"   <div class=\"block dot drugH1Div\" id=\"F13786647\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adjustment for Toxicity",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     <b>",
"      Adverse events:",
"     </b>",
"     May require temporary interruption, dose decreases (reduce dose from 5 mg twice daily to 3 mg twice daily; further reduce to 2 mg twice daily) or discontinuation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     <b>",
"      Hypertension:",
"     </b>",
"     Treat with standard antihypertensive therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Persistent hypertension: May require dose reduction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Severe, persistent (despite antihypertensives and dose reduction), or evidence of hypertensive crisis: Discontinue treatment",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     <b>",
"      Hemorrhage:",
"     </b>",
"     Any bleeding requiring medical intervention: Temporarily interrupt treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     <b>",
"      Proteinuria (moderate-to-severe):",
"     </b>",
"     Reduce dose or temporarily interrupt treatment.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F13791478\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Inlyta&reg;: 1 mg, 5 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F13786545\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block accres drugH1Div\" id=\"F13804152\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Prescribing and Access Restrictions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Available from select specialty pharmacies. Further information may be obtained at 877-744-5675 or www.inlytahcp.com.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F13786579\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: Swallow tablet whole with a glass of water. May be taken with or without food. If a dose is missed or vomited, do not make up; resume dosing with the next scheduled dose.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (meets NIOSH, 2012 criteria)",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F13745300\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of advanced renal cell cancer (RCC) after failure of one prior systemic treatment",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F13786544\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Axitinib may be confused with gefitinib, imatinib, pazopanib, ponatinib, SORAfenib, SUNItinib, vandetanib, vemurafenib",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This medication is in a class the Institute for Safe Medication Practices (ISMP) includes among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F13786554\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cardiovascular: Hypertension (40%; grades 3/4: 16%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Fatigue (39%), dysphonia (31%), headache (14%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Dermatologic: Palmar-plantar erythrodysesthesia syndrome (27%; grades 3/4: 5%), rash (13%; grades 3/4: &lt;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Endocrine &amp; metabolic: Bicarbonate decreased (44%), hypocalcemia (39%), hyperglycemia (28%), hypothyroidism (19%; grades 3/4: &lt;1%), hypernatremia (17%), hyperkalemia (15%), hypoalbuminemia (15%),  hyponatremia (13%), hypophosphatemia (13%), hypoglycemia (11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Diarrhea (55%; grades 3/4: 11%), appetite decreased (34%), nausea (32%; grades 3/4: 3%), lipase increased (3% to 27%), amylase increased (25%), weight loss (25%), vomiting (24%; grades 3/4: 3%), constipation (20%), mucosal inflammation (15%), stomatitis (15%), abdominal pain (8% to 14%), taste alteration (11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Hematologic: Anemia (4% to 35%; grades 3/4: &lt;1%), lymphopenia (33%; grades 3/4: 3%), hemorrhage (16%; grades 3/4 1%), thrombocytopenia (15%; grades 3/4: &lt;1%), leukopenia (11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Hepatic: Alkaline phosphatase increased (30%), ALT increased (22%; grades 3/4: &lt;1%), AST increased (20%; grades 3/4: &lt;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Neuromuscular &amp; skeletal: Weakness (21%), arthralgia (15%), limb pain (13%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Renal: Creatinine increased (55%), proteinuria (11%; grade 3: 3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Respiratory: Cough (15%), dyspnea (15%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cardiovascular: Venous thrombotic events (grades 3/4: 3%), arterial thrombotic events (2%; grade 3/4: 1%), deep vein thrombosis (1%), transient ischemic attack (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Dizziness (9%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Dermatologic: Dry skin (10%), pruritus (7%), alopecia (4%), erythema (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Endocrine &amp; metabolic: Dehydration (6%), hyperthyroidism (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Dyspepsia (10%), hemorrhoids (4%), rectal hemorrhage (2%), fistula (1%), gastrointestinal perforation (&le;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Hematologic: Hemoglobin increased (9%), polycythemia (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Neuromuscular &amp; skeletal: Myalgia (7%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Ocular: Retinal vein occlusion/thrombosis (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Otic: Tinnitus (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Renal: Hematuria (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Respiratory: Epistaxis (6%), hemoptysis (2%), pulmonary embolism (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &lt;1% (Limited to important or life-threatening): Cerebral bleeding, cerebrovascular accident, fever, hypertensive crisis, heart failure, neutropenia, reversible posterior leukoencephalopathy syndrome (RPLS)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F13786550\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no contraindications listed within the manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F13786551\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gastrointestinal events: Gastrointestinal perforation and fistulas (including a fatality) have been reported. Monitor for signs/symptoms throughout treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hemorrhage: Hemorrhagic events (cerebral hemorrhage, gastrointestinal hemorrhage, hematuria, hemoptysis, and melena) have been reported (with some fatalities). Temporarily interrupt treatment with any hemorrhage requiring medical intervention.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypertension: May cause hypertension; the median onset is within the first month, and has been observed as early as 4 days after treatment initiation. Hypertensive crisis has been reported. Blood pressure should be well-controlled prior to treatment initiation. Monitor blood pressure and treat with standard antihypertensive therapy. Persistent hypertension (despite antihypertensive therapy) may require dose reduction; discontinue if severe and persistent despite concomitant antihypertensives (or dose reduction), or with evidence of hypertensive crisis. Monitor for hypotension if on antihypertensive therapy and axitinib is withheld or discontinued.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Proteinuria: Proteinuria is associated with use. Monitor for proteinuria. If moderate or severe proteinuria occurs, reduce dose or temporarily withhold treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Reversible posterior leukoencephalopathy syndrome (RPLS): Cases of RPLS have been reported. Symptoms of RPLS include confusion, headache, hypertension (mild-to-severe), lethargy, seizure, blindness and/or other vision or neurologic disturbances; interrupt treatment and manage hypertension. MRI is recommended to confirm RPLS diagnosis. Discontinue axitinib if RPLS is confirmed. The safety of reinitiating axitinib in patients previously experiencing RPLS is unknown.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thrombotic events: Arterial thrombotic events (cerebrovascular accident, MI, retinal artery occlusion, and transient ischemic attack), with fatalities, have been reported. Venous thrombotic events, including pulmonary embolism, deep vein thrombosis, retinal vein occlusion and retinal vein thrombosis, have been observed (with some fatalities). Use with caution in patients with a history of or risks for arterial or venous thrombotic events; has not been studied in patients within 12 months of an arterial thrombotic event or within 6 months of a venous thrombotic event.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thyroid dysfunction: Hypothyroidism occurs commonly with tyrosine kinase inhibitors, including axitinib. Hyperthyroidism has also been reported. Monitor thyroid function. Thyroid disorders should be treated according to standard practice to achieve/maintain euthyroid state.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Wound healing complications: Although the effect on wound healing has not been studied with axitinib, vascular endothelial growth factor (VEGF) receptor inhibitors are associated with impaired wound healing. Discontinue treatment at least 24 hours prior to scheduled surgery; treatment reinitiation should be guided by clinical judgment and wound assessment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Brain metastases: Has not been studied in patients with evidence of untreated brain metastases; use is not recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gastrointestinal bleeding: Has not been studied in patients with recent active gastrointestinal bleeding; use is not recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Systemic exposure to axitinib is increased in patients with moderate impairment (Child-Pugh class B); dose reductions are recommended. Has not been studied in patients with severe impairment (Child-Pugh class C). Increases in ALT have been observed; monitor liver function tests.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Special handling:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hazardous agent: Use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (meets NIOSH, 2012 criteria)",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13800670\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP1A2 (minor), CYP2C19 (minor), CYP3A4 (major), UGT1A1;",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F13800668\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiac Glycosides: Antineoplastic Agents may decrease the absorption of Cardiac Glycosides. This may only affect digoxin tablets.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Digitoxin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May decrease the serum concentration of Axitinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Weakly to Moderately Effective): May decrease the serum concentration of Axitinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Moderate): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May increase the serum concentration of Axitinib. Management: Avoid concurrent use of axitinib with any strong CYP3A inhibitor whenever possible.  If a strong CYP3A inhibitor must be used with axitinib, a 50% axitinib dose reduction is recommended.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Grapefruit Juice: May increase the serum concentration of Axitinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP3A4 Substrates. Management: Minimize doses of CYP3A4 substrates, and monitor for increased concentrations/toxicity, during and 2 weeks following treatment with mifepristone. Avoid cyclosporine, dihydroergotamine, ergotamine, fentanyl, pimozide, quinidine, sirolimus, and tacrolimus.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     St Johns Wort: May decrease the serum concentration of Axitinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Antineoplastic Agents may enhance the anticoagulant effect of Vitamin K Antagonists. Antineoplastic Agents may diminish the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F13786558\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Food: Axitinib serum concentrations may be increased when taken with grapefruit or grapefruit juice. Management: Avoid concurrent use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herb/Nutraceutical: St John&rsquo;s wort may decrease axitinib serum concentrations. Management: Avoid concurrent use.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F13786546\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     D (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13786547\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic, embryotoxic, and fetotoxic events were observed in animal reproduction studies when administered in doses less than the normal human dose. Based on its mechanism of action and because axitinib inhibits angiogenesis (a critical component of fetal development), adverse effects on pregnancy would be expected. Women of childbearing potential should be advised to avoid pregnancy during therapy.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F13786548\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F13786549\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The decision to discontinue axitinib or discontinue breast-feeding during therapy should take into account the benefits of treatment to the mother.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F13786581\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be taken without regard to food. Avoid grapefruit and grapefruit juice.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16322929\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Inlyta Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1 mg (180): $11007.36",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg (60): $11007.36",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F13786582\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hepatic function (ALT, AST, and bilirubin; baseline and periodic), thyroid function (baseline and periodic), urinalysis (for proteinuria; baseline and periodically); blood pressure, signs/symptoms of RPLS, gastrointestinal bleeding/perforation/fistula",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     Thyroid function testing recommendations (Hamnvik, 2011):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Preexisting levothyroxine therapy: Obtain baseline TSH levels, then monitor every 4 weeks until levels and levothyroxine dose are stable, then monitor every 2 months",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Without pre-existing thyroid hormone replacement: TSH at baseline, then monthly for 4 months, then every 2-3 months",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F13786561\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Axitinib is a selective second generation tyrosine kinase inhibitor which blocks angiogenesis and tumor growth by inhibiting vascular endothelial growth factor receptors (VEGFR-1, VEGFR-2, and VEGFR-3).",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F13786563\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Absorption: Rapid (Rugo, 2005)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 160 L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protein binding: &gt;99%; to albumin (primarily) and to alpha",
"     <sub>",
"      1",
"     </sub>",
"     acid glycoprotein (AAG)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metabolism: Hepatic; primarily via CYP3A4/5 and to a lesser extend via CYP1A2, CYP2C19 and UGT1A1",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bioavailability: 58%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life elimination: 2.5-6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Time to peak: 2.5-4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Excretion: Feces (~41%; 12% as unchanged drug); urine (~23%; as metabolites)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Hamnvik OP, Larsen PR, and Marqusee E, &ldquo;Thyroid Dysfunction From Antineoplastic Agents,&rdquo;",
"      <i>",
"       J Natl Cancer Inst",
"      </i>",
"      , 2011, 103(21):1572-87.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/13/43222/abstract-text/22010182/pubmed\" id=\"22010182\" target=\"_blank\">",
"        22010182",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Occupational Safety and Health (NIOSH), \"NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012.\" Available at",
"      <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"       file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf",
"      </a>",
"      . Accessed January 21, 2013.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pithavala YK, Chen Y, Toh M, et al, &ldquo;Evaluation of the Effect of Food on the Pharmacokinetics of Axitinib in Healthy Volunteers,&rdquo;",
"      <i>",
"       Cancer Chemother Pharmacol",
"      </i>",
"      , 2012, 70(1):103-12.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/13/43222/abstract-text/22644797/pubmed\" id=\"22644797\" target=\"_blank\">",
"        22644797",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rini  BI, Escudier B, Tomczak P, et al, &ldquo;Comparative Effectiveness of Axitinib Versus Sorafenib in Advanced Renal Cell Carcinoma (AXIS): A Randomised Phase 3 Trial,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 2011, 378(9807):1931-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/13/43222/abstract-text/22056247/pubmed\" id=\"22056247\" target=\"_blank\">",
"        22056247",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rini BI, Escudier BJ, Michaelson MD, et al, &ldquo;Phase III AXIS Trial for Second-Line Metastatic Renal Cell Carcinoma (Mrcc): Effect of Prior First-Line Treatment Duration and Axitinib Dose Titration on Axitinib Efficacy,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2012, 30(5):354 [abstract 354 from 2012 ASCO Genitourinary Cancers Symposium].",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rini BI, Wilding G, Hudes G, et al, &ldquo;Phase II Study of Axitinib in Sorafenib-Refractory Metastatic Renal Cell Carcinoma,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2009, 27(27):4462-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/13/43222/abstract-text/19652060/pubmed\" id=\"19652060\" target=\"_blank\">",
"        19652060",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rixe O, Bukowski RM, Michaelson MD, et al, &ldquo;Axitinib Treatment in Patients With Cytokine-Refractory Metastatic Renal-Cell Cancer: A Phase II Study,&rdquo;",
"      <i>",
"       Lancet Oncol",
"      </i>",
"      , 2007, 8(11):975-84.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/13/43222/abstract-text/17959415/pubmed\" id=\"17959415\" target=\"_blank\">",
"        17959415",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rugo HS, Herbst RS, Liu G, et al, &ldquo;Phase I Trial of the Oral Antiangiogenesis Agent AG-013736 in Patients With Advanced Solid Tumors: Pharmacokinetic and Clinical Results,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2005, 23(24):5474-83.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/13/43222/abstract-text/16027439/pubmed\" id=\"16027439\" target=\"_blank\">",
"        16027439",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 17141 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-58.240.98.179-704953041C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_13_43222=[""].join("\n");
var outline_f42_13_43222=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13811819\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15125561\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13745298\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13786577\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13786578\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13786575\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13786574\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13786647\">",
"      Dosing: Adjustment for Toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13791478\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13786545\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13804152\">",
"      Prescribing and Access Restrictions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13786579\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13745300\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13786544\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13786554\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13786550\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13786551\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13800670\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13800668\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13786558\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13786546\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13786547\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13786548\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13786549\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13786581\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16322929\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13786582\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13786561\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13786563\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/17141\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/17141|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?18/61/19414?source=related_link\">",
"      Axitinib: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_13_43223="Management of apnea of prematurity";
var content_f42_13_43223=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management of apnea of prematurity",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/13/43223/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/13/43223/contributors\">",
"     Richard Martin, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/13/43223/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/13/43223/contributors\">",
"     Joseph A Garcia-Prats, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/13/43223/contributors\">",
"     George B Mallory, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/13/43223/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/13/43223/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?42/13/43223/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 21, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Apnea of prematurity is a developmental disorder in premature infants, which occurs as a direct consequence of immature respiratory control. In an infant less than 37 weeks gestational age, apneic spells are considered clinically significant if the episodes are greater than 20-second duration or when shorter episodes are accompanied by hypoxia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bradycardia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The frequency and severity of symptoms is inversely proportional to gestational age, and almost all extremely low birth weight infants (birth weight below 1000 g) are affected [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The management of apnea of prematurity will be reviewed here. The pathogenesis, clinical features, and diagnosis of apnea of prematurity are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/4/12360?source=see_link\">",
"     \"Pathogenesis, clinical presentation, and diagnosis of apnea of prematurity\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H778059835\">",
"    <span class=\"h1\">",
"     MONITORING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Premature infants with a gestational age less than 35 weeks should be monitored for apnea because of the high prevalence of apnea in this group of patients. In most neonatal intensive care units (NICUs), cardiac monitors, pulse oximeters, and impedance pneumography are used to monitor for apnea of prematurity and its associated bradycardia and hypoxemia. The accuracy of pneumography is limited by movement artifacts and the inability to detect obstructive apnea episodes, and is generally not used. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/4/12360?source=see_link&amp;anchor=H372637470#H372637470\">",
"     \"Pathogenesis, clinical presentation, and diagnosis of apnea of prematurity\", section on 'Incidence'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/61/29656?source=see_link\">",
"     \"Oxygen monitoring and therapy in the newborn\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/61/29656?source=see_link&amp;anchor=H15#H15\">",
"     \"Oxygen monitoring and therapy in the newborn\", section on 'Pulse oximetry'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are no data on the optimal threshold settings to determine significant apnea events. In our practice, we use the following threshold settings to detect episodes of apnea and its associated bradycardia and hypoxemia. The lower thresholds are used when the decision is being made to discontinue",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/20/32069?source=see_link\">",
"     caffeine",
"    </a>",
"    therapy or discharge the infant home. Other centers utilize different parameters.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Apnea &ge;15 or 20 seconds",
"     </li>",
"     <li>",
"      Heart rate &le;70 or 80 beats per minute",
"     </li>",
"     <li>",
"      Oxygen saturation (SpO2) less than 80 or 85 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17699592\">",
"    <span class=\"h1\">",
"     MANAGEMENT OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of apnea of prematurity is instituted if:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Apneic spells are frequent, prolonged, or associated with bradycardia or frequent hemoglobin oxygen saturation (SpO2) values. In our practice, we use oxygen saturation (SpO2) threshold of 85 percent or less.",
"      <br/>",
"      <br/>",
"      <strong>",
"       OR",
"      </strong>",
"     </li>",
"     <li>",
"      The infant requires intervention with bag and mask ventilation, or multiple episodes of tactile stimulation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Therapy often is needed for several weeks until the apnea resolves as the respiratory control of the infant matures.",
"   </p>",
"   <p>",
"    Management is a combination of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      General measures that reduce the risk of apnea or its associated hypoxia",
"     </li>",
"     <li>",
"      Nasal continuous positive airway pressure",
"     </li>",
"     <li>",
"      Methylxanthine therapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients who fail to respond to these interventions require intubation and mechanical ventilation or may be a candidate for nasal intermittent positive pressure ventilation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/39/4729?source=see_link&amp;anchor=H3#H3\">",
"     \"Mechanical ventilation in neonates\", section on 'Indications for ventilation'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H450997925\">",
"     'Nasal intermittent positive pressure ventilation'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     GENERAL MEASURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;General measures are usually preventive in nature and are applied to all infants less than 35 weeks gestation who are at risk for apnea. These interventions are directed towards eliminating factors that increase the risk of apnea or reduce the prevalence of associated hypoxia.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Environmental temperature control &ndash; A servo-controlled radiant warmer or incubator is used to provide a stable thermal environment, thereby eliminating temperature fluctuations that precipitate apneic episodes. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/4/12360?source=see_link&amp;anchor=H2#H2\">",
"       \"Pathogenesis, clinical presentation, and diagnosis of apnea of prematurity\", section on 'Pathogenesis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Consider underlying causes of new onset of apnea or increased severity, such as neonatal sepsis. Temperature instability may be a manifestation of sepsis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/4/12360?source=see_link&amp;anchor=H723201127#H723201127\">",
"       \"Pathogenesis, clinical presentation, and diagnosis of apnea of prematurity\", section on 'Differential diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Head and neck position &ndash; Infants are positioned to avoid extreme flexion or extension of the neck, which decreases the patency of the upper airway. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/4/12360?source=see_link&amp;anchor=H89276269#H89276269\">",
"       \"Pathogenesis, clinical presentation, and diagnosis of apnea of prematurity\", section on 'Upper airway patency'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Maintain nasal patency &ndash; Nasal patency is preserved by avoiding vigorous nasal suctioning or prolonged use of nasogastric tubes. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/4/12360?source=see_link&amp;anchor=H747224#H747224\">",
"       \"Pathogenesis, clinical presentation, and diagnosis of apnea of prematurity\", section on 'Nasal obstruction'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Oxygen supplementation to maintain SpO2 90 to 95 percent &ndash; We provide oxygen supplementation to avoid episodes of severe hypoxia. We use pulse oximetry to monitor oxygen saturation in infants with apnea. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/61/29656?source=see_link&amp;anchor=H18#H18\">",
"       \"Oxygen monitoring and therapy in the newborn\", section on 'Oxygen target levels'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nasal continuous positive airway pressure (CPAP) reduces the incidence of mixed and obstructive apnea, maintains functional residual capacity (FRC), and alters timing of breathing in preterm infants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. CPAP is thought to be effective by splinting the pharyngeal airway with positive pressure, thereby reducing the risk of upper airway collapse and obstruction. CPAP decreases respiratory frequency, primarily by prolongation of expiratory time, without altering ventilatory response to CO2 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/5\">",
"     5",
"    </a>",
"    ]. CPAP also increases oxygenation by improving ventilation-perfusion matching and provides continuous distending pressure that optimizes FRC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/4/12360?source=see_link&amp;anchor=H89276269#H89276269\">",
"     \"Pathogenesis, clinical presentation, and diagnosis of apnea of prematurity\", section on 'Upper airway patency'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Nasal CPAP is applied using nasal prongs or in the smallest infants, a nasal mask is used to minimize nasal trauma. In our practice, CPAP is initiated at 3 to 5 cm H2O pressure. In some cases, patients have already been placed on CPAP as an intervention for respiratory distress syndrome. Although data are lacking, some clinicians may increase CPAP pressure in attempt to optimize FRC based on estimating lung volume on chest radiography. However, many of these infants have good lung compliance, and pressures above 8 cm H2O may overdistend the lungs or impair circulatory function. Changing prongs and nasal suctioning are minimized to avoid irritation, unless increased secretions obstruct nasal airflow.",
"   </p>",
"   <p>",
"    Humidified high flow nasal cannulas have also been used to treat apnea of prematurity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/6\">",
"     6",
"    </a>",
"    ]. Nasal cannulae are an effective method to provide oxygen supplementation, but high flow though nasal cannulas provide unpredictable levels of CPAP based on the",
"    <span class=\"nowrap\">",
"     close/open",
"    </span>",
"    status of the mouth. As a result, we do not recommend high flow nasal cannula therapy for CPAP delivery. This technique and its limitation are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/61/29656?source=see_link&amp;anchor=H9#H9\">",
"     \"Oxygen monitoring and therapy in the newborn\", section on 'Continuous flow nasal cannula'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H450997925\">",
"    <span class=\"h1\">",
"     NASAL INTERMITTENT POSITIVE PRESSURE VENTILATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nasal intermittent positive pressure ventilation (NIPPV) is an augmentation of continuous positive airway pressure (CPAP), which superimposes inflations set to a peak pressure delivered through nasal prongs or mask. NIPPV may be a useful tool to augment the beneficial effects of CPAP in preterm infants with apnea, and available data suggest that NIPPV provides additional benefit over CPAP. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/39/4729?source=see_link&amp;anchor=H12#H12\">",
"     \"Mechanical ventilation in neonates\", section on 'Noninvasive mechanical ventilation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     METHYLXANTHINE THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Methylxanthines cause stimulation of respiratory neural output presumably by inhibiting adenosine receptors. The two methylxanthines used in apnea of prematurity are",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/20/32069?source=see_link\">",
"     caffeine",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?23/49/24344?source=see_link\">",
"     theophylline",
"    </a>",
"    . Caffeine is the preferred agent because of its longer half-life, wider margin of safety, and lower frequency of adverse effects. (See",
"    <a class=\"local\" href=\"#H778060737\">",
"     'Mechanism of action'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H15\">",
"     'Caffeine versus theophylline'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Efficacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several trials have established that methylxanthines are effective in the treatment of apnea of prematurity.",
"   </p>",
"   <p>",
"    In a 2012 update of a systematic review, results from five trials that studied short-term effects of methylxanthine therapy demonstrated that patients treated with methylxanthine compared with those who received placebo were less likely to have apneic episodes (RR 0.44, 95% CI 0.32-0.60) and require assisted ventilation (RR 0.34, 95% CI 0.12-0.97) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A sixth trial, the",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/20/32069?source=see_link\">",
"     Caffeine",
"    </a>",
"    for Apnea of Prematurity (CAP) trial, was included in the updated review [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/8\">",
"     8",
"    </a>",
"    ]. However, the data from this trial were not pooled with the other studies because the trial&rsquo;s primary composite outcome was death and disability, and not apnea. In the CAP trial of 2006 premature infants (birth weight between 500 and 1250 g), there was no difference in the rate of death, abnormal brain ultrasound, or necrotizing enterocolitis between the treated and control groups. However, caffeine therapy was associated with reduced risk of patent ductus arteriosus ligation (RR 0.37, 95% CI 0.21 to 0.66) and bronchopulmonary dysplasia (RR 0.72, 95% CI 0.58-0.89), earlier discontinuation of supplemental oxygen, and a lower age at the time of last endotracheal tube use.",
"   </p>",
"   <p>",
"    In a subsequent report of the CAP trial, for infants who required positive pressure ventilation,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/20/32069?source=see_link\">",
"     caffeine",
"    </a>",
"    benefit was associated with shorter duration of mechanical ventilation compared with placebo [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/9\">",
"     9",
"    </a>",
"    ]. The earlier discontinuation of positive airway pressure support with caffeine indirectly suggests a decrease in the frequency of apnea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/10\">",
"     10",
"    </a>",
"    ], and the reduction of BPD suggests that caffeine might have a preventive role in the development of this disorder. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/24/15753?source=see_link\">",
"     \"Management of bronchopulmonary dysplasia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although an initial study of the CAP trial reported a higher patient survival rate without neurodevelopmental disability at a corrected age of 18 to 21 months in patients who received",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/20/32069?source=see_link\">",
"     caffeine",
"    </a>",
"    compared with controls (59.8 versus 53.8 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/11\">",
"     11",
"    </a>",
"    ], a follow-up report demonstrated no clear difference between the two groups in the combined survival without neurodevelopmental disability at corrected age of five years (78.9 versus 75.2 percent), although longer-term benefit cannot be excluded [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H874089807\">",
"    <span class=\"h3\">",
"     Prophylactic use",
"    </span>",
"    &nbsp;&mdash;&nbsp;Due to increasing efforts to avoid intubation and mechanical ventilation, there has been an increase in prophylactic use of",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/20/32069?source=see_link\">",
"     caffeine",
"    </a>",
"    for very premature infants who are at-risk for apnea. However, data are limited on the effect of prophylactic methylxanthines use in premature infants on the incidence of apnea and related symptoms. In a review of 104 infants from two trials, there were no differences between the caffeine and placebo groups in the number of infants with apnea, bradycardia, hypoxic events, the use of intermittent positive pressure ventilation, and side effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/13\">",
"     13",
"    </a>",
"    ]. In another study of 140 premature infants with birth weights &le;1250 g, early administration of caffeine before the third day of life compared with later administration was associated with lower rates of the primary outcome of death and bronchopulmonary dysplasia (25 versus 53 percent) and of secondary outcomes of a shorter median duration of ventilation (6 versus 22 days) and risk of patent ductus arteriosus (10 versus 36 percent) that was treated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/14\">",
"     14",
"    </a>",
"    ]. It was unclear whether or not the early administration was due to prophylactic or therapeutic use as the authors suggest that initiating earlier treatment or universal prophylaxis may be of added benefit.",
"   </p>",
"   <p>",
"    Although we do not routinely administer prophylactic",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/20/32069?source=see_link\">",
"     caffeine",
"    </a>",
"    to all preterm infants, we and other centers will frequently use prophylactic caffeine in extremely low birth weight infants (birth weight &lt;1000 g) to avoid intubation and mechanical ventilation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H778060737\">",
"    <span class=\"h2\">",
"     Mechanism of action",
"    </span>",
"    &nbsp;&mdash;&nbsp;Methylxanthines are competitive inhibitors of adenosine receptors. Because adenosine is an inhibitory neuromodulator of respiratory drive, blockage of its receptors by methylxanthines results in increased ventilatory responsiveness to carbon dioxide, reversal of central hypoxic depression of breathing, enhanced force of diaphragmatic contraction, and improved pharyngeal muscle tone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one study of 51 preterm infants (median gestational age 29 weeks), increased cerebral cortical activity, decreased transcutaneous carbon dioxide partial pressure, and an increase in mean arterial pressure were observed during the two-hour period after",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/20/32069?source=see_link\">",
"     caffeine",
"    </a>",
"    administration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/16\">",
"     16",
"    </a>",
"    ]. Caffeine may also reduce the effects of hypoxia on perinatal white matter injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/15\">",
"     15",
"    </a>",
"    ]. Some of the effects of caffeine may be due to its ability to inhibit pro- and anti-inflammatory mechanisms, which are mediated by the various adenosine receptor subtypes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Side effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adverse effects of methylxanthine treatment include feeding intolerance and tachycardia. These side effects occur less frequently with",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/20/32069?source=see_link\">",
"     caffeine",
"    </a>",
"    than with",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?23/49/24344?source=see_link\">",
"     theophylline",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/18\">",
"     18",
"    </a>",
"    ]. Theophylline can cause gastroesophageal reflux, perhaps because of delayed gastric emptying [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/19\">",
"     19",
"    </a>",
"    ]; however, this does not present as a clinically significant problem.",
"   </p>",
"   <p>",
"    Methylxanthines also increase metabolic rate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/16\">",
"     16",
"    </a>",
"    ], however, the long-term impact of these effects is not known. In a study of metabolic rate and oxygen consumption,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/20/32069?source=see_link\">",
"     caffeine",
"    </a>",
"    significantly increased oxygen consumption (7 to 8.8",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    per min) and energy expenditure (2.1 to 3",
"    <span class=\"nowrap\">",
"     kcal/kg",
"    </span>",
"    per hour) compared with baseline measurements [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/20\">",
"     20",
"    </a>",
"    ]. During the four-week study period, treated infants required a lower incubator temperature to maintain normal body temperature and had less weight gain with similar caloric intake than untreated infants (21 versus 42",
"    <span class=\"nowrap\">",
"     g/day).",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Caffeine versus theophylline",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/20/32069?source=see_link\">",
"     Caffeine",
"    </a>",
"    has therapeutic advantages over",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?23/49/24344?source=see_link\">",
"     theophylline",
"    </a>",
"    including its longer half-life, ranging from 65 to 100 hours [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/21\">",
"     21",
"    </a>",
"    ]. As a result, caffeine can be administered once daily instead of the more frequent dosing required for theophylline. In addition, enteral absorption of caffeine is more reliable, and the wide therapeutic index of caffeine minimizes side effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/22\">",
"     22",
"    </a>",
"    ]. Finally, monitoring serum levels is generally required in patients treated with theophylline because of the smaller margin of safety and greater variability of absorption, whereas caffeine levels are usually only measured if there are signs of toxicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A systematic review of the literature that included five trials reported similar rates of reduction of apnea and bradycardia during the first week between",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/20/32069?source=see_link\">",
"     caffeine",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?23/49/24344?source=see_link\">",
"     theophylline",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/22\">",
"     22",
"    </a>",
"    ]. However, adverse reactions (ie, tachycardia and feeding intolerance) were lower in the group treated with caffeine compared with theophylline (RR 0.17, 95% CI 0.04-0.72).",
"   </p>",
"   <p>",
"    Based upon these data and the need to administer",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?23/49/24344?source=see_link\">",
"     theophylline",
"    </a>",
"    on a more frequent basis and obtain serum levels, we recommend",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/20/32069?source=see_link\">",
"     caffeine",
"    </a>",
"    as the preferred methylxanthine for the treatment of apnea of prematurity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Caffeine administration",
"    </span>",
"    &nbsp;&mdash;&nbsp;In preterm infants with apnea of prematurity, a loading dose of 20",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    of",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/20/32069?source=see_link\">",
"     caffeine",
"    </a>",
"    citrate (equivalent to 10",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    caffeine base) is given intravenously, or enterally [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/8,11\">",
"     8,11",
"    </a>",
"    ]. A daily maintenance dose of 5 to 10",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose (equivalent to 2.5 to 5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    caffeine base) is started 24 hours after the loading dose, which can also be administered either intravenously or orally.",
"   </p>",
"   <p>",
"    Steady state concentrations of",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/20/32069?source=see_link\">",
"     caffeine",
"    </a>",
"    are attained five to seven days after the drug is started. The therapeutic trough serum concentration is 5 to 25",
"    <span class=\"nowrap\">",
"     mg/L.",
"    </span>",
"    Because of the wide therapeutic index and lack of an established dose-response relationship, routine measurement of serum drug concentration is not necessary. In an observational study of 101 preterm infants, the median caffeine citrate dose was 5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    (range 2.5 to 10.9",
"    <span class=\"nowrap\">",
"     mg/kg)",
"    </span>",
"    that resulted in levels from 3 to 23.8",
"    <span class=\"nowrap\">",
"     mg/L",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/23\">",
"     23",
"    </a>",
"    ]. In 95 percent of samples, the level was between 5 and 20",
"    <span class=\"nowrap\">",
"     mg/L.",
"    </span>",
"    Comparable results were seen in the 23 patients with renal dysfunction (elevated serum creatinine or BUN levels) and in the 13 patients with elevated liver function studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H874091489\">",
"    <span class=\"h2\">",
"     Discontinuation of caffeine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data are lacking on when to discontinue",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/20/32069?source=see_link\">",
"     caffeine",
"    </a>",
"    therapy. Based on our experience and the natural course of apnea of prematurity, we discontinue caffeine when the infant reaches a postmenstrual age (PMA) between 32 and 34 weeks and there have been no apneic episodes requiring intervention for approximately five days. [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/24\">",
"     24",
"    </a>",
"    ]. It takes up to seven days for caffeine to be totally eliminated from the neonate. An alternate approach used in other centers is discontinuing caffeine at either 33 weeks PMA or if there has been no clinically significant episode of apnea for seven days, whichever comes first.",
"   </p>",
"   <p>",
"    Cardiorespiratory monitoring is continued when",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/20/32069?source=see_link\">",
"     caffeine",
"    </a>",
"    is discontinued, and is performed until the infant is discharged home. Caffeine is rarely needed to be reinstituted, but if there are frequent episodes of apnea, bradycardia, or oxygen desaturation, or if the infant requires intervention with a bag and mask, caffeine therapy may be restarted. (See",
"    <a class=\"local\" href=\"#H17699592\">",
"     'Management overview'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H108858589\">",
"    <span class=\"h2\">",
"     Response failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, infants who remain apneic despite",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/20/32069?source=see_link\">",
"     caffeine",
"    </a>",
"    therapy and continuous positive airway pressure require intubation and mechanical intubation or may be a candidate for nasal intermittent positive pressure ventilation (NIPPV). (See",
"    <a class=\"local\" href=\"#H17699592\">",
"     'Management overview'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/39/4729?source=see_link&amp;anchor=H3#H3\">",
"     \"Mechanical ventilation in neonates\", section on 'Indications for ventilation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/39/4729?source=see_link&amp;anchor=H12#H12\">",
"     \"Mechanical ventilation in neonates\", section on 'Noninvasive mechanical ventilation'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H450997925\">",
"     'Nasal intermittent positive pressure ventilation'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     OTHER THERAPIES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Possible role of transfusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;The frequency and severity of apnea occasionally are increased in premature infants who develop significant anemia at one to two months of age. It appears that transfusion reduces the frequency of apnea. This was best illustrated in a study of VLBW infants that demonstrated a decreased apnea rate after transfusion based on data from continuous computer monitoring of chest impedance and electrocardiographic and oximetry signals, and bedside nursing records [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We consider packed red blood cell transfusion in infants with hematocrits less than 25 to 30 percent who have frequent",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    severe apnea despite administration of",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/20/32069?source=see_link\">",
"     caffeine",
"    </a>",
"    therapy. The indications for transfusion in the preterm infants are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/53/9048?source=see_link&amp;anchor=H2#H2\">",
"     \"Red blood cell transfusions in the newborn\", section on 'Indications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H778059843\">",
"    <span class=\"h1\">",
"     PERSISTENT APNEA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some infants, especially those born &le;28 weeks gestation, may have persistent apneic spells at 37 to 40 weeks postmenstrual age (PMA) when they may otherwise be ready for discharge to home from the hospital. Control of breathing matures in almost all infants by 44 weeks PMA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/26\">",
"     26",
"    </a>",
"    ]. Although pneumogram (two-channel impedance pneumography that measures chest wall movement and heart rate) is often used to evaluate apnea that persists beyond term PMA or when apnea is unusually severe, it is not useful in predicting which infants are at risk for severe cardiopulmonary events or sudden infant death syndrome. Multichannel comprehensive physiologic recording measures respiratory airflow, inspiratory effort, gastroesophageal reflux (via esophageal pH or multiple intraluminal impedance), and sleep state, and is used less commonly. It may be helpful when there is a clinical suspicion that the apnea may be due to other causes such as airway obstruction or seizure. These studies may be useful in demonstrating severity of episodes, and in the case of the multichannel recording, the occasional temporal relationship to reflux; however, they should not be performed routinely in preterm infants prior to discharge [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/26\">",
"     26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/20/37194?source=see_link&amp;anchor=H6178967#H6178967\">",
"     \"Sudden infant death syndrome: Risk factors and risk reduction strategies\", section on 'History of apnea'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H874090019\">",
"    <span class=\"h1\">",
"     DISCHARGE PLANNING",
"    </span>",
"    &nbsp;&mdash;&nbsp;At discharge, home cardiorespiratory monitoring is",
"    <strong>",
"     not",
"    </strong>",
"    needed for infants who are otherwise ready for discharge and remain free of any episode of apnea, bradycardia, or oxygen desaturation for five to seven days, as the risk of a subsequent clinically significant apnea event is very low [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/27\">",
"     27",
"    </a>",
"    ]. However if a premature infant is ready for discharge but mild apnea continues to be a concern, it remains uncertain what is the optimal approach [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43223/abstract/2\">",
"     2",
"    </a>",
"    ]. Many of these infants have persistent mild bradycardia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    desaturation events that are detected by cardiorespiratory monitoring, which are associated with short undetected respiratory pauses as they remain below the apnea alarm threshold. These events are probably of no prognostic significance. If",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/20/32069?source=see_link\">",
"     caffeine",
"    </a>",
"    has only recently been discontinued, we generally advise that the infant not be discharged home unless there is an event-free period of seven (as opposed to five) days to allow caffeine to be either eliminated or reach low subtherapeutic levels. (See",
"    <a class=\"local\" href=\"#H778059835\">",
"     'Monitoring'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Discharge criteria vary. Most centers wait until infants are free of apnea and off",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/20/32069?source=see_link\">",
"     caffeine",
"    </a>",
"    therapy before discharge, while some may discharge infants home with cardiorespiratory monitoring, and on or off caffeine therapy. If the infant is to be monitored at home, prior to discharge, the parents or primary home care provider must demonstrate proficiency in managing the monitor, providing stimulation, and performing cardiorespiratory resuscitation. Such home monitoring can almost always be discontinued at around 43 to 44 weeks postmenstrual age. Implementation of home cardiorespiratory monitoring in infants including discontinuation is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/58/21414?source=see_link&amp;anchor=H6#H6\">",
"     \"Use of home cardiorespiratory monitors in infants\", section on 'Preterm infants with persistent symptoms related to apnea of prematurity'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H116325052\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The management of apnea of prematurity typically includes supportive care, positive airway pressure (CPAP), and",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/20/32069?source=see_link\">",
"       caffeine",
"      </a>",
"      therapy.",
"     </li>",
"     <li>",
"      We recommend initial cardiorespiratory monitoring for all premature infants less than 35 weeks gestation as they are at-risk for apnea (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H778059835\">",
"       'Monitoring'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/4/12360?source=see_link&amp;anchor=H372637470#H372637470\">",
"       \"Pathogenesis, clinical presentation, and diagnosis of apnea of prematurity\", section on 'Incidence'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Supportive care is focused on eliminating factors that increase the risk of apnea. It includes maintenance of a stable thermal environment and nasal patency, avoidance of extreme neck flexion and extension, and identifying any other underlying condition associated with apnea (eg, sepsis). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'General measures'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/61/29656?source=see_link&amp;anchor=H18#H18\">",
"       \"Oxygen monitoring and therapy in the newborn\", section on 'Oxygen target levels'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In preterm infants with apnea, we suggest the use of nasal positive airway pressure (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). Positive airway pressure reduces the risk of upper airway collapse and obstruction, and increases oxygenation. In these patients, positive airway pressure is begun at a pressure between 3 and 5 cm H2O via nasal prongs or mask. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Nasal continuous positive airway pressure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In infants with apnea of prematurity, we recommend treatment with methylxanthine therapy versus general measures alone (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). We recommend the use of",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/20/32069?source=see_link\">",
"       caffeine",
"      </a>",
"      rather than",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?23/49/24344?source=see_link\">",
"       theophylline",
"      </a>",
"      as the preferred methylxanthine for infants with apnea of prematurity (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Caffeine is the preferred agent because of its longer half-life and wider safety margin associated with a lower incidence of adverse effects. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Caffeine versus theophylline'",
"      </a>",
"      above.).",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/20/32069?source=see_link\">",
"       Caffeine",
"      </a>",
"      is given as a loading dose of 20",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      of caffeine citrate (equivalent to 10",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      caffeine base). It is followed in 24 hours by a daily maintenance dose of 5 to 10",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per dose (equivalent to 2.5 to 5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      caffeine base). Both the loading and maintenance doses can be administered intravenously or orally. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Caffeine administration'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In our center, we do not routinely use prophylactic",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/20/32069?source=see_link\">",
"       caffeine",
"      </a>",
"      therapy for the prevention of apnea of prematurity. However, we and other centers will frequently administer prophylactic caffeine therapy in extremely low birth weight infants (birth weight below 1000 g) to avoid intubation and mechanical ventilation. (See",
"      <a class=\"local\" href=\"#H874089807\">",
"       'Prophylactic use'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest red cell blood transfusions for infants with hematocrits of less than 25 to 30 percent who have frequent",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      severe apnea requiring intervention (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Possible role of transfusion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In our center, discontinuation of",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/20/32069?source=see_link\">",
"       caffeine",
"      </a>",
"      is considered for infants at a postmenstrual age between 32 and 34 weeks who have a five-day period that is free of any apnea, bradycardia, or desaturation alarm event episode. (See",
"      <a class=\"local\" href=\"#H874091489\">",
"       'Discontinuation of caffeine'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If an infant is ready for discharge but mild apnea (ie, apneic episodes greater than 15 seconds that do not require intervention or are not accompanied with bradycardia and desaturation) continues to be a concern, home cardiorespiratory monitoring may be considered until the infant is 43 to 44 weeks postmenstrual age. Prior to discharge, the parents or primary home care provider must demonstrate proficiency in managing the monitor, providing stimulation, and performing cardiorespiratory resuscitation. Infants still exhibiting apnea with associated bradycardia or oxygen desaturation are not candidates for discharge and home monitoring. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/58/21414?source=see_link&amp;anchor=H9#H9\">",
"       \"Use of home cardiorespiratory monitors in infants\", section on 'Implementation'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6070556\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editorial staff at UpToDate, Inc. would like to acknowledge Dr. James M Adams, Jr, who contributed to earlier versions of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43223/abstract/1\">",
"      National Institutes of Health Consensus Development Conference on Infantile Apnea and Home Monitoring, Sept 29 to Oct 1, 1986. Pediatrics 1987; 79:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43223/abstract/2\">",
"      Committee on Fetus and Newborn. American Academy of Pediatrics. Apnea, sudden infant death syndrome, and home monitoring. Pediatrics 2003; 111:914.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43223/abstract/3\">",
"      Miller MJ, Carlo WA, Martin RJ. Continuous positive airway pressure selectively reduces obstructive apnea in preterm infants. J Pediatr 1985; 106:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43223/abstract/4\">",
"      Stark AR, Goldman MD, Frantz ID 3rd. Lung volume changes, occlusion pressure and chest wall configuration in human infants. Pediatr Res 1979; 13:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43223/abstract/5\">",
"      Durand M, McCann E, Brady JP. Effect of continuous positive airway pressure on the ventilatory response to CO2 in preterm infants. Pediatrics 1983; 71:634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43223/abstract/6\">",
"      Sreenan C, Lemke RP, Hudson-Mason A, Osiovich H. High-flow nasal cannulae in the management of apnea of prematurity: a comparison with conventional nasal continuous positive airway pressure. Pediatrics 2001; 107:1081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43223/abstract/7\">",
"      Henderson-Smart DJ, De Paoli AG. Methylxanthine treatment for apnoea in preterm infants. Cochrane Database Syst Rev 2010; :CD000140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43223/abstract/8\">",
"      Schmidt B, Roberts RS, Davis P, et al. Caffeine therapy for apnea of prematurity. N Engl J Med 2006; 354:2112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43223/abstract/9\">",
"      Davis PG, Schmidt B, Roberts RS, et al. Caffeine for Apnea of Prematurity trial: benefits may vary in subgroups. J Pediatr 2010; 156:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43223/abstract/10\">",
"      Bancalari E. Caffeine for apnea of prematurity. N Engl J Med 2006; 354:2179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43223/abstract/11\">",
"      Schmidt B, Roberts RS, Davis P, et al. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med 2007; 357:1893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43223/abstract/12\">",
"      Schmidt B, Anderson PJ, Doyle LW, et al. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. JAMA 2012; 307:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43223/abstract/13\">",
"      Henderson-Smart DJ, De Paoli AG. Prophylactic methylxanthine for prevention of apnoea in preterm infants. Cochrane Database Syst Rev 2010; :CD000432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43223/abstract/14\">",
"      Patel RM, Leong T, Carlton DP, Vyas-Read S. Early caffeine therapy and clinical outcomes in extremely preterm infants. J Perinatol 2013; 33:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43223/abstract/15\">",
"      Abu-Shaweesh JM, Martin RJ. Neonatal apnea: what's new? Pediatr Pulmonol 2008; 43:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43223/abstract/16\">",
"      Supcun S, Kutz P, Pielemeier W, Roll C. Caffeine increases cerebral cortical activity in preterm infants. J Pediatr 2010; 156:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43223/abstract/17\">",
"      Martin RJ, Wang K, K&ouml;rolu O, et al. Intermittent hypoxic episodes in preterm infants: do they matter? Neonatology 2011; 100:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43223/abstract/18\">",
"      Steer PA, Henderson-Smart DJ. Caffeine versus theophylline for apnea in preterm infants. Cochrane Database Syst Rev 2000; :CD000273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43223/abstract/19\">",
"      Gounaris A, Kokori P, Varchalama L, et al. Theophylline and gastric emptying in very low birthweight neonates: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2004; 89:F297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43223/abstract/20\">",
"      Bauer J, Maier K, Linderkamp O, Hentschel R. Effect of caffeine on oxygen consumption and metabolic rate in very low birth weight infants with idiopathic apnea. Pediatrics 2001; 107:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43223/abstract/21\">",
"      Aranda JV, Cook CE, Gorman W, et al. Pharmacokinetic profile of caffeine in the premature newborn infant with apnea. J Pediatr 1979; 94:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43223/abstract/22\">",
"      Henderson-Smart DJ, Steer PA. Caffeine versus theophylline for apnea in preterm infants. Cochrane Database Syst Rev 2010; :CD000273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43223/abstract/23\">",
"      Natarajan G, Botica ML, Thomas R, Aranda JV. Therapeutic drug monitoring for caffeine in preterm neonates: an unnecessary exercise? Pediatrics 2007; 119:936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43223/abstract/24\">",
"      Darnall RA, Kattwinkel J, Nattie C, Robinson M. Margin of safety for discharge after apnea in preterm infants. Pediatrics 1997; 100:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43223/abstract/25\">",
"      Zagol K, Lake DE, Vergales B, et al. Anemia, apnea of prematurity, and blood transfusions. J Pediatr 2012; 161:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43223/abstract/26\">",
"      Ramanathan R, Corwin MJ, Hunt CE, et al. Cardiorespiratory events recorded on home monitors: Comparison of healthy infants with those at increased risk for SIDS. JAMA 2001; 285:2199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43223/abstract/27\">",
"      Lorch SA, Srinivasan L, Escobar GJ. Epidemiology of apnea and bradycardia resolution in premature infants. Pediatrics 2011; 128:e366.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5048 Version 15.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-221.179.173.170-7B5B02C4AA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_13_43223=[""].join("\n");
var outline_f42_13_43223=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H116325052\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H778059835\">",
"      MONITORING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17699592\">",
"      MANAGEMENT OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      GENERAL MEASURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H450997925\">",
"      NASAL INTERMITTENT POSITIVE PRESSURE VENTILATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      METHYLXANTHINE THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Efficacy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H874089807\">",
"      - Prophylactic use",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H778060737\">",
"      Mechanism of action",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Side effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Caffeine versus theophylline",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Caffeine administration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H874091489\">",
"      Discontinuation of caffeine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H108858589\">",
"      Response failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      OTHER THERAPIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Possible role of transfusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H778059843\">",
"      PERSISTENT APNEA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H874090019\">",
"      DISCHARGE PLANNING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H116325052\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6070556\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/24/15753?source=related_link\">",
"      Management of bronchopulmonary dysplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/39/4729?source=related_link\">",
"      Mechanical ventilation in neonates",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/61/29656?source=related_link\">",
"      Oxygen monitoring and therapy in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/4/12360?source=related_link\">",
"      Pathogenesis, clinical presentation, and diagnosis of apnea of prematurity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/53/9048?source=related_link\">",
"      Red blood cell transfusions in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/20/37194?source=related_link\">",
"      Sudden infant death syndrome: Risk factors and risk reduction strategies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/58/21414?source=related_link\">",
"      Use of home cardiorespiratory monitors in infants",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_13_43224="ANA staining patterns";
var content_f42_13_43224=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F53431&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F53431&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 577px\">",
"   <div class=\"ttl\">",
"    Antinuclear antibody staining patterns",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 557px; height: 404px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Antinuclear antibody staining patterns on mouse liver by immunofluorescence.",
"    <br>",
"     (Top left panel) There is homogeneous or diffuse staining of the nuclei. The pattern is strongly associated with antibodies to nucleosomes. It is seen in patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and drug-induced lupus.",
"     <br>",
"      (Top right panel) The peripheral (also called rim) pattern, in which the periphery of the nucleus reacts with the patient's serum. This pattern correlates with antibodies to double-stranded DNA (dsDNA) and nuclear envelope proteins and is suggestive of SLE.",
"      <br>",
"       (Bottom left panel) The speckled pattern in which there may be few or many speckles, and small or large speckles. The pattern represents antibodies to the components of extractable nuclear antigens, eg, Smith (SM), ribonucleoprotein (RNP), Ro (SSA), La (SSB) and probably other nuclear antigens. The pattern may be seen in patients with SLE, Sj&ouml;gren's syndrome, scleroderma, infectious mononucleosis and other conditions, and in normal subjects (especially in low titer).",
"       <br>",
"        (Bottom right panel) There is a nucleolar pattern, in which the patient's serum only reacts with the nucleoli. This pattern represents antibodies to nucleolar RNA associated proteins or complexes, and is primarily seen in scleroderma.",
"        <div class=\"footnotes\">",
"        </div>",
"        <div class=\"reference\">",
"         Courtesy of Peter H Schur, MD.",
"        </div>",
"       </br>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_13_43224=[""].join("\n");
var outline_f42_13_43224=null;
var title_f42_13_43225="Screening tests in children and adolescents";
var content_f42_13_43225=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Screening tests in children and adolescents",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/13/43225/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/13/43225/contributors\">",
"     Nancy R Kelly, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/13/43225/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/13/43225/contributors\">",
"     Jan E Drutz, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/13/43225/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/13/43225/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?42/13/43225/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 15, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The schedule of and recommendations for common screening tests in children in the United States will be reviewed here. The specific diseases and conditions are discussed separately. (See appropriate topic reviews).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     General principles",
"    </span>",
"    &nbsp;&mdash;&nbsp;Screening is defined as testing for disease in an individual or population that appears to be healthy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/1\">",
"     1",
"    </a>",
"    ]. The goal of screening is to identify children who are at increased risk of disease and warrant additional testing.",
"   </p>",
"   <p>",
"    The following characteristics of a disease render it a good candidate for screening [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Substantial morbidity or mortality occurs if the disease is untreated",
"     </li>",
"     <li>",
"      The prevalence warrants testing in an apparently healthy population",
"     </li>",
"     <li>",
"      The existence of a preclinical phase is detectable by the test",
"     </li>",
"     <li>",
"      A cost-effective treatment is available",
"     </li>",
"     <li>",
"      Preclinical detection of disease provides some benefit (eg, improved prognosis, ease of treatment, decreased risk of transmission to others)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Screening tests for diseases conducive to screening should [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Be easy to perform and interpret",
"     </li>",
"     <li>",
"      Measure something directly related to the disease",
"     </li>",
"     <li>",
"      Have low risk, morbidity, and cost",
"     </li>",
"     <li>",
"      Be highly sensitive and specific",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Adverse effects of screening that must be weighed against the potential benefits include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      False-positive test results must be followed up",
"     </li>",
"     <li>",
"      False-negative test results may delay diagnosis",
"     </li>",
"     <li>",
"      The cost of the screening program may compete with the cost of diagnosis, treatment, or primary prevention efforts",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Test characteristics",
"    </span>",
"    &nbsp;&mdash;&nbsp;In choosing an appropriate screening test, the sensitivity, specificity, and predictive value of the test must be considered [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. These concepts are depicted in the classic 2 x 2 table (",
"    <a class=\"graphic graphic_table graphicRef77832 \" href=\"mobipreview.htm?7/50/7979\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/18/22823?source=see_link\">",
"     \"Glossary of common biostatistical and epidemiological terms\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sensitivity &ndash; Proportion of individuals who have the disease and have a positive test result.",
"     </li>",
"     <li>",
"      Specificity &ndash; Proportion of individuals who do not have the disease and have a negative test result.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The best screening tests have a high sensitivity (few false negatives) so that individuals who have the disease are identified by the screening test. A test that has a high specificity (few false positives) is also desired so that individuals are not erroneously labeled as having disease when they are disease free.",
"   </p>",
"   <p>",
"    In addition to sensitivity and specificity, interpretation of test results also depends upon the test's predictive value:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Positive-predictive value &ndash; The proportion of patients with a positive test that have the disease.",
"     </li>",
"     <li>",
"      Negative-predictive value &ndash; The proportion of patients with a negative test that do not have disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The predictive values (and the proportion of positive and negative evaluations that can be expected) depend upon the prevalence of a disease within a population. Thus, for given values of sensitivity and specificity, a patient with a positive test is more likely to truly have the disease if the patient belongs to a population with a high prevalence of the disease (",
"    <a class=\"graphic graphic_figure graphicRef68072 \" href=\"mobipreview.htm?23/36/24142\">",
"     figure 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/18/22823?source=see_link\">",
"     \"Glossary of common biostatistical and epidemiological terms\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Types of screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two types of screening programs:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Universal (or population) screening refers to the screening of every individual within a population",
"     </li>",
"     <li>",
"      Selective (targeted or risk-based) screening refers to the screening of individuals for whom there is reason to believe that the screening may be positive",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Selective screening increases the positive predictive value of a test by increasing the prevalence of the disease in the population that is screened (",
"    <a class=\"graphic graphic_figure graphicRef68072 \" href=\"mobipreview.htm?23/36/24142\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Screening guidelines",
"    </span>",
"    &nbsp;&mdash;&nbsp;In pediatric practice, screening is routinely performed for a number of conditions, as discussed below. For most of these conditions, there is a lack of direct evidence from randomized controlled trials supporting the beneficial effects of screening",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    quantifying the potential benefits and harms. The lack of evidence does not necessarily mean that screening is not beneficial, only that it has not yet been adequately tested [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When deciding whether screening should be performed, the potential benefits and harms of screening must be considered. The balance between risks and benefits varies depending upon the condition, the clinical circumstances of the child and family, the availability of resources, and the values that patients (or patients' caregivers) place on the potential benefits and harms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For many conditions, screening is regulated by local, state, or federal policies. In addition, recommendations regarding screening for various conditions are made by several professional groups and updated periodically. In the United States, these groups include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"external\" href=\"file://brightfutures.aap.org/pdfs/aap bright futures periodicity sched 101107.pdf\">",
"       The American Academy of Pediatrics and Bright Futures",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/6,7\">",
"       6,7",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.aafp.org/online/en/home/clinical/exam.html\">",
"       The American Academy of Family Physicians",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/8\">",
"       8",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.uspreventiveservicestaskforce.org/uspstopics.htm\">",
"       The United States Preventive Services Task Force",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.cdc.gov/\">",
"       The Centers for Disease Control and Prevention",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Recommendations regarding screening vary from country to country. The information below focuses on screening in the United States. A discussion of screening recommendations for other countries is beyond the scope of this topic review. Policies for individual countries may be available online (eg,",
"    <a class=\"external\" href=\"file://www.screening.nhs.uk/\">",
"     United Kingdom",
"    </a>",
"    ,",
"    <a class=\"external\" href=\"file://canadiantaskforce.ca/\">",
"     Canada",
"    </a>",
"    HYPERLINK).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     COMMON SCREENING TESTS IN PEDIATRICS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Newborn screen",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States, programs for screening newborns for genetic and metabolic disease vary from state to state. Clinicians should comply with local regulations. All states test for phenylketonuria and congenital hypothyroidism. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/58/35753?source=see_link&amp;anchor=H9#H9\">",
"     \"Overview of phenylketonuria\", section on 'Diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/39/2682?source=see_link&amp;anchor=H12#H12\">",
"     \"Clinical features and detection of congenital hypothyroidism\", section on 'Newborn screening programs'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other diseases that may be included in the newborn screen are biotinidase deficiency, maple syrup urine disease, congenital adrenal hyperplasia, cystic fibrosis, galactosemia, homocystinuria, hemoglobinopathies, toxoplasmosis, and tyrosinemia. Newborn screening is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/2/2088?source=see_link\">",
"     \"Newborn screening\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Hearing screen",
"    </span>",
"    &nbsp;&mdash;&nbsp;Significant bilateral hearing loss is present in 0.1 to 0.3 percent of newborn infants in the well-baby nursery population and in 2 to 4 percent in the neonatal intensive care population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/9\">",
"     9",
"    </a>",
"    ]. In addition, hearing loss of at least 16 dB in either low- or high-frequency range is present in approximately 15 percent of children aged 6 to 19 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/10\">",
"     10",
"    </a>",
"    ]. Causes of hearing loss are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/38/19050?source=see_link\">",
"     \"Etiology of hearing impairment in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Newborns",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States, programs for universal hearing screening vary from state to state. Clinicians should comply with local regulations. The American Academy of Pediatrics (AAP) recommends universal hearing screening for all newborns by one month of age, with a goal of detecting hearing loss in infants before three months of age, and appropriate intervention no later than six months of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/11\">",
"     11",
"    </a>",
"    ]. The American Academy of Family Physicians (AAFP) and United States Preventive Services Task Force (USPSTF) found insufficient evidence to make a recommendation for or against universal newborn hearing screening [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/8,12\">",
"     8,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Newborn hearing screening is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/13/27865?source=see_link\">",
"     \"Screening the newborn for hearing loss\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Infants and children",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hearing screening beyond the newborn period is necessary to identify children with hearing loss that is acquired (eg, from meningitis, trauma, noise exposure), progressive (eg, related to particular neurodegenerative syndromes), has delayed onset (eg, intrauterine infection), or was not detected on newborn hearing screen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/38/19050?source=see_link\">",
"     \"Etiology of hearing impairment in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although most children with hearing impairment are identified before they begin school [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/16\">",
"     16",
"    </a>",
"    ], some cases are missed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/17\">",
"     17",
"    </a>",
"    ]. In accord with the",
"    <span class=\"nowrap\">",
"     AAP/Bright",
"    </span>",
"    Futures guidelines, we suggest a hearing risk assessment at all health maintenance visits, and periodic hearing screening between 4 and 10 years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. The",
"    <span class=\"nowrap\">",
"     AAP/Bright",
"    </span>",
"    Futures guidelines suggest hearing screening if risk factors are identified during risk assessment at any health maintenance visit and for all children at 4, 5, 6, 8, and 10 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/6,7,18\">",
"     6,7,18",
"    </a>",
"    ]. These suggestions place a high value on the potential for improved outcome with early detection and intervention (compared to the cost, inconvenience, and lost time necessary for follow-up of a potentially false-positive result).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Risk assessment",
"      </strong>",
"      &ndash; Hearing risk assessment consists of auditory skills monitoring, developmental surveillance, and assessment of parental concern [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/18,19\">",
"       18,19",
"      </a>",
"      ]. Additional risk factors associated with an increased risk of permanent congenital, delayed-onset, or progressive hearing loss in childhood include [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/11,18,20\">",
"       11,18,20",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Caregiver concerns regarding hearing, speech, language or developmental delay",
"     </li>",
"     <li>",
"      Family history of permanent childhood hearing loss (however, because most hereditary hearing loss is autosomal recessive, many children with hereditary hearing loss may not have affected relatives)",
"     </li>",
"     <li>",
"      Neonatal intensive care unit (NICU) stay of &gt;5 days",
"     </li>",
"     <li>",
"      NICU stay (regardless of duration) requiring extracorporeal membrane oxygenation, assisted ventilation, exchange transfusion for hyperbilirubinemia, or exposure to ototoxic drugs or loop diuretics",
"     </li>",
"     <li>",
"      Congenital or central nervous system infections",
"     </li>",
"     <li>",
"      Ototoxic drug exposure, including chemotherapy",
"     </li>",
"     <li>",
"      Congenital head and neck deformities (eg, anomalies of the pinna or temporal bone, ear canal, ear tags, ear pits) and trauma (particularly basal skull and temporal bone fractures)",
"     </li>",
"     <li>",
"      Neurodegenerative disorders",
"     </li>",
"     <li>",
"      Syndromes associated with hearing loss (",
"      <a class=\"graphic graphic_table graphicRef66758 \" href=\"mobipreview.htm?12/21/12638\">",
"       table 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Chronic or recurrent otitis media with effusion",
"     </li>",
"     <li>",
"      Anatomic deformities and other disorders that affect eustachian tube function",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Children with one or more of the above risk factors should have at least one diagnostic audiology assessment by 24 to 30 months of age and ongoing developmentally appropriate hearing screening [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/19/44344?source=see_link\">",
"     \"Evaluation of hearing impairment in children\"",
"    </a>",
"    .)",
"    <br/>",
"    <br/>",
"    The use of digital music players is another risk factor that must be considered, particularly if they are used for extended periods of time and at high volume [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/38/19050?source=see_link&amp;anchor=H30#H30\">",
"     \"Etiology of hearing impairment in children\", section on 'Noise exposure'",
"    </a>",
"    .)",
"    <br/>",
"    <br/>",
"    The following questions can be used to identify older children and adolescents for whom a hearing screen may be necessary [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/22\">",
"     22",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Do you have a problem hearing over the telephone?",
"     </li>",
"     <li>",
"      Do you have trouble following the conversation when two or more people are talking at the same time?",
"     </li>",
"     <li>",
"      Do others complain that you turn the television volume too high?",
"     </li>",
"     <li>",
"      Do you have to strain to understand conversation?",
"     </li>",
"     <li>",
"      Do you have trouble hearing in a noisy background?",
"     </li>",
"     <li>",
"      Do you find yourself asking other people to repeat themselves?",
"     </li>",
"     <li>",
"      Do many people you talk to seem to mumble (or not speak clearly)?",
"     </li>",
"     <li>",
"      Do you misunderstand what others are saying and respond inappropriately?",
"     </li>",
"     <li>",
"      Do you have trouble understanding the speech of women and children?",
"     </li>",
"     <li>",
"      Do people get annoyed because you misunderstand what they say?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <strong>",
"       Screening methods",
"      </strong>",
"      &ndash; In older children, hearing can be screened in the office setting with any of the following methods:",
"      <br/>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Otoacoustic emissions [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/23\">",
"       23",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      In-office audiology [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/19\">",
"       19",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Otoscope audiograms [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/24\">",
"       24",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Children who fail hearing screening by any of these methods should be referred for formal audiologic testing, as should all children who are at risk for hearing loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/18\">",
"     18",
"    </a>",
"    ]. The abnormal results should be explained to the parents, and the child's medical record should be flagged to facilitate follow-up. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/19/44344?source=see_link\">",
"     \"Evaluation of hearing impairment in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Vision screen",
"    </span>",
"    &nbsp;&mdash;&nbsp;Screening for vision problems varies with the age of the child.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Children &lt;5 years",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of undetected vision problems in preschool children is estimated to be 5 to 10 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/25\">",
"     25",
"    </a>",
"    ]. One to 3 percent have amblyopia (\"lazy eye,\" loss of vision due to disuse) that usually develops between infancy and five to seven years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/26\">",
"     26",
"    </a>",
"    ]. Early detection and treatment of amblyopia improves the prognosis for normal eye development. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/59/24505?source=see_link\">",
"     \"Visual development and vision assessment in infants and children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/61/8153?source=see_link&amp;anchor=H3#H3\">",
"     \"Overview of amblyopia\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In accord with the AAP, AAFP, and USPSTF, we recommend screening to detect amblyopia, strabismus, and defects in visual acuity in children younger than five years of age (",
"    <a class=\"graphic graphic_table graphicRef62277 \" href=\"mobipreview.htm?14/43/15037\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/6-8,27\">",
"     6-8,27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/59/24505?source=see_link\">",
"     \"Visual development and vision assessment in infants and children\"",
"    </a>",
"    .) A video that reviews practical techniques for vision screening in children from birth through age five years is available through the",
"    <a class=\"external\" href=\"file://one.aao.org/flash/visionscreening/pediatricvisionscreening.html\">",
"     American Academy of Ophthalmology",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    The",
"    <span class=\"nowrap\">",
"     AAP/Bright",
"    </span>",
"    Futures guidelines suggest vision risk assessment at all health maintenance visits, and vision screening or referral, as indicated, if risk factors are identified [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Risk factors for vision problems include a history of prematurity; family history of congenital cataracts, retinoblastoma, and metabolic or genetic disease; significant developmental delay or neurologic difficulty; and systemic diseases associated with eye problems [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/28\">",
"     28",
"    </a>",
"    ]. Parents should be asked [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/28\">",
"     28",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Does the child seem to see well?",
"     </li>",
"     <li>",
"      Does the child hold objects close to his or her face when trying to focus?",
"     </li>",
"     <li>",
"      Do the child's eyes appear straight, or do they seem to cross or drift or seem lazy?",
"     </li>",
"     <li>",
"      Do the child's eyes appear unusual?",
"     </li>",
"     <li>",
"      Do the child's eyelids droop, or does one eyelid tend to close?",
"     </li>",
"     <li>",
"      Have the child's eyes ever been injured?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The",
"    <span class=\"nowrap\">",
"     AAP/Bright",
"    </span>",
"    Futures guidelines suggest vision screening at three and four years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. Vision screening should include tests of monocular distance acuity and stereopsis (",
"    <a class=\"graphic graphic_table graphicRef62277 \" href=\"mobipreview.htm?14/43/15037\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/6,7,29,30\">",
"     6,7,29,30",
"    </a>",
"    ]. If the child is uncooperative for vision screening at three years of age, he or she should be rescreened within six months; children four years and older who are unable to be screened should be rescreened within one month [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/29\">",
"     29",
"    </a>",
"    ]. Any child who is unable to be tested after two attempts or in whom an abnormality is suspected or detected should be referred to an ophthalmologist experienced in the care of children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Systematic reviews of vision screening tests for the detection of amblyopia found few high-quality data regarding the performance of preschool vision screening [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/4,30,31\">",
"     4,30,31",
"    </a>",
"    ]. However, because of the importance of early detection, vision risk assessment should be performed at every well-child visit, with subsequent screening as indicated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Children &ge;5 years",
"    </span>",
"    &nbsp;&mdash;&nbsp;In accord with the",
"    <span class=\"nowrap\">",
"     AAP/Bright",
"    </span>",
"    Futures guidelines, we suggest vision risk assessment at all health maintenance visits, and vision screening or referral, as indicated, if risk factors are identified [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. We also suggest periodic assessment of visual acuity (vision screening) throughout childhood and adolescence. For children &ge;5 years of age, the",
"    <span class=\"nowrap\">",
"     AAP/Bright",
"    </span>",
"    Futures guidelines suggest visual acuity measurement at ages 5, 6, 8, 10, 12, 15, and 18 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/6,7,29\">",
"     6,7,29",
"    </a>",
"    ]. These suggestions place a high value on the potential for improved outcome with early detection and intervention (compared to the cost, inconvenience, and lost time necessary for follow-up of a potentially false-positive result). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/59/24505?source=see_link&amp;anchor=H7#H7\">",
"     \"Visual development and vision assessment in infants and children\", section on 'Visual history'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Data are limited regarding the prevalence of uncorrected refractive errors and undiagnosed vision problems in school children and adolescents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/32\">",
"     32",
"    </a>",
"    ]. Evidence that early detection of refractive errors is associated with important clinical benefits, compared to testing based on symptoms, is sparse [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The AAP, American Academy of Ophthalmology, the American Association of Certified Orthoptists, and the American Association for Pediatric Ophthalmology and Strabismus recommend routine vision screening beginning at three to four years of age, and every one to three years thereafter throughout childhood and adolescence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/6,7,29\">",
"     6,7,29",
"    </a>",
"    ]. The USPSTF found insufficient evidence to recommend for or against routine screening for diminished visual acuity among asymptomatic schoolchildren and adolescents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Development and behavior screens",
"    </span>",
"    &nbsp;&mdash;&nbsp;The",
"    <span class=\"nowrap\">",
"     AAP/Bright",
"    </span>",
"    Futures recommend developmental screening at 9, 18, and 30 months of age and autism screening at 18 and 24 months of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. Developmental and behavioral screening are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/49/26394?source=see_link&amp;anchor=H18501566#H18501566\">",
"     \"Developmental-behavioral surveillance and screening in primary care\", section on 'When to perform developmental-behavioral screening'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/17/35097?source=see_link&amp;anchor=H13#H13\">",
"     \"Surveillance and screening for autism spectrum disorders in primary care\", section on 'Guidelines for surveillance and screening'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Iron deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;The",
"    <span class=\"nowrap\">",
"     AAP/Bright",
"    </span>",
"    Futures guidelines recommend risk assessment for iron deficiency anemia at four months of age and measurement of hemoglobin or hematocrit at 12 months of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/7,35\">",
"     7,35",
"    </a>",
"    ]. They also suggest repeat risk assessment at 18 and 24 months of age and annually thereafter. The risk assessment at four months of age includes history of prematurity or low birth weight, and diet (ie, use of low-iron formula or not receiving iron-fortified formula) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/19,36,37\">",
"     19,36,37",
"    </a>",
"    ]. Risk assessment after one year of age includes questions about socioeconomic status (particularly children of Mexican American descent), limited access to food, diets low in iron (eg, vegetarian diet), exposure to lead, and excessive menstrual bleeding (for girls who are menstruating) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/19,36,37\">",
"     19,36,37",
"    </a>",
"    ]. The AAFP and USPSTF found insufficient evidence to recommend for or against routine screening for iron deficiency anemia in asymptomatic children aged 6 to 12 months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/8,38\">",
"     8,38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Screening for iron deficiency in infants, children, and adolescents is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/18/22826?source=see_link&amp;anchor=H8#H8\">",
"     \"Iron deficiency in infants and young children: Screening, prevention, clinical manifestations, and diagnosis\", section on 'Screening recommendations'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/14/4329?source=see_link&amp;anchor=H22449339#H22449339\">",
"     \"Iron requirements and iron deficiency in adolescents\", section on 'Screening'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Lead poisoning",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 2012, the Centers for Disease Control and Prevention (CDC) revised the definition for elevated blood lead level (BLL) for children in the US from 10",
"    <span class=\"nowrap\">",
"     mcg/dL",
"    </span>",
"    (0.48",
"    <span class=\"nowrap\">",
"     micromol/L)",
"    </span>",
"    to a reference value based on the 97.5",
"    <sup>",
"     th",
"    </sup>",
"    percentile of the BLL distribution among children one to five years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. The 2012 reference value is 5",
"    <span class=\"nowrap\">",
"     mcg/dL",
"    </span>",
"    (0.24",
"    <span class=\"nowrap\">",
"     micromol/L);",
"    </span>",
"    the reference value will be updated every four years. This change emphasizes the absence of a specific threshold for lead&rsquo;s irreversible neurodevelopmental effects.",
"   </p>",
"   <p>",
"    The revised definition is part of the CDC Advisory Committee on Childhood Lead Poisoning Prevention&rsquo;s (ACCLPP) renewed emphasis on primary prevention of lead poisoning [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/40\">",
"     40",
"    </a>",
"    ]. In addition, the ACCLPP recommends that clinicians educate families about prevention of lead exposure and provide environmental assessments to identify sources of lead exposure",
"    <strong>",
"     before",
"    </strong>",
"    testing children for lead poisoning. Blood lead screening remains necessary to identify children for whom primary prevention is unsuccessful.",
"   </p>",
"   <p>",
"    The goal of primary prevention is to minimize the neurodevelopmental effects of lead poisoning through source control and early detection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/24/394?source=see_link\">",
"     \"Childhood lead poisoning: Clinical manifestations and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/47/11001?source=see_link\">",
"     \"Childhood lead poisoning: Exposure and prevention\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As the prevalence of childhood lead poisoning declines, there has been a move from universal to targeted screening [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/41-50\">",
"     41-50",
"    </a>",
"    ]. The",
"    <span class=\"nowrap\">",
"     AAP/Bright",
"    </span>",
"    Futures guidelines and the ACCLPP suggest that screening for lead poisoning should be done in accordance with state law as applicable [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/7,35,40,47\">",
"     7,35,40,47",
"    </a>",
"    ]. Information regarding state screening plans is available through the",
"    <a class=\"external\" href=\"file://www.cdc.gov/HealthyHomes/programs.html\">",
"     Centers for Disease Control and Prevention",
"    </a>",
"    . For children who live in states that do not have a state screening program in place, we suggest universal screening during the ages of peak exposure; the",
"    <span class=\"nowrap\">",
"     AAP/Bright",
"    </span>",
"    Futures guidelines and the ACCLPP suggest universal screening for such children at ages 12 and 24 months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/7,35,40,47\">",
"     7,35,40,47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/47/11001?source=see_link\">",
"     \"Childhood lead poisoning: Exposure and prevention\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The AAFP and USPSTF found insufficient evidence to recommend for or against routine screening for elevated BLL children aged one to five years who are at increased risk of lead poisoning, and recommend against routine screening in children who are at average risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/8,48,51\">",
"     8,48,51",
"    </a>",
"    ]. The USPSTF found no direct evidence from controlled studies that screening children resulted in improved health outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/48\">",
"     48",
"    </a>",
"    ]. For children with elevated BLL, they found conflicting evidence regarding the effectiveness of early detection and intervention.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Universal screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;Universal screening for lead poisoning is suggested for communities in the United States with one or more of the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/40,46,47\">",
"     40,46,47",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Inadequate data on the prevalence of elevated BLLs",
"     </li>",
"     <li>",
"      &ge;27 percent of housing built before 1950",
"     </li>",
"     <li>",
"      &ge;12 percent of children 12 to 36 months of age with BLLs &ge;10",
"      <span class=\"nowrap\">",
"       mcg/dL",
"      </span>",
"      (0.48",
"      <span class=\"nowrap\">",
"       micromol/L)",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Given the decreasing disparity in elevated BLLs between Medicaid-eligible and non-Medicaid-eligible children, the CDC no longer recommends universal lead screening for Medicaid-eligible children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/50\">",
"     50",
"    </a>",
"    ]. They should undergo screening according to the state law as applicable.",
"   </p>",
"   <p>",
"    When universal screening is performed, screening (measurement of BLL) should be performed at 12 months and 24 months of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/40,46,47\">",
"     40,46,47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The CDC also recommends universal lead screening upon entering the United States for recent immigrant, foreign adoptee, and refugee children between the ages of 6 months and 16 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/50,52\">",
"     50,52",
"    </a>",
"    ]. For such children between six months and six years, lead screening should be repeated three to six months after placement in a permanent residence, regardless of the initial test results.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Targeted screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;Targeted screening for lead poisoning is recommended in communities with [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/46\">",
"     46",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      &lt;27 percent of the houses built before 1950",
"     </li>",
"     <li>",
"      &lt;12 percent of children 12 to 36 months of age with BLLs &ge;10",
"      <span class=\"nowrap\">",
"       mcg/dL",
"      </span>",
"      (0.48",
"      <span class=\"nowrap\">",
"       micromol/L)",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In communities that perform targeted screening, screening should be done in accordance with state law as applicable [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/40\">",
"     40",
"    </a>",
"    ]. The",
"    <span class=\"nowrap\">",
"     AAP/Bright",
"    </span>",
"    Futures recommendations for preventive health care suggest that the risk for lead poisoning be assessed at 6, 9, 12, 18, and 24 months of age, and annually thereafter through six years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/47\">",
"     47",
"    </a>",
"    ]. The BLL should be checked if any risk is detected.",
"   </p>",
"   <p>",
"    Three basic questions adapted from the CDC to assess risk of lead poisoning include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/46\">",
"     46",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Does your child live in or regularly visit a house or child care facility built before 1950?",
"     </li>",
"     <li>",
"      Does your child live in or regularly visit a house or child care facility built before 1978 that is being or recently has been renovated or remodeled (within the last six months)?",
"     </li>",
"     <li>",
"      Does your child have a sibling or playmate who has or did have lead poisoning?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Community-specific risk assessment questions also should be incorporated as indicated. The Department of Public Health in Santa Clara, CA, for example, added the following questions to the CDC's high-risk questionnaire [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/44\">",
"     44",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Does your child play in or put dirt in",
"      <span class=\"nowrap\">",
"       his/her",
"      </span>",
"      mouth?",
"     </li>",
"     <li>",
"      Has your child ever been in Mexico, Central America, or South America?",
"     </li>",
"     <li>",
"      Have you ever given your child any of these home remedies: Azarcon, Alarcon, Greta, Rueda, Pay-loo-Ah?",
"     </li>",
"     <li>",
"      Do you use pottery or ceramic vessels or plates for cooking, eating, or drinking?",
"     </li>",
"     <li>",
"      Do you live within one block of a freeway?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The additional questions increased the sensitivity from 30 to 90 percent and the negative predictive value from 93 to 98 percent for identifying children between 6 and 72 months of age with a BLL &gt;10",
"    <span class=\"nowrap\">",
"     mcg/dL",
"    </span>",
"    (0.48",
"    <span class=\"nowrap\">",
"     micromol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another risk factor that should be considered is exposure to one or more of the following: recent immigration, home renovation, folk remedies, old ceramic or pewter cookware, and some parental occupations (smelting, soldering, auto body repair) or hobbies (",
"    <a class=\"graphic graphic_table graphicRef53953 \" href=\"mobipreview.htm?9/3/9277\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/48,50\">",
"     48,50",
"    </a>",
"    ]. Patient risk factors include inadequate nutrition, frequent hand-mouth activity, and developmental disabilities. Abused or neglected children also should be considered for blood lead testing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/53\">",
"     53",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/47/11001?source=see_link\">",
"     \"Childhood lead poisoning: Exposure and prevention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/24/394?source=see_link&amp;anchor=H17#H17\">",
"     \"Childhood lead poisoning: Clinical manifestations and diagnosis\", section on 'History'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Screening for and management of lead poisoning in pregnant and lactating women is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/39/12922?source=see_link&amp;anchor=H1318049#H1318049\">",
"     \"Adult lead poisoning\", section on 'Pregnancy and breastfeeding'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The management of children with lead poisoning is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/5/21594?source=see_link\">",
"     \"Childhood lead poisoning: Management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Oral health screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;In accord with the",
"    <span class=\"nowrap\">",
"     AAP/Bright",
"    </span>",
"    Futures guidelines, we suggest oral health risk assessment, including the need for fluoride supplementation, beginning at six months of age and referral to a dental home at one year of age or as soon thereafter as possible [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/7,35\">",
"     7,35",
"    </a>",
"    ]. The",
"    <span class=\"nowrap\">",
"     AAP/Bright",
"    </span>",
"    Futures guidelines recommend oral health risk assessment at six and nine months, and referral to a dental home at one year of age, if a dental home is available [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/7,35\">",
"     7,35",
"    </a>",
"    ]. Oral health risk assessment should continue at 18, 24, and 30 months until a dental home is available. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/26/33192?source=see_link&amp;anchor=H2#H2\">",
"     \"Preventive dental care and counseling for infants and young children\", section on 'Risk assessment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Latent tuberculosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In accord with the AAP, AAFP, CDC, American Thoracic Society, and the Infectious Disease Society of America, we recommend targeted screening for latent tuberculosis infection (LTBI) with the",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/35/15924?source=see_link\">",
"     tuberculin skin test",
"    </a>",
"    (TST) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/7,8,35,54,55\">",
"     7,8,35,54,55",
"    </a>",
"    ]. The",
"    <span class=\"nowrap\">",
"     AAP/Bright",
"    </span>",
"    Futures guidelines suggest tuberculosis risk assessment by one month of age, at ages 6, 12, 18, and 24 months, and annually thereafter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/7,35\">",
"     7,35",
"    </a>",
"    ]. Screening for latent tuberculosis in children is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/53/13143?source=see_link\">",
"     \"Latent tuberculosis infection in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Urinalysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The AAP no longer recommends a screening urinalysis for children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/7,35,56,57\">",
"     7,35,56,57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Lipid profile",
"    </span>",
"    &nbsp;&mdash;&nbsp;The",
"    <span class=\"nowrap\">",
"     AAP/Bright",
"    </span>",
"    Futures guidelines recommend dyslipidemia risk assessment at 2, 4, 6, 8, and 10 years, and annually thereafter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/7,35\">",
"     7,35",
"    </a>",
"    ]. They recommend dyslipidemia screening (a fasting lipid profile) between 18 and 21 years of age. Risk factors for dyslipidemia include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Family history of dyslipidemia, premature (&lt;55 years of age) cardiovascular disease (CVD), or diabetes.",
"     </li>",
"     <li>",
"      Specific disease states associated with CVD (",
"      <a class=\"graphic graphic_algorithm graphicRef54963 \" href=\"mobipreview.htm?0/45/726\">",
"       algorithm 1",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/15/40184?source=see_link\">",
"       \"Diseases associated with atherosclerosis in childhood\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Children and adolescents for whom family history is not known or those with body mass index &ge;85th percentile for age and sex (",
"      <a class=\"calc calc_professional\" href=\"mobipreview.htm?35/14/36070?source=see_link\">",
"       calculator 1",
"      </a>",
"      ) [boys] and (",
"      <a class=\"calc calc_professional\" href=\"mobipreview.htm?34/60/35782?source=see_link\">",
"       calculator 2",
"      </a>",
"      ) [girls], hypertension (",
"      <a class=\"calc calc_professional\" href=\"mobipreview.htm?9/15/9463?source=see_link\">",
"       calculator 3",
"      </a>",
"      ) [boys] and (",
"      <a class=\"calc calc_professional\" href=\"mobipreview.htm?9/33/9751?source=see_link\">",
"       calculator 4",
"      </a>",
"      ) [girls], cigarette smoking,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      insulin resistance are considered at risk and should be screened with a fasting lipid profile [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/58\">",
"       58",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Screening for dyslipidemia is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/48/25352?source=see_link&amp;anchor=H1256953#H1256953\">",
"     \"Pediatric prevention of adult cardiovascular disease: Promoting a healthy lifestyle and identifying at-risk children\", section on 'Identifying children at risk for CVD'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/17/281?source=see_link\">",
"     \"Definition and screening for dyslipidemia in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Screening for STI",
"    </span>",
"    &nbsp;&mdash;&nbsp;The screening of sexually active adolescents for sexually transmitted infections (STI) is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/30/490?source=see_link&amp;anchor=H16#H16\">",
"     \"Screening for sexually transmitted infections\", section on 'Screening sexually active patients'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Cervical dysplasia screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;The screening of sexually active female adolescents for cervical cancer is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/16/38154?source=see_link\">",
"     \"Screening for cervical cancer: Rationale and recommendations\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Alcohol and substance use",
"    </span>",
"    &nbsp;&mdash;&nbsp;In accord with the",
"    <span class=\"nowrap\">",
"     AAP/Bright",
"    </span>",
"    Futures guidelines, we suggest screening for alcohol, tobacco, and substance use annually, beginning at age 11 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/35,59,60\">",
"     35,59,60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Data from the 2011 Youth Risk Behavior Surveillance System indicate that among high school students in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/61\">",
"     61",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Approximately 21 percent reported having their first drink of alcohol before they were 13 years old",
"     </li>",
"     <li>",
"      Approximately 10 percent reported having smoked a whole cigarette before they were 13 years old",
"     </li>",
"     <li>",
"      Approximately 8 percent reported having tried marijuana before they were 13 years old",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Early alcohol and substance use has been associated with increased risk of unintentional injuries, motor vehicle crashes, abuse and dependence during adulthood, and alcohol-related health and social problems during adulthood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/62,63\">",
"     62,63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite the lack of evidence to support the counseling of adolescents in the primary care setting against alcohol and substance use, the",
"    <span class=\"nowrap\">",
"     AAP/Bright",
"    </span>",
"    Futures guidelines suggest risk assessment for alcohol and drug use yearly beginning at age 11 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/35,60,64\">",
"     35,60,64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The",
"    <span class=\"nowrap\">",
"     AAP/Bright",
"    </span>",
"    Futures guidelines suggest asking the adolescent directly about experimentation with or use of tobacco (including smokeless tobacco), alcohol, or drugs (including inhalants and anabolic steroids) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/59\">",
"     59",
"    </a>",
"    ]. If substance use is reported, additional information is gathered regarding duration, amount, and frequency.",
"   </p>",
"   <p>",
"    The CRAFFT questionnaire is a brief screening tool for identification of problematic substance use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/65\">",
"     65",
"    </a>",
"    ]. It has been validated for use in the adolescent primary care setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/65\">",
"     65",
"    </a>",
"    ]. It includes the following questions:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <strong>",
"       C",
"      </strong>",
"      (ar) &ndash; Have you ever ridden in a car driven by someone (including yourself) who was \"high\" or had been using alcohol or drugs?",
"     </li>",
"     <li>",
"      <strong>",
"       R",
"      </strong>",
"      (elax) &ndash; Do you ever use alcohol or drugs to relax, feel better about yourself, or fit in?",
"     </li>",
"     <li>",
"      <strong>",
"       A",
"      </strong>",
"      (lone) &ndash; Do you ever use alcohol or drugs while you are by yourself, alone?",
"     </li>",
"     <li>",
"      <strong>",
"       F",
"      </strong>",
"      (orget) &ndash; Do you ever forget things you did while using alcohol or drugs?",
"     </li>",
"     <li>",
"      <strong>",
"       F",
"      </strong>",
"      (riends) &ndash; Do your family or friends ever tell you that you should cut down on your drinking or drug use?",
"     </li>",
"     <li>",
"      <strong>",
"       T",
"      </strong>",
"      (rouble) &ndash; Have you ever gotten into trouble while you were using alcohol or drugs?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    One point is scored for each \"yes\" answer. In a large, hospital-based adolescent clinic, a score of &ge;2 had a sensitivity and specificity of 76 and 94 percent, respectively, for identifying problem use (use associated with adverse consequences), abuse (continued use despite harm), or dependence (associated with tolerance, withdrawal) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/13/43225/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We suggest hearing risk assessment at all health maintenance visits and periodic hearing screening between 4 and 10 years of age (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/13/27865?source=see_link&amp;anchor=H27#H27\">",
"       \"Screening the newborn for hearing loss\", section on 'State laws'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H11\">",
"       'Infants and children'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend screening to detect amblyopia, strabismus, and defects in visual acuity for children younger than five years of age (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). Screening includes vision risk assessment at all health maintenance visits and vision screening at three, four, and five years of age. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Children &lt;5 years'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/59/24505?source=see_link\">",
"       \"Visual development and vision assessment in infants and children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For children older than five years, we suggest vision risk assessment at all health maintenance visits and periodic vision screening throughout childhood and adolescence (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Children &ge;5 years'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/59/24505?source=see_link\">",
"       \"Visual development and vision assessment in infants and children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Screening for lead poisoning should be performed in accordance with state laws as applicable. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Lead poisoning'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest oral health risk assessment beginning at six months of age and referral to a dental home at one year of age or as soon thereafter as possible (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Oral health screening'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/26/33192?source=see_link&amp;anchor=H2#H2\">",
"       \"Preventive dental care and counseling for infants and young children\", section on 'Risk assessment'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We recommend targeted screening for tuberculosis (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). Tuberculosis risk assessment should be performed at 1, 6, 12, 18, and 24 months, and annually thereafter. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Latent tuberculosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest screening for alcohol, tobacco, and substance use annually, beginning at age 11 years (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Alcohol and substance use'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Screening for other conditions is discussed separately. These include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Screening newborns for genetic and metabolic disease and hearing loss. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/2/2088?source=see_link\">",
"       \"Newborn screening\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/13/27865?source=see_link\">",
"       \"Screening the newborn for hearing loss\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Iron deficiency in infants and adolescents. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/18/22826?source=see_link&amp;anchor=H8#H8\">",
"       \"Iron deficiency in infants and young children: Screening, prevention, clinical manifestations, and diagnosis\", section on 'Screening recommendations'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?4/14/4329?source=see_link&amp;anchor=H22449339#H22449339\">",
"       \"Iron requirements and iron deficiency in adolescents\", section on 'Screening'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Developmental and behavioral problems. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/17/35097?source=see_link\">",
"       \"Surveillance and screening for autism spectrum disorders in primary care\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/49/26394?source=see_link&amp;anchor=H3#H3\">",
"       \"Developmental-behavioral surveillance and screening in primary care\", section on 'Rationale for surveillance and screening'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Dyslipidemia. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/48/25352?source=see_link&amp;anchor=H1256953#H1256953\">",
"       \"Pediatric prevention of adult cardiovascular disease: Promoting a healthy lifestyle and identifying at-risk children\", section on 'Identifying children at risk for CVD'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/17/281?source=see_link\">",
"       \"Definition and screening for dyslipidemia in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Sexually transmitted infections. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/30/490?source=see_link&amp;anchor=H16#H16\">",
"       \"Screening for sexually transmitted infections\", section on 'Screening sexually active patients'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cervical cancer. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/16/38154?source=see_link\">",
"       \"Screening for cervical cancer: Rationale and recommendations\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Minkovitz C, Wissow L. Evaluating and using laboratory tests. In: Oski's Pediatrics. Principles and Practice, 4th, McMillan JA, Feigin RD, DeAngelis C, Jones MD (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.95.",
"    </li>",
"    <li>",
"     Fletcher RW, Fletcher SW.. Prevention. In: Clinical Epidemiology The Essentials, 4th, Lippincott Williams &amp; Wilkins, Philadelphia 2005. p.147.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/3\">",
"      Ades AE. Evaluating screening tests and screening programmes. Arch Dis Child 1990; 65:792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/4\">",
"      Powell C, Porooshani H, Bohorquez MC, Richardson S. Screening for amblyopia in childhood. Cochrane Database Syst Rev 2005; :CD005020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/5\">",
"      Barratt A, Irwig L, Glasziou P, et al. Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based Medicine Working Group. JAMA 1999; 281:2029.",
"     </a>",
"    </li>",
"    <li>",
"     Bright Futures/American Academy of Pediatrics. Recommendations for preventive pediatric health care. practice.aap.org/content.aspx?aid=1599 (Accessed on August 23, 2011).",
"    </li>",
"    <li>",
"     Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents, 3rd, Hagan JF, Shaw JS, Duncan PM (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2008.",
"    </li>",
"    <li>",
"     American Academy of Family Physicians. Recommendations for Clinical Preventive Services. www.aafp.org/online/en/home/clinical/exam.html (Accessed on August 23, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/9\">",
"      Erenberg A, Lemons J, Sia C, et al. Newborn and infant hearing loss: detection and intervention.American Academy of Pediatrics. Task Force on Newborn and Infant Hearing, 1998- 1999. Pediatrics 1999; 103:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/10\">",
"      Niskar AS, Kieszak SM, Holmes A, et al. Prevalence of hearing loss among children 6 to 19 years of age: the Third National Health and Nutrition Examination Survey. JAMA 1998; 279:1071.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/11\">",
"      American Academy of Pediatrics, Joint Committee on Infant Hearing. Year 2007 position statement: Principles and guidelines for early hearing detection and intervention programs. Pediatrics 2007; 120:898.",
"     </a>",
"    </li>",
"    <li>",
"     US Preventive Services Task Force. Screening for newborn hearing. Available at: www.ahrq.gov/clinic/uspstf/uspsnbhr.htm (Accessed on March 04, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/13\">",
"      Weichbold V, Nekahm-Heis D, Welzl-Mueller K. Universal newborn hearing screening and postnatal hearing loss. Pediatrics 2006; 117:e631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/14\">",
"      Foulon I, Naessens A, Foulon W, et al. A 10-year prospective study of sensorineural hearing loss in children with congenital cytomegalovirus infection. J Pediatr 2008; 153:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/15\">",
"      Dedhia K, Kitsko D, Sabo D, Chi DH. Children with sensorineural hearing loss after passing the newborn hearing screen. JAMA Otolaryngol Head Neck Surg 2013; 139:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/16\">",
"      O'Mara LM, Isaacs S, Chambers LW. Follow-up of participants in a preschool hearing screening program in child care centres. Can J Public Health 1992; 83:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/17\">",
"      Bristow K, Fortnum H, Fonseca S, Bamford J. United Kingdom school-entry hearing screening: current practice. Arch Dis Child 2008; 93:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/18\">",
"      Harlor AD Jr, Bower C, Committee on Practice and Ambulatory Medicine, Section on Otolaryngology-Head and Neck Surgery. Hearing assessment in infants and children: recommendations beyond neonatal screening. Pediatrics 2009; 124:1252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/19\">",
"      Duncan PM, Duncan ED, Swanson J. Bright Futures: the screening table recommendations. Pediatr Ann 2008; 37:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/20\">",
"      Cristobal R, Oghalai JS. Hearing loss in children with very low birth weight: current review of epidemiology and pathophysiology. Arch Dis Child Fetal Neonatal Ed 2008; 93:F462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/21\">",
"      Vogel I, Brug J, Hosli EJ, et al. MP3 players and hearing loss: adolescents' perceptions of loud music and hearing conservation. J Pediatr 2008; 152:400.",
"     </a>",
"    </li>",
"    <li>",
"     Ten ways to recognize hearing loss. National Institute on Deafness and Other Communication Disorders. NIH Publication No 01-4913. National Instututes of Health, Bethesda, MD 2006. Available at: www.nidcd.nih.gov/health/hearing/10ways.asp (Accessed on April 07, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/23\">",
"      Richardson MP, Williamson TJ, Lenton SW, et al. Otoacoustic emissions as a screening test for hearing impairment in children. Arch Dis Child 1995; 72:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/24\">",
"      Pearlman RC, Skinner HG, Pierce JD, Goins MA 3rd. Reliability of a sound-generating otoscope. Arch Otolaryngol 1985; 111:792.",
"     </a>",
"    </li>",
"    <li>",
"     National Center for Health Statistics. Refraction status and motility defects of persons 4-74 years. U.S. 1971-72: Vital health statistics, Series 11, 1978.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/26\">",
"      Thompson JR, Woodruff G, Hiscox FA, et al. The incidence and prevalence of amblyopia detected in childhood. Public Health 1991; 105:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/27\">",
"      US Preventive Services Task Force. Vision screening for children 1 to 5 years of age: US Preventive Services Task Force Recommendation statement. Pediatrics 2011; 127:340.",
"     </a>",
"    </li>",
"    <li>",
"     Rationale and Evidence. In: Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents, 3rd ed, Hagan JF, Shaw JS, Duncan PM (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2008. p.221.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/29\">",
"      Committee on Practice and Ambulatory Medicine, Section on Ophthalmology. American Association of Certified Orthoptists, American Association for Pediatric Ophthalmology and Strabismus, American Academy of Ophthalmology. Eye examination in infants, children, and young adults by pediatricians. Pediatrics 2003; 111:902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/30\">",
"      Hartmann EE, Dobson V, Hainline L, et al. Preschool vision screening: summary of a Task Force report. Behalf of the Maternal and Child Health Bureau and the National Eye Institute Task Force on Vision Screening in the Preschool Child. Pediatrics 2000; 106:1105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/31\">",
"      Kemper AR, Margolis PA, Downs SM, Bordley WC. A systematic review of vision screening tests for the detection of amblyopia. Pediatrics 1999; 104:1220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/32\">",
"      Powell C, Wedner S, Richardson S. Screening for correctable visual acuity deficits in school-age children and adolescents. Cochrane Database Syst Rev 2005; :CD005023.",
"     </a>",
"    </li>",
"    <li>",
"     US Preventive Services Task Force: Guide to Clinical Preventive Services, 2nd ed, Williams &amp; Wilkins, Baltimore 1996.",
"    </li>",
"    <li>",
"     Blustein JN, Fryback D. Visual impairment. In: US Preventive Services Task Force. Guide to Clinical Preventive Services, 2nd ed, Williams &amp; Wilkins, Baltimore 1996. p.373.",
"    </li>",
"    <li>",
"     Recommendations for preventive pediatric health care. Pediatrics 2007; 120:1376. practice.aap.org/content.aspx?aid=1599 (Accessed on November 10, 2011).",
"    </li>",
"    <li>",
"     Rationale and Evidence. In: Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents, 3rd ed, Hagan JF, Shaw JS, Duncan PM (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2008. p.221.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/37\">",
"      Baker RD, Greer FR, Committee on Nutrition American Academy of Pediatrics. Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age). Pediatrics 2010; 126:1040.",
"     </a>",
"    </li>",
"    <li>",
"     US Preventive Services Task Force. Screening and Supplementation for Iron Deficiency Anemia. Available at: www.ahrq.gov/clinic/uspstf/uspsiron.htm (Accessed on March 04, 2008).",
"    </li>",
"    <li>",
"     CDC response to Advisory Committee on Childhood Lead Poisoning Prevention Recommendations in \"Low Level Lead Exposure Harms Children:  A Renewed Call of Primary Prevention\" file://www.cdc.gov/nceh/lead/ACCLPP/activities.htm (Accessed on May 17, 2012).",
"    </li>",
"    <li>",
"     Low level lead exposure harms children: A renewed call for primary prevention. Report of the Advisory Committee on Childhood Lead Poisoning Prevention. www.cdc.gov/nceh/lead/ACCLPP/Final_Document_030712.pdf (Accessed on June 06, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/41\">",
"      Robin LF, Beller M, Middaugh JP. Statewide assessment of lead poisoning and exposure risk among children receiving Medicaid services in Alaska. Pediatrics 1997; 99:E9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/42\">",
"      Tejeda DM, Wyatt DD, Rostek BR, Solomon WB. Do questions about lead exposure predict elevated lead levels? Pediatrics 1994; 93:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/43\">",
"      Binns HJ, LeBailly SA, Poncher J, et al. Is there lead in the suburbs? Risk assessment in Chicago suburban pediatric practices. Pediatric Practice Research Group. Pediatrics 1994; 93:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/44\">",
"      Snyder DC, Mohle-Boetani JC, Palla B, Fenstersheib M. Development of a population-specific risk assessment to predict elevated blood lead levels in Santa Clara County, California. Pediatrics 1995; 96:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/45\">",
"      France EK, Gitterman BA, Melinkovich P, Wright RA. The accuracy of a lead questionnaire in predicting elevated pediatric blood lead levels. Arch Pediatr Adolesc Med 1996; 150:958.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. Screening young children for lead poisoning. Guidance for state and local public health officials. U.S. Dept of Health and Human Services, Public Health Service, Atlanta, GA, 1997.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/47\">",
"      American Academy of Pediatrics Committee on Environmental Health. Lead exposure in children: prevention, detection, and management. Pediatrics 2005; 116:1036.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/48\">",
"      Rischitelli G, Nygren P, Bougatsos C, et al. Screening for elevated lead levels in childhood and pregnancy: an updated summary of evidence for the US Preventive Services Task Force. Pediatrics 2006; 118:e1867.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. Preventing Lead Poisoning in Young Children. CDC Atlanta, GA, 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/50\">",
"      Wengrovitz AM, Brown MJ, Advisory Committee on Childhood Lead Poisoning, Division of Environmental and Emergency Health Services, National Center for Environmental Health, Centers for Disease Control and Prevention. Recommendations for blood lead screening of Medicaid-eligible children aged 1-5 years: an updated approach to targeting a group at high risk. MMWR Recomm Rep 2009; 58:1.",
"     </a>",
"    </li>",
"    <li>",
"     US Preventive Services Task Force. Screening for lead levels in childhood and pregnancy. Available at: www.ahrq.gov/clinic/uspstf/uspslead.htm (Accessed on March 04, 2008).",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. Lead Poisoning Prevention in Newly Arrived Regugee Children. Available at: www.cdc.gov/nceh/lead/Publications/RefugeeToolKit/Refugee_Tool_Kit.htm (Accessed on March 31, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/53\">",
"      Screening for elevated blood lead levels. American Academy of Pediatrics Committee on Environmental Health. Pediatrics 1998; 101:1072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/54\">",
"      Taylor Z, Nolan CM, Blumberg HM, et al. Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Recomm Rep 2005; 54:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/55\">",
"      Lobato MN, Jereb JA, Starke JR. Unintended consequences: mandatory tuberculin skin testing and severe isoniazid hepatotoxicity. Pediatrics 2008; 121:e1732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/56\">",
"      Kaplan RE, Springate JE, Feld LG. Screening dipstick urinalysis: a time to change. Pediatrics 1997; 100:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/57\">",
"      Sekhar DL, Wang L, Hollenbeak CS, et al. A cost-effectiveness analysis of screening urine dipsticks in well-child care. Pediatrics 2010; 125:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/58\">",
"      Daniels SR, Greer FR, Committee on Nutrition. Lipid screening and cardiovascular health in childhood. Pediatrics 2008; 122:198.",
"     </a>",
"    </li>",
"    <li>",
"     Adolescence. In: Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents, 3rd ed, Hagan JF, Shaw JS, Duncan PM (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2008. p.515.",
"    </li>",
"    <li>",
"     Promoting Mental Health. In: Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents, 3rd ed, Hagan JF, Shaw JS, Duncan PM (Eds), American Academy of Pediatrics, Elk Grove Village, 2008. p.77.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/61\">",
"      Eaton DK, Kann L, Kinchen S, et al. Youth risk behavior surveillance - United States, 2011. MMWR Surveill Summ 2012; 61:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/62\">",
"      Weinberg NZ, Rahdert E, Colliver JD, Glantz MD. Adolescent substance abuse: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 1998; 37:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/63\">",
"      Hingson R, Heeren T, Zakocs R. Age of drinking onset and involvement in physical fights after drinking. Pediatrics 2001; 108:872.",
"     </a>",
"    </li>",
"    <li>",
"     US Preventive Services Task Force. Screening for alcohol misuse. Available at: www.ahrq.gov/clinic/uspstf/uspsdrin.htm (Accessed on June 17, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/13/43225/abstract/65\">",
"      Knight JR, Sherritt L, Shrier LA, et al. Validity of the CRAFFT substance abuse screening test among adolescent clinic patients. Arch Pediatr Adolesc Med 2002; 156:607.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2872 Version 17.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-213.131.41.98-853D91569B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_13_43225=[""].join("\n");
var outline_f42_13_43225=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H27\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      General principles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Test characteristics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Types of screening",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Screening guidelines",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      COMMON SCREENING TESTS IN PEDIATRICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Newborn screen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Hearing screen",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Newborns",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Infants and children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Vision screen",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Children &lt;5 years",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Children &ge;5 years",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Development and behavior screens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Iron deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Lead poisoning",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Universal screening",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Targeted screening",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Oral health screening",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Latent tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Urinalysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Lipid profile",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Screening for STI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Cervical dysplasia screening",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Alcohol and substance use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/2872\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/2872|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?0/45/726\" title=\"algorithm 1\">",
"      NHLBI pediatric risk stratification associated with CVD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/2872|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?23/36/24142\" title=\"figure 1\">",
"      Prevalence on PPV and NPV",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/2872|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?7/50/7979\" title=\"table 1\">",
"      Sensitivity specificity PPV NPV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?12/21/12638\" title=\"table 2\">",
"      Syndromes with hearing loss",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?14/43/15037\" title=\"table 3\">",
"      Vision screen infants children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?9/3/9277\" title=\"table 4\">",
"      Sources of lead exposure",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"mobipreview.htm?35/14/36070?source=related_link\" title=\"calculator 1\">",
"      Calculator: Body Mass Index (BMI) percentiles for boys (2 to 20 years)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"mobipreview.htm?34/60/35782?source=related_link\" title=\"calculator 2\">",
"      Calculator: Body Mass Index (BMI) percentiles for girls (2 to 20 years)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"mobipreview.htm?9/15/9463?source=related_link\" title=\"calculator 3\">",
"      Calculator: Blood pressure percentiles for boys (2 to 17 years)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"mobipreview.htm?9/33/9751?source=related_link\" title=\"calculator 4\">",
"      Calculator: Blood pressure percentiles for girls (2 to 17 years)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/39/12922?source=related_link\">",
"      Adult lead poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/24/394?source=related_link\">",
"      Childhood lead poisoning: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/47/11001?source=related_link\">",
"      Childhood lead poisoning: Exposure and prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/5/21594?source=related_link\">",
"      Childhood lead poisoning: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/39/2682?source=related_link\">",
"      Clinical features and detection of congenital hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/17/281?source=related_link\">",
"      Definition and screening for dyslipidemia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/49/26394?source=related_link\">",
"      Developmental-behavioral surveillance and screening in primary care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/15/40184?source=related_link\">",
"      Diseases associated with atherosclerosis in childhood",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/38/19050?source=related_link\">",
"      Etiology of hearing impairment in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/19/44344?source=related_link\">",
"      Evaluation of hearing impairment in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/18/22823?source=related_link\">",
"      Glossary of common biostatistical and epidemiological terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/18/22826?source=related_link\">",
"      Iron deficiency in infants and young children: Screening, prevention, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/14/4329?source=related_link\">",
"      Iron requirements and iron deficiency in adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/53/13143?source=related_link\">",
"      Latent tuberculosis infection in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/2/2088?source=related_link\">",
"      Newborn screening",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/61/8153?source=related_link\">",
"      Overview of amblyopia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/58/35753?source=related_link\">",
"      Overview of phenylketonuria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/48/25352?source=related_link\">",
"      Pediatric prevention of adult cardiovascular disease: Promoting a healthy lifestyle and identifying at-risk children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/26/33192?source=related_link\">",
"      Preventive dental care and counseling for infants and young children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/16/38154?source=related_link\">",
"      Screening for cervical cancer: Rationale and recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/30/490?source=related_link\">",
"      Screening for sexually transmitted infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/13/27865?source=related_link\">",
"      Screening the newborn for hearing loss",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/17/35097?source=related_link\">",
"      Surveillance and screening for autism spectrum disorders in primary care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/59/24505?source=related_link\">",
"      Visual development and vision assessment in infants and children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_13_43226="Advanced case 8";
var content_f42_13_43226=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F54392&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F54392&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1274px;\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Advanced case 8",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 332px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 594px\">",
"   <div class=\"ttl\">",
"    Normal ECG",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 594px; height: 337px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal electrocardiogram showing normal sinus rhythm at a rate of 75 beats/min, a PR interval of 0.14 sec, a QRS interval of 0.10 sec, and a QRS axis of approximately 75&deg;.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_13_43226=[""].join("\n");
var outline_f42_13_43226=null;
var title_f42_13_43227="Indications pacing modes II";
var content_f42_13_43227=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F55317&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F55317&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Indications for different pacing modes - II",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Mode",
"       </td>",
"       <td class=\"subtitle1\">",
"        Generally agreed upon indications",
"       </td>",
"       <td class=\"subtitle1\">",
"        Controversial indications",
"       </td>",
"       <td class=\"subtitle1\">",
"        Contraindicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        DVI*",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        VDD&bull;",
"       </td>",
"       <td>",
"        <p>",
"         Congenital AV block",
"        </p>",
"        <p>",
"         AV block when sinus node function can be proven normal",
"        </p>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        <p>",
"         Sinus node dysfunction",
"        </p>",
"        <p>",
"         AV block when accompanied by sinus",
"        </p>",
"        <p>",
"         node dysfunction",
"        </p>",
"        <p>",
"         When adequate atrial sensing cannot be attained",
"        </p>",
"        <p>",
"         AV block when accompanied by paroxysmal supraventricular tachycardias",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        VDDR&Delta;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * DVI as a stand-alone pacing mode, ie a pacemaker capable of DVI as the only dual-chamber mode of operation, is obselete. All primary uses of this mode should be considered individually.",
"     <br>",
"      &bull; VDD as a stand-alone pacing mode, ie a pacemaker capable of VDD as the only dual-chamber mode of operation, is currently used primarily as a single-lead VDD system. If a dual lead system is implanted, then the capability of DDD pacing is desirable.",
"      <br>",
"       &Delta; In current single-lead VDDR pacemakers, p-wave tracking occurs as long as the sinus rate is appropriate. However, in the presence of sinus bradycardia or chronotropic incompetence, the pacemaker operates in the VVIR mode.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_13_43227=[""].join("\n");
var outline_f42_13_43227=null;
var title_f42_13_43228="Service resources for children with developmental-behavioral con";
var content_f42_13_43228=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F70428&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F70428&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Service resources for children with confirmed or suspected developmental and behavioral disabilities",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Resource",
"       </td>",
"       <td class=\"subtitle1\">",
"        Service or information",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        After school/tutoring programs",
"       </td>",
"       <td>",
"        <p>",
"         Boys and Girls Club",
"        </p>",
"        <p>",
"         www.bgca.org",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The child's public school",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         YWCA",
"        </p>",
"        <p>",
"         www.ywca.org",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Autism spectrum disorder services and information",
"       </td>",
"       <td>",
"        <p>",
"         First Signs",
"        </p>",
"        <p>",
"         www.firstsigns.org",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Developmental-behavioral, neurodevelopmental, general and other subspecialty pediatricians",
"       </td>",
"       <td>",
"        <p>",
"         American Academy of Pediatrics: Find a Pediatrician",
"        </p>",
"        <p>",
"         www.aap.org/referral/",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Early intervention programs (state, regional or local IDEA programs)",
"       </td>",
"       <td>",
"        <p>",
"         National Early Childhood Technical Assistance Center",
"        </p>",
"        <p>",
"         www.nectac.org",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Head Start programs",
"       </td>",
"       <td>",
"        <p>",
"         Early Head Start National Resource Center",
"        </p>",
"        <p>",
"         www.ehsnrc.org",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Mental health services",
"       </td>",
"       <td>",
"        <p>",
"         Substance Abuse and Mental Health Services Administration",
"        </p>",
"        <p>",
"         www.mentalhealth.org",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Parent training programs",
"       </td>",
"       <td>",
"        <p>",
"         Parents as Teachers",
"        </p>",
"        <p>",
"         www.patnc.org",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         YWCA",
"        </p>",
"        <p>",
"         www.ywca.org",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Quality preschool and day care programs",
"       </td>",
"       <td>",
"        <p>",
"         Child Care Aware",
"        </p>",
"        <p>",
"         www.childcareaware.org",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         National Association for the Education of Young Children",
"        </p>",
"        <p>",
"         www.naeyc.org",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Services for school age children",
"       </td>",
"       <td>",
"        Call the school psychologist or the speech-language pathologist in the child's public school district",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Social services (including domestic violence, child abuse and neglect, adoption, state, and local services, etc)",
"       </td>",
"       <td>",
"        <p>",
"         US Department of Health and Human Services Administration for Children and Families",
"        </p>",
"        <p>",
"         www.acf.hhs.gov",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Testing services for young children with suspected or known disabilities",
"       </td>",
"       <td>",
"        <p>",
"         National Early Childhood Technical Assistance Center",
"        </p>",
"        <p>",
"         www.nectac.org",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     IDEA: Individuals with Disabilities Education Act.",
"    </div>",
"    <div class=\"reference\">",
"     Frances Page Glascoe, 2011, Nolensville, TN: PEDSTest.com, LLC, www.pedstest.com. Adapted with permission.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_13_43228=[""].join("\n");
var outline_f42_13_43228=null;
var title_f42_13_43229="ELF activity with monthly AAT";
var content_f42_13_43229=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F79807&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F79807&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Maintenance of adequate ELF antitrypsin activity with monthly infusions",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 390px; height: 241px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Effect of monthly infusions of 250 mg/kg of alpha-1 antitrypsin (AAT) on epithelial lining fluid (ELF) levels of AAT in three patients. The AAT levels are based upon a true laboratory standard. The dashed line represents the theoretical protective threshold. AAT levels were maintained above this threshold with monthly infusions.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from Hubbard, RC, Sellers, S, Czerski, D, et al, JAMA 1988; 260:1259.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_13_43229=[""].join("\n");
var outline_f42_13_43229=null;
var title_f42_13_43230="Anterior chest pain bone scan";
var content_f42_13_43230=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F54771&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F54771&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Manubriosternal, sternoclavicular, and xyphisternal involvement",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 246px; height: 351px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An abnormal technetium labled pyrophosphate bone scan showing increased uptake at the xiphisternal, manubriosternal, and sternoclavicular articulations.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Christopher Wise, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_13_43230=[""].join("\n");
var outline_f42_13_43230=null;
var title_f42_13_43231="Tryptase levels examples";
var content_f42_13_43231=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F58418&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F58418&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 584px\">",
"   <div class=\"ttl\">",
"    Examples of patterns of tryptase elevations and interpretations",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 564px; height: 508px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Measurements of total and mature tryptase (top table) or total alone (bottom table) can provide support to the clinical diagnosis of anaphylaxis. Tryptase values alone are not sufficient to make the diagnosis, however. If only measurements of total tryptase are available, a follow-up sample should be drawn after full resolution of symptoms, in order to accurately interpret the findings. High baseline tryptase levels increase the risk for more severe anaphylaxis and may be associated with clonal mast cell disorders when higher than 11.4 ng/mL.",
"    <div class=\"footnotes\">",
"     ND: not determined due to a denominator of &lt;1. c/w: consistent with",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_13_43231=[""].join("\n");
var outline_f42_13_43231=null;
